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Abstract 
 
Neurodegenerative diseases have become a challenge to modern societies 
in industrialized countries due to the high social and economic impacts 
and therefore demand intensive research. These diseases present diverse 
common features, in which oxidative stress plays a very important role. As 
result of oxidative stress, some molecular mechanisms become 
dysfunctional and ultimately lead to cell death. Amongst the compounds 
displaying neuroprotective activity, phenolics have been identified 
amongst the most active substances from natural sources. 
The purpose of the work presented in this thesis was to address the 
neuroprotective capacity of phenolic compounds from juniper leaves 
(Juniperus sp.) and blackberry fruits (Rubus sp.) from Portuguese native 
plants that  display high phenolic content. Two different approaches in 
the prevention of neurodegenerative diseases could be foreseen: 
nutritional and pharmacological approaches. 
Concerning the pharmacological approach, leaves from four junipers were 
evaluated and all displayed characteristics for promising neuroprotective 
products. Among these species, Juniperus oxycedrus badia was 
distinguished by the capacity of its phenolic compounds to protect 
neuronal viability and functionality. Junipers are evergreen plants with 
leaves available all the year, although their phenolic composition could be 
affected by environmental factors. Therefore, it is important to 
understand the seasonal dynamics of their phytochemical content and 
variation due to stress. In periods when active growth is retarded, 
particularly in winter, junipers had higher phenolic content. Juniper 
species displayed different susceptibilities to stresses, and salt stress 
enhanced the phenolic content of J. oxycedrus badia. The increase in total 
content was due to a general rise in all classes of compounds with a few 
alterations in the relative content of specific compounds. This increase 
was concomitant with the enhancement of transcripts encoding 
phenylalanine ammonia lyase, a key enzyme of the pathway responsible 
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by the production of polyphenols. Therefore, junipers phytochemicals 
yield can be modulated/maximized.  
Related to the nutritional perspective, the impact of gastrointestinal 
digestion on blackberry polyphenols was accessed to ensure that the 
physiological conditions affecting foods were taken into account. This 
approach was then used to evaluate the neuroprotective potential of 
polyphenols from Portuguese wild blackberries compared to commercial 
blackberries. Although they presented few quantitative chemical 
differences, differential cytoprotective activities were discovered. Wild 
blackberry species were revealed as more effective in neuroprotection 
possibly through the mediation of molecular adaptive responses. 
Therefore, a transcriptomic approach was used to compare the differential 
molecular mechanisms mediating neuroprotection between commercial 
species and R. vagabundus. Blackberry metabolites were able to 
differentially prevent transcript alterations induced by oxidative stress, 
with wild blackberry more effective in reducing the number of genes 
altered. The main pathways differentially affected between stressed and 
blackberry pre-treated cells were related to transport, cell cycle and DNA 
repair. A common regulation by small GTP-binding proteins and/or 
associated pathways could be foreseen, although confirmatory 
biochemical assays are required. In conclusion, metabolites from  
J. oxycedrus badia and R. vagabundus show neuroprotection potential 
that could be explored in future studies. 
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Resumo 
 
As doenças neurodegenerativas têm-se tornado um desafio das 
sociedades modernas nos países industrializados, devido ao elevado 
impacto económico e social, requerendo por isso de uma investigação 
intensiva. Estas doenças apresentam diversas características em comum 
das quais se destaca o stress oxidativo. Como resultado deste, alguns 
mecanismos moleculares tornam-se disfuncionais podendo conduzir à 
morte celular. Entre os compostos apresentando atividade neuroprotetora, 
os compostos fenólicos têm sido identificados como entre as substâncias 
mais ativas obtidas da Natureza. 
O objetivo do trabalho apresentado na presente tese foi de determinar a 
capacidade neuroprotetora de compostos fenólicos de folhas de zimbro 
(Juniperus sp.) e amoras de silva (Rubus sp.), obtidos de plantas nativas 
portuguesas com um elevado conteúdo em compostos fenólicos. Duas 
abordagens diferentes podem ser antecipadas na prevenção das doenças 
neurodegenerativas: farmacológica e nutricional. 
Relativamente à abordagem farmacológica, folhas de quatro espécies de 
zimbro foram avaliadas e todas demonstraram características importantes 
para a obtenção de produtos neuroprotetores promissores. J. oxycedrus 
badia foi distinguido pela capacidade dos seus compostos fenólicos 
protegerem a viabilidade e funcionalidade neuronal. Sendo os zimbros 
plantas perenes, cuja composição fenólica das folhas pode ser afetada 
pelos fatores ambientais, revelou-se importante perceber a dinâmica 
sazonal dos fitoquímicos bem como as suas variações devido a stresses. 
Em períodos em que o crescimento ativo é retardado, particularmente no 
Inverno, os zimbros apresentaram um elevado conteúdo em compostos 
fenólicos. As diferentes espécies de zimbro apresentaram diferentes 
suscetibilidades aos stresses, tendo o stresse salino aumentado o 
conteúdo em polifenóis de J. oxycedrus badia. O aumento do conteúdo 
total deveu-se ao aumento geral de compostos das várias classes, 
apresentando poucas alterações no conteúdo relativo de compostos em 
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particular. Este aumento foi concomitante com o aumento de transcritos 
que codificam fenilalanina amónia liase, um enzima chave da via 
responsável pela produção de polifenóis. Verificou-se portanto que a 
produção de fitoquímicos nos zimbros pode ser modulada/maximizada. 
Quanto à perspetiva nutricional, de forma a garantir que as condições 
fisiológicas que afetam os alimentos eram comtempladas, foi 
determinado o impacto da digestão gastrointestinal sobre os polifenóis de 
amoras. Esta abordagem foi posteriormente usada na avaliação do 
potencial neuroprotetor dos polifenóis de amoras silvestres portuguesas 
comparativamente com amoras comerciais. Apesar da composição 
química das amoras apresentar poucas diferenças quantitativas entre 
espécies, as atividades citoprotetoras foram diferenciadas. As espécies de 
amora silvestres mostraram-se mais efetivas na neuroprotecção, 
possivelmente devido à mediação de respostas adaptativas moleculares. 
Consequentemente, foi usada uma abordagem transcritómica para 
comparar os mecanismos moleculares que intervêm na neuroprotecção e 
que são diferentes entre as amoras comerciais e selvagens, 
particularmente R. vagabundus. Os metabolitos de ambas as amoras 
conseguiram prevenir as alterações nos transcritos induzidas pelo stresse 
oxidativo, apresentando-se a amora silvestre mais efetiva na redução do 
número de genes alterados. As principais vias diferencialmente alteradas 
entre células stressadas e pré-tratadas com amoras encontram-se 
relacionadas com funções de transporte, ciclo celular e reparação de DNA. 
Uma regulação comum pelas pequenas proteínas de ligação ao GTP e/ou 
vias associadas pode ser antecipada, apesar de ser necessário a realização 
de ensaios bioquímicos confirmatórios. Em conclusão, os metabolitos de  
J. oxycedrus badia e R. vagabundus mostram um potencial neuroprotetor 
que poderá ser explorado em estudos futuros. 
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Thesis outline 
 
This thesis is organized in seven chapters. 
The first chapter (General introduction) brings in the main topics related 
to the work developed and necessary to its comprehension, namely 
neurodegenerative diseases, polyphenols and the possible role of 
polyphenols activities in protecting human body against 
neurodegeneration. 
Presentation of experimental work is divided in two parts:  Juniperus sp. 
(A) and Rubus sp. (B), where is presented work developed applied to 
species of these two genus. 
In the second and third chapters are presented the results concerning the 
first type of strategy, the role of phenolic extracts from Juniperus sp. 
leaves as natural products. The second chapter rely on the potential 
neuroprotective activity of the extracts and the third chapter on 
understanding polyphenols dynamics in plants due to seasonality and 
stress induction. 
The fourth, fifth and sixth chapters rely on a nutritional approach, where 
the neuroprotective potential of blackberries  polyphenols are determined. 
In the fourth chapter it is highlighted  the importance of using a more 
physiological model to unravel the real potential of polyphenols that are 
submitted to gastrointestinal digestion, by using a commercial variety of 
blackberry. In the fifth chapter it is evaluated the neuroprotective 
potential of two Portuguese wild blackberries. In the sixth chapter the 
potential molecular mechanisms underlying the protective effect 
previously verified by blackberries are studied using transcriptomics 
approach. 
In the seventh chapter (General discussion) it is presented a general 
discussion of findings obtained and the main conclusions as well as future 
perspectives of the work. 
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1. Neurodegeneratives diseases (NDDs) 
NDDs are a heterogeneous debilitating and until now an incurable group 
of degenerative disorders. They are  characterized by a slow and 
progressive loss of neuronal cells, leading to gradual and progressive 
impairments of selective functions of central nervous system (CNS), 
depending upon the involved type of neuronal cells 
1
. The increase in life 
expectancy observed over the last century has led to the emergence of 
these age-related disorders that pose novel challenges to modern 
societies in industrialized countries and demand intensive research 
2
. 
1.1. Social and Economic impact 
These diseases cause devastating effects on the patient and are currently 
only treated palliatively. Despite the profound impact on patients and on 
their families, the combination of expensive formal care services, 
increasing number of affected people and major reliance on informal care, 
remains a great challenge for society. It was estimated in 2004 by WHO 
that NDDs (Alzheimer’s disease (AD), other dementias and Parkinson’s 
disease (PD)) reached 29.4 million people all around the world 
3
. 
Focusing just on dementia, a more recent survey estimated that there 
were about 10.11 million people affected in Europe 
4
. The total costs of 
illness for these disorders in the whole Europe were €177 billion, being 
the cost per demented person about €22,000 per year 
4
.  
1.2. The main NDDs 
Alzheimer’s disease 
AD is the most common NDD, where patients experience progressive 
cognitive deterioration, behavioral changes, and neuropsychiatric  
changes 
5
. AD is characterized by the loss of neurons, synapses, and 
neurotransmitters throughout the brain, especially in the hippocampus 
and cerebral cortex 
6
. The pathological hallmarks of AD are neuronal loss, 
extracellular senile plaques containing the peptide -amyloid (A) and 
neurofibrillary tangles, composed of a hyperphosphorylated form of the 
microtubular protein tau 
7
.  
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Parkinson’s disease 
PD is a slowly progressive NDD, the second most common, characterized 
by loss of catecholaminergic neurons from the substantia nigra (SN) that 
eventually leads to bradykinesia, muscle rigidity, resting tremor, and 
postural instability 
8
. The motor symptoms of PD are directly related to the 
loss of pigmented cells in the SN and to the reduction of the 
neurotransmitter dopamine in the striatum. The characteristic hallmark is 
also the presence of the Lewy body, aggregates of  proteins containing 
ubiquitin and alpha-synuclein, within the cytoplasm of dying nerve cells. 
Huntington’s disease (HD) 
HD is characterized by personality changes as well as motor and cognitive 
symptoms, including the hallmark feature, chorea, psychiatric 
disturbances and dementia 
9
. Pathologically it is characterized by loss of 
long projection neurons in the cortex and striatum  and premature  
death 
10,11
. HD is an autosomal dominant disease that causes degeneration 
of medium spiny GABAergic neurons in the striatum. This 
neurodegeneration causes a progressive atrophy of the caudate nucleus, 
putamen, and globus pallidus 
5
. HD is a genetic disease caused by a CAG 
repeat expansion of exon 1 in the gene that encodes huntingtin protein.  
Amyotrophic lateral sclerosis (ALS) 
ALS is a devastating disease resulting in progressive skeletal muscle 
weakness, muscle atrophy, paralysis, and ultimately death within 2–5 
years of onset. ALS results from a progressive degeneration of motor 
neurons within the ventral horn of the spinal cord, brainstem, and motor 
cortex. Degeneration also occurs within the corticospinal tract. 
Approximately 20 % of patients have a mutation in the superoxide 
dismutase 1 (SOD1) gene, however, the majority of patients have normal 
SOD1 activity 
12
. 
1.3. Common features of NDDs 
The various NDDs have different symptoms, affect different parts of the 
brain and have different physiological causes 
13
. NDDs constitute a 
heterogeneous group of pathologies with a complex multifactorial 
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pathogenesis.  Cellular features that have been thought to contribute to 
neuronal loss include oxidative stress, abnormal protein dynamics, 
molecular chaperones, fragmentation of neuronal Golgi apparatus (GA), 
disruption of cellular/axonal transport, ion channel changes, 
neuroinflammatory process, dysfunction of neurotrophins, choline deficit 
and neuronal death (Fig.  1) 
14
.  
 
1.3.1. Oxidative stress 
Oxidative stress has been implicated in the pathogenesis of several 
disease processes, including, ischemia/reperfusion injury, AD, PD, among 
others 
15
. It is basically a pathologic metabolic condition arising upon 
imbalance between the production of potentially toxic reactive oxygen 
species (ROS; e.g. hydrogen peroxide, superoxide and hydroxyl radical) 
and the antioxidants, in favor of the former 
16
. ROS include oxygen free 
radicals and non-radical derivatives of O
2
 that participate in free radical 
production.  
ROS have been shown to play both beneficial and deleterious roles. At 
very low concentration, in non-pathological conditions, it may act as a 
 
Fig.  1- Cellular features that contribute to neuronal loss.  
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second messenger in some signal transduction pathways 
17
. However, 
overproduction of ROS can damage cells through free radicals generation 
that leads to a progressive decline in physiological function 
18
. ROS can 
attack proteins 
19
, oxidize lipids and damage DNA 
20
. 
Protein oxidation 
ROS may damage the proteins via nitration or oxidation 
21,22
. Protein 
oxidation contributes to the inhibition or impairment of multiple enzymes, 
thus affecting multiple cellular functions, ranging from protein synthesis, 
energy production, and cytoskeleton dynamics to signal transduction 
23
. 
Additionally, protein oxidative modification could contribute to the 
formation of intracellular protein aggregates, which may have additional 
effects on intracellular homeostasis 
24
. Once protein aggregation begins, 
other proteins may be sequestered into the protein aggregates, resulting 
in their loss of cellular function 
22,25
.  
Lipid peroxidation 
All cellular membranes are especially vulnerable to oxidation due to their 
high concentrations of unsaturated fatty acid 
21
. Thus lipid peroxidation 
(LPO) is the consequence of ROS attack. Their role is well established in 
the pathogenesis of a wide range of NDDs 
26
. LPO causes changes in 
fluidity and permeability of the cell membranes leading to the production 
of conjugated dienic hydroperoxides 
27,28
. These unstable substances 
decompose either into various aldehydes, such as malondialdehyde and  
4-hydroxynonenal (HNE) 
28
. HNE in primary neurons and tissues leads to 
the activation of cell repair or cell death programs, being its adducts used 
as biomarkers of oxidative damage within cells 
29
. HNE accumulation has 
been observed in NDDs, including AD, PD, and ALS 
30
. 
DNA oxidation 
Although DNA is a stable and well-protected molecule, ROS can promote 
extensive damages. The damage of nuclear DNA can be caused by two 
different mechanisms: oxidative modification and endonuclease-mediated 
DNA fragmentation 
31
. Several types of DNA damages could be caused by 
ROS: modification of DNA bases, single- and double-DNA breaks, loss of 
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purines, damage to the deoxyribose sugar, DNA–protein cross-linkage and 
damage of the DNA repair system 
21
. All these chemical damages impair 
function and leads to cellular debilitation and possibly premature death 
32
. 
The 8-hydroxydeoxyguanosine (8-OHdG), an oxidized form of guanine, is 
a major oxidative DNA-damage product that can produce mutations.  
 
The consequences of oxidative stress increase may result in imbalance 
calcium homeostasis, alterations in cellular  signaling cascades and 
changes in gene expression 
33,34
. These effects are detected as more 
elevated in the aging population 
35,36
, AD 
37-39
 and PD 
40,41
. 
Cells are also equipped to counteract these oxidative attacks with 
numerous cellular antioxidant defenses, such as glutathione (GSH), 
glutathione peroxidase (GPx), SOD, and catalase (CAT) 
42
. However, during 
aging and various disease states, these antioxidant defense systems can 
be altered leading to progressive oxidative damage and subsequent cell 
death and/or significant loss of function 
43
. 
Brain sensitivity to oxidative stress 
The brain is particularly sensitive to oxidative stress since it presents: 
high content of peroxidizable unsaturated fatty acids, high oxygen 
consumption per unit of weight, high content in iron and ascorbate (LPO 
key ingredients) and a scarcity of antioxidant defense systems(e.g. GSH, 
GPx, CAT and vitamin E) 
44-49
. 
In fact, neurons have high metabolic demand. In humans, the brain 
accounts for only a few percent of the body weight, but it processes 20 % 
of basal oxygen consumption. A neuron uses much of oxygen via 
mitochondrial respiratory chain to make ATP for maintaining low 
gradients (high intracellular K
+
, low Na
+
, very low and free Ca
2+
) 
50,51
.  
Mitochondria role 
Mitochondria are the ‘‘powerhouses’’ of the cells. The main function is the 
production of ATP 
52
. It has been estimated that about 90 % of mammalian 
oxygen consumption is mitochondrial, which primarily serves to 
synthesize ATP. This makes mitochondria particularly important in 
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7 
 
neurons, owing to their high demands for energy because of their 
specialized functions, complex morphology, and synaptic activity 
53
. It has 
been increasing attention for the recognition of NDDs as mitochondrial 
diseases 
54
. Although each of the NDDs has its distinct etiological 
processes and different affected brain regions, neurodegenerative 
disorders as a whole, share similar mitochondrial dysfunctions 
54
. Since 
neurons in the brain strongly depend on mitochondrial driven aerobic 
respiration, when mitochondria become dysfunctional, it starts a vicious 
and detrimental cycle in which neurons become much more susceptible to 
oxidative stress. Mitochondria have already a high level of oxidative stress 
and, therefore, any increase in internal or external ROS leads to 
dysfunctional mitochondria, which in turn produces more ROS. 
Additionally, mitochondrial DNA is also a target of oxidation which can 
mediate impairment of mitochondrial functions, leading to more oxidative 
stress and eventual cell death (Fig.  2). 
 
Role of oxidative stress on the main NDDs 
Oxidative stress seems to be involved in the neuronal loss that occurs in 
AD although its cause is unclear 
55
. Oxidative damage occurs early in the 
AD brain, before the onset of significant plaque pathology, and seems 
also to precede the A deposition in animal models 56. Increased protein 
oxidation, protein nitration, and LPO occur in neurofibrillary tangles and 
neuritic plaques of AD patients and also levels of oxidation products are 
increased in cerebrospinal fluid of AD patients 
57
. Increased amounts of 
 
Fig.  2- Vicious cycle of mitochondria promoted by oxidative stress. 
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glutathione reductase (GR) glutaredoxin (Grx) and GPx were found in 
postmortem samples from AD patients, suggesting the activation of an 
antioxidant defense response 
58,59
.  
Oxidative stress is also involved in the pathology of PD. Although the 
disease could be attributed to genetic or environmental factors, both lead 
to oxidative stress, mitochondrial dysfunction and protein aggregation 
60
. 
The pathogenesis of PD has been reported to include increased dopamine 
turnover, diminished GSH content, and increased iron levels in the SN 
61
. 
Dopaminergic neurons of the SN from brains of PD patients also exhibit 
hallmarks of oxidative stress, including LPO, nucleic acid and protein 
oxidation, and changes in some antioxidant molecules 
62
. Mitochondrial 
defects are observed in PD 
63
; specifically, reduced activity of the 
mitochondrial respiratory complex I (NAD(P)H: quinone oxidoreductase 
(NQO)) in the SN 
64
 as well as the frontal cortex 
65,66
. It is well known that 
PD pathology includes the selective loss of dopamine neurons 
67
, and it is 
hypothesized that the main cause of this loss is the high levels of ROS in 
dopamine neurons due to dopamine metabolism and their high iron 
content 
68
.  
Oxidative stress is also present in HD as represented by increased DNA 
oxidative products and elevated DNA strand breaks 
5
. Oxidative 
challenges present with HD are thought to arise from poor mitochondrial 
membrane integrity. Impaired function of complex II and complex III of 
the electron transport chain 
69
,  should contribute to the decreased ATP 
levels detected in HD patients.  
In ALS like disease, onset and progression is also associated with 
enhanced production of ROS in the spinal cords 
70
. Oxidative stress has 
been suggested as favoring neuronal damage 
71
. Protein carbonyls and 
protein nitration have been found to be elevated in human ALS  
patients 
72,73
. Markers for LPO and higher levels of  8-OHdG were detected 
in spinal cord from ALS patients 
74,75
. Other cellular characteristics of ALS 
include a loss of mitochondrial membrane potential and increased 
cytosolic calcium 
12
. 
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1.3.2. Abnormal protein dynamics  
Aberrant self-aggregating misfolded proteins with formation of intra- or 
extra-cellular high-ordered insoluble fibrils deposits are common 
pathological hallmarks of many NDDs 
76,77
. A causative link between the 
formation of protein aggregates and NDD has been established, which 
may occur as a result of the toxic action of substances produced during 
early phases, where soluble oligomers and protofibrillar derivatives of 
misfolded proteins may play a pathogenic role 
78-86
.  
 
 
Fig.  3- Abnormal protein model of protein misfolding and fibrillation leading to 
the deposition of aggregated proteins via misfolded proteins, formation of 
aggresomes or to degradation via autophagy–lysosome pathway (ALP) or 
ubiquitin–proteasome system (UPS) (adapted from Jellinger 
14
). 
 
Progressive intracellular protein accumulation can result from various 
pathological processes: abnormal synthesis and folding, abnormal 
interaction with other proteins, overproduction of protein constituents, 
impaired degradation and turnover, altered post-translational 
modifications of newly synthesized proteins, abnormal proteolytic 
cleavage, improper expression or altered gene splicing, insufficient 
molecular chaperone activity, impaired intracellular transport of proteins 
and protein folding/misfolding modified on surfaces such as lipid 
membranes 
87
. 
Aberrant proteins often cannot fold correctly and will be trapped in 
misfolded conformations. To get rid of the misfolded proteins, the living 
Native
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cell contains a large number of intracellular proteases, which, together 
with the chaperones, comprise the cellular protein quality-control systems 
in the endoplasmic reticulum (ER) 
88
. The two principal routes of 
intracellular protein catabolism are the UPS and the ALP (autophagy). Both 
were implicated to play important roles in the pathogenesis of NDDs 
89
, 
but also to collaborate in neuroprotection 
90
. When the capacity of UPS to 
degrade misfolded proteins is overwhelmed, aggregation occurs and 
proteins are moved to ubiquitin-rich structures termed aggresome 
91
. The 
formation of these structures has been associated with activation of 
caspases and apoptosis 
92
. However, is not clear if the formation of 
aggresomes is causative or protective, although data suggest that they 
facilitate the degradation of toxic proteins 
93
.  Not all aberrant proteins 
can be eliminated and the misfolded protein may accumulate and form 
toxic oligomeric and/or aggregated inclusions. By this way, the loss of 
protein function may be accompanied by a gain of pathogenic function, 
culminating in death of affected cells 
94,95
. 
1.3.3. Molecular chaperones defective function 
Molecular chaperones have essential roles in many cellular processes, 
including protein folding, targeting, transport, degradation, and signal 
transduction. Chaperones have been found to be effective in preventing 
misfolding of different disease-causing proteins, reducing the severity of 
several NDDs and many other protein-misfolding diseases. They are 
ubiquitous in cells and are stress-induced or administered 
pharmacologically. Mutations on chaperones, such as heat shock proteins 
(HSP) have been increasingly associated to diseases 
96
. It is likely that 
molecular chaperones facilitate neuroprotection by functioning at various 
levels. They could prevent protein aggregation, interfere with oxidative 
stress (eg. HSP27 through GSH uphold) and block apoptotic signaling 
pathways, thus promoting survival. Thus, molecular chaperones may 
increasingly become new targets for the therapy of NDDs 
96
. 
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1.3.4. Fragmentation of neuronal GA 
Fragmentation of the neuronal GA was reported in ALS, AD, PD, 
Creutzfeldt–Jakob disease and in spinocerebellar ataxia type 2 
97
. Since the 
GA is involved in numerous important functions, such as the transport, 
processing, and targeting of proteins synthesized in the ER, fragmentation 
of Golgi might have detrimental effects and lead to dysfunction of the 
cytoplasmic machinery in neurons. In ALS cell model expressing mutant 
SOD1, fragmentation of the GA is associated with dysfunction of the 
secretory pathway 
98
. Several types of neuronal insult induce Golgi 
fragmentation, including excitotoxicity (nerve cells are damaged and 
killed by excessive stimulation by neurotransmitters), ROS, reactive 
nitrogen species (RNS) and ER stresses. GA has been found as a sensor for 
controlling entry into apoptosis 
99
. Evidences from Nakagomi et al. work 
have suggested that GA fragmentation/dispersal is a process downstream 
mitochondria and ER cell death pathway in response to apoptotic effectors 
99
. Moreover, this process seems to be an early event in neuronal cell 
death, initiated prior to tubulin degeneration, which is observed in the 
middle stages of apoptosis and not a consequence of cytoskeletal 
degradation during cell death. Finally, it has been suggested that GA 
fragmentation aberrant entry into the cell cycle can trigger neuronal 
apoptosis. Since mature neurons cannot undergo mitosis, the initiation of 
cell cycle events, such as GA fragmentation, may contribute to an 
apoptotic pathway 
99,100
.  
1.3.5. Disruption of cellular/axonal transport 
Defective neuronal and axonal transport also plays a mechanistic role in 
several NDDs 
101-103
. Most of the transport uses the microtubule system, 
which is proposed to form a network of trafficking highways, and also 
active proteins (Fig.  4). All axonal components are synthesized in the cell 
body and transported from there into the axonal processes. Axonal 
transport is essential for the movement of vital proteins, vesicles, 
organelles, signaling molecules, and other materials to the axon, and 
between cell body and synapse. A complementary mechanism functions in 
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the opposite direction, i.e., away from the axon into the cell body. Similar 
mechanisms exist in the dendrites, regulated by synaptic plasticity, but 
little is known about these mechanisms. It has been postulated that 
defects in axonal transport may be responsible for NDDs 
104
. Three 
developments have highlighted the significance of disrupted 
cellular/axonal transport in human NDDs: discovery of human motor 
protein mutations in these disorders; axonal transport defects in animal 
and in vitro cellular models harboring human mutations; and newly 
discovered roles for pathogenic proteins like amyloid precursor protein 
(APP), tau, presenilin, and synuclein, in the regulation of axonal  
transport 
102
. 
 
Fig.  4- Axonal transport. The motors for anterograde and retrograde fast axonal 
transport are the kinesins and dynactin complex proteins, respectively; 
microtubules provide the tracks for these motors. Vesicles for transport are sorted 
and loaded onto transport motors both in the cell body and the distal nerve 
terminal. The former are transported not only into the axon but also into 
dendrites. Those in the distal nerve terminal permit uptake and axosomatic 
movement of substances such as trophic proteins. Figure from Pasinelli et al. 
105
 
 
1.3.6. Ion channels changes 
Ion channels have a critical role in maintaining proper CNS function, and 
have long been suspected as a critical factor in NDDs 
106
. Perturbations in 
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Ca
2+
 homeostasis can promote alterations of Ca
2+
 buffering capacities, 
deregulation of Ca
2+
 channel activities, or excitotoxicity and were 
observed in several  neurodegenerative disorders including AD, PD, HD  
and ALS 
107-110
. In AD, accumulation of A peptides in neurons has been 
shown to activate ion channels, causing an influx of Ca
2+
 that disrupts 
homeostasis, leading to mitochondria dysfunction, oxidative stress and 
apoptosis of neurons 
111
. Moreover, reduction of K
+
 in cells can cause 
neuronal apoptosis 
112
. Voltage-gated K
+
 (KV) channels are responsible for 
the electrical activity in neurons. The drop in cytosolic K
+
 relieves 
inhibition of an array of pro-apoptotic enzymes such as caspases and 
nucleases 
113,114
. Blocking KV channels has been known to prevent neuronal 
apoptosis by preventing K
+
 efflux. 
1.3.7. Neuroinflammatory process 
Chronic inflammatory reactions and signs of immune activation in the CNS, 
involving major histocompatibility complex class II expression, glial 
reaction, T-cell infiltration and blood–brain-barrier (BBB) dysfunction are 
well-known features in the pathogenesis and progression of NDDs 
115-120
. 
Microglial cells are the primary immune cells in the CNS. Their primary 
functions are to promote defense by destroying pathogens, removing 
deleterious debris, promoting tissue repair and facilitating tissue 
homeostasis, through their influence on surrounding astrocytes and 
neurons 
121
. In most cases, neuroinflammatory process promoted by 
microglial activation stops once homeostasis has been restored. However, 
continued, uncontrolled activation of microglia can lead to an excess 
production of various factors that contribute to neuronal injury 
122-124
 . The 
insufficient clearance by microglia is also present in several NDDs and in 
aging, associated with an inadequate regenerative response 
125
 (Fig.  5). 
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Fig.  5- Neuroinflammatory process. Microglia activation induce increased 
expression of inducible nitric oxide synthase (iNOS) 
126
 that promotes excessive 
nitric oxide production that can lead to protein S-nitrosylation and nitration 
127
 and 
disruption of neuronal mitochondrial electron transport chain function 
128
. The 
activation of NADPH oxidase 
129
 also promoted by microglia activation mediates 
superoxide production and the release of pro-inflammatory molecules 
130
. 
Superoxide itself can increased iNOS expression 
131
 and react with nitric oxide 
generating peroxynitrite 
132
. This highly reactive oxygen and nitrogen species 
(RONS) can inhibit mitochondrial respiration, induce caspase-dependent neuronal 
apoptosis, and to induce glutamate release resulting in excitotoxicity and 
neuronal death 
132,133
. Additionally, longer lived cytokines are produced which 
enhance the expression of iNOS, increasing nitric oxide production and 
stimulating the release of additional cytokines that activate neuronal death 
signaling cascades. 
134,135
. Glial cytokine may also bind to specific cell surface 
receptors in neurons that activate pro-apoptotic pathways 
136,137
. 
 
1.3.8. Dysfunctions of neurotrophins (NTFs) 
Reduced neurotrophic support is a significant factor in the pathogenesis 
of NDDs 
138,139
. NTFs regulate development and maintenance of the CNS. 
They affect neuronal survival, influence synaptic function and plasticity 
and are central to many aspects of the CNS. Since NTFs in neurons are 
subject to transport from and to targeting neurons, their effects may be 
related to synthesis or to changes in axonal transport. NTFs activate 
signaling pathways through binding of tropomyosin-receptor-kinase (Trk) 
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Neuron
NO•
NO•
ONOO-
O2-
Cell death genes 
activation
Mitochondrial
dysfunction
Caspase
Excitotoxicity
Apoptosis/Necrosis
Pro-inflammatory stimuli
Oxidative stress
Chapter 1: Introduction 
15 
 
receptors, receptors dimerization and subsequent phosphorylation of the 
intracellular kinase domain 
139
. Neurotrophic support is inversely 
correlated with oxidative stress 
140
. In NDDs, such as AD, PD and HD, 
oxidative stress appears linked to the loss of neurotrophic support, 
causing down-regulation of NTFs which, in turn, can up-regulate 
antioxidant enzymes and promote the expression of antioxidant proteins. 
1.3.9. Choline deficit 
Acetylcholine (ACh) is a neurotransmitter widely distributed in the nervous 
system and has been implicated in cerebral cortical development, cortical 
activity, controlling of cerebral blood flow, sleep–wake cycle as well as in 
modulating cognitive performances and learning and memory  
processes 
141
. It plays an essential role in structural and functional 
remodelling of cortical circuits by establishing synaptic contacts in 
networks of cells that will support complex cognitive functions in 
adulthood 
142
. However, in NDDs it has been registered a cholinergic 
deficit 
143
. To the cholinergic dysfunction may contribute imbalances in the 
expression of neurotrophins, their precursors or in neurotrophin 
receptors, changes in ACh release, high-affinity choline uptake, as well as 
alterations in muscarinic and nicotinic ACh receptor expression. As a 
consequence of cholinergic hypofunction, cell atrophy may be mediated 
by decrements in gene expression, impairments in intracellular signaling 
and cytoskeletal transport that lead to functional decline in the brain. 
Malfunction of the cholinergic system may be tackled pharmacologically 
by intervening in cholinergic as well as neurotrophic signaling cascades 
that have been shown to ameliorate the cholinergic deficit at early stages 
of the disease, and slow-down its progression. Acetylcholinesterase 
(AChE), catalyzes the hydrolysis of the neurotransmitter ACh to  choline 
(Fig.  6). This process is necessary to return an activated cholinergic 
neuron to a resting state. AChE inhibition has been reported to ameliorate 
the symptoms of NDDs 
144-146
.  
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Fig.  6- Acetylcoline cycle. Cholinergic nerve transmission is terminated by the 
enzyme AChE, that is found both on the post-synaptic membrane of cholinergic 
synapses and in other tissues. ACh binds to AChE and is hydrolysed to acetate and 
choline. This inactivates the ACh and the nerve impulse is halted. AChE inhibitors 
prevent the hydrolysis of ACh, increasing its concentration of in the synaptic cleft. 
 
1.3.10. Neuronal death 
Neuronal death is the most critical hallmark of many NDDs 
14
. The nature, 
time course, molecular causes of cell death in NDDs and their relations to 
basic processes are still a matter of discussion. Based on distinct 
morphologic criteria and biochemical features, three major mechanisms 
of neuronal failure could be found: apoptosis, a specific form of gene-
directed programmed cell death (PCD); necrosis, a passive killing of the 
cell; autophagic degeneration 
147,148
. 
Morphologically, apoptotic cell death is characterized by chromatin 
condensation (pyknosis), nuclear fragmentation, cell shrinkage, and 
plasma membrane blabbing. Eventually, the cell breaks into small 
membrane surrounded fragments (apoptotic bodies), which are cleared by 
phagocytosis without inciting an inflammatory response 
149
. Apoptosis can 
occur locally, without damaging healthy adjacent cells 
150
. 
In contrast, necrotic cell death, an accidental and uncontrolled mode of 
cell death, exhibits rapid cell swelling and subsequent rupture of the 
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plasma membrane that due to an inflammatory response, usually induces 
substantial secondary cell damage in the surrounding tissue 
151
. 
Cell death with autophagy is a normal physiological process active in both 
homeostasis and atrophy, probably representing a failure of 
neuroprotective mechanisms 
152
. It is characterized by the formation of 
numerous autophagic vacuoles, endocytosis, enlargement of the GA for 
the vacuolization of the ER and moderate condensation of nuclear 
chromatin that may ultimately leave the pyknotic nuclei and to be 
destroyed by autophagosomes 
153
. 
Increasing evidences suggests that regulation of neuronal cell death is 
complex, utilizing multiple pathways that are dependent on the damaging 
insult 
154
. 
 
2. Polyphenols 
2.1. General aspects 
2.1.1. Occurrence and function 
Polyphenols (PPs) are among the most widespread class of metabolites in 
nature, and their distribution is almost ubiquitous. It is estimated that 
exist 100,000 to 200,000 secondary metabolites in plants 
155
 and 20 % of 
the carbon fixed by photosynthesis is channeled into the phenylpropanoid 
pathway, thus generating the majority of the natural-occurring  
phenolics 
156
. PPs are plant secondary metabolites, i.e. substances that in 
plants have little or no role in primary metabolism: photosynthesis, 
respiration, growth and development, but which may accumulate in 
surprisingly high concentrations 
157
. 
PPs appear to have many diverse functions in plants, e.g. colour of leaves, 
flowers and fruit, anti-microbial function, anti-fungal function, insect 
feeding deterrence, screening from damage by solar UV radiation, 
chelation of toxic heavy metals and antioxidant protection from free 
radicals generated during the photosynthetic process 
158
.  
One of the most obvious roles for colored phenolics is in making flowers 
attractive to pollinating animals. Also certain soil bacteria, including 
Chapter 1: Introduction 
18 
 
Rhizobium spp., are positively chemotactic towards plant phenolics 
159
, 
which is advantageous to the plant in the development of a favourable 
rhizosphere environment and in the establishment of symbiotic 
relationships, such as with nitrogen-fixing bacteria. Phenolics also protect 
plants against damage produced by UV light, by enhancing their 
accumulation or shifting towards more hydroxylated PPs 
160
. Flavonoids, a 
particular group of phenolic compounds, are major components of this 
screen, that occur in highest levels in plant tissues exposed to strong 
light, such as flowers and leaves. 
161
.  
One of the most important roles of phenolics is the defense from 
pathogens and herbivorous predators. This protective role results from 
PPs activities such as antibacterial, antiviral, damage tissues seal and 
insect feeding deterrents. Moreover, the higher-molecular-weight PPs (also 
known as tannins) precipitate proteins in the mammalian digestive system 
and impair digestion.  
2.1.2. Chemistry 
PPs are characterized structurally by the presence of one or more six- 
-carbon aromatic rings and two or more phenolic (i.e. linked directly to the 
aromatic ring) hydroxyl groups. Some compounds are usually integrated 
in the group of PPs as ”honorary” PPs, however not sharing the 
characteristic chemical properties, such as phenolic acids, stilbenes, etc.  
Phenolic compounds display diverse chemical aspects relevant to their 
biological actions, such as: (a) interaction of the hydroxyl groups with the 
p-electrons of the benzene ring make them able to scavenging reactive 
radicals and generate more stable radicals; (b) chelation of pro-oxidants 
metal ions, that requires vicinal hydroxyl groups; (c) readily ionized, 
acting as weak acids and thus influencing their chemical reactivity;  
(d) good hydrogen donors, forming complexes with other molecules 
extremely stable and with tendency to precipitate; (e) cis-trans isomerism. 
PPs are a diverse class of plant secondary metabolites (Fig.  7). They 
possess a vast range of precise chemical structures, ranging from simple 
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molecules such as catechol, through to complicated macromolecular 
polymers 
162
. 
2.1.2.1. Biosynthesis 
Although a large variety of plant phenols exists, PPs are mostly 
synthesized from phenylalanine, from shikimic acid pathway. Biosynthesis 
in then conducted via phenylpropanoids pathway, producing the large 
variety of plant phenols (Fig.  8). 
The flux into phenolic biosynthesis in plants is known to be highly 
sensitive to environmental conditions and also biotic and abiotic  
stresses 
158
. Detailed examination by molecular biological approaches has 
indicated that the phenomenon is largely due to enhanced transcription of 
the phenolic biosynthetic genes following exposure to the inducing 
stimulus 
163
. Genes for the initial enzymes in the phenylpropanoid pathway 
appear to be induced very early on, typically in a co-ordinated, “block-wise” 
manner 
158
. Mineral nutrition, such as a limited nitrogen supply and boron 
deficiency, lower temperatures, water availability and light are 
environmental factors able to influence phenolic metabolism
164
. 
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Fig.  7- Polyphenols classification. Schematic representation of polyphenols groups, including main examples of molecules. 
Polyphenols
Flavonoids
Anthocyanins
E.g. cyanidin, delphinidin, pelargonidin, malvidin, 
peonidin, petunidin, etc.
Flavonols
E.g. quercetin, kaempferol, myricetin, fisetin, galangin, 
gossypetin, isorhamnetin, morin, etc.
Flavones
E.g. apigenin, luteolin, tangeritin, baicalein, 
scutellarein, diosmin, etc.
Flavanones
E.g.  hesperetin, hesperidin, naringenin, naringin, 
butin, eriodictyol, etc.
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Isoflavones
E.g. genistein, daidzein, lonchocarpane, laxiflorane, 
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Isoflavanes E.g. equol, etc.
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E.g. catechin, epicatechin (EC), epigallocatechin (EGC), 
epicatechin gallate (ECG), epigallocatechin gallate
(EGCG), epiafzelechin, etc.
Oligomers and 
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E.g. theaflavins, thearubigins, condensed tannins, 
proanthocyanidins etc.
Non-
flavonoids
Phenolic acids
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cinnamic acid
E.g. p-coumaric acid, caffeic acid, chlorogenic acid, 
ferulic acid, sinapic acid, etc.
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Fig.  8- Biosynthetic pathway of phenylpropanoids. Adapted from Berli et al. 
165
. 
Legend: 4CL- 4-coumarate:CoA ligase (EC 6.2.1.12); ACC- acetyl-CoA carboxylase 
(EC 6.4.1.2); ANR- anthocyanidin reductase (EC 1.3.1.77); ANS- anthocyanidin 
synthase (EC 1.14.11.19 );C3H- p-coumarate 3 hydroxylase (EC 1.14._._);  
C4H- cinnamate 4-hydroxylase (EC 1.14.13.11); CHI- chalcone isomerase  
(EC 5.5.1.6); CHS- chalcone synthase (EC 2.3.1.74); DFR- dihydroflavonol reductase 
(EC 1.1.1.219); F3H- flavanone 3-hydroxylase (EC 1.14.11.9); F3′H- flavonoid  
3′-hydroxylase (EC 1.14.13.21); F3′5′H- flavonoid 3′5′-hydroxylase (EC 1.14.13.88); 
FLS- flavonol synthase (EC 1.14.11.23); FS- flavone synthase (EC 1.14.11.22);  
LAR- leucoanthocyanidin reductase (EC 1.17.1.3); OMT- o-methyltransferase  
(EC 2.1.1._); PAL- phenylalanine ammonia-lyase (EC 4.3.1.5); STS- stilbene synthase 
(EC 2.3.1.95); UFGT- UDP glucose-flavonoid 3-glucosyltransferase (EC 2.4.1.115 ). 
The pathway starts with PAL that catalyzes the conversion of phenylalanine to 
cinnamate. The C4H catalyzes the synthesis of p-hydroxycinnamate from 
cinnamate and 4CL converts p-coumarate to its coenzyme-A ester, activating it for 
reaction with malonyl CoA. The flavonoid biosynthetic pathway starts with the 
condensation of one molecule of 4-coumaroyl-CoA and three molecules of 
malonyl-CoA, yielding naringenin chalcone. This reaction is carried out by the CHS. 
Chalcone is isomerised to a flavanone by the CHI. From these central 
intermediates, the pathway diverges into several side branches, each resulting in a 
different class of flavonoids. F3H catalyzes the stereospecific 3ß-hydroxylation of 
(2S)-flavanones to dihydroflavonols. For the biosynthesis of anthocyanins, DFR 
catalyzes the reduction of dihydroflavonols to flavan-3,4-diols (leucoanthocyanins), 
which are converted to anthocyanidins by ANS. Leucoanthocyanins can also be 
catalyzed by LAR to flavan-3-ol. ANR catalyzes the reduction of anthocyanidins to 
epi-flavan-3-ol. The formation of glucosides is catalyzed by UFGT, which stabilize 
the anthocyanidins by 3-O-glucosylation. 
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2.1. Neuroprotective potential 
It has been suggested that phenolics are among the most active 
substances from natural sources, displaying a variety of health-promoting 
properties 
166,167
. PPs and PP-rich extracts have been implicated as 
beneficial agents in a multitude of disease states 
168,169
, most commonly 
cancer, cardiovascular disease, and neurodegenerative disorders.  
It is now believed that the activity of these low-molecular-weight, non 
nutrient components and their metabolites on neurological processes can 
be defined through a number of distinct biological processes: (a) neuronal 
signaling pathways, leading to inhibition of apoptosis, neuronal survival 
and differentiation 
170,171
; (b) inhibition of neuropathological processes in 
specific brain regions 
172,173
; (c) changes in brain blood flow 
174-176
.  
2.1.1. Interactions with neuronal signaling pathways 
There is extensive evidence indicating that some native flavonoids 
171,177
, 
their small intestinal metabolites 
178,179
 and also large intestinal  
derivatives 
180-182
 are capable of exerting beneficial effects on neurological 
processes and that this is linked to their interactions with neuronal 
signaling pathways. Receptor binding by flavonoids and their metabolites 
may underlie changes in the activation status of various downstream 
kinases, including various members of both the mitogen-activated protein 
kinase (MAPK) and the phosphoinositide 3-kinase (PI3K)  
pathways 
170,171,183,184
 and the nuclear factor-B (Nf-B) pathway 185. Various 
flavonoid-binding sites on neurons have now been described, whose 
include adenosine 
186
, gamma-aminobutyric acid (GABA
A
) 
187,188
, delta- 
-opioid 
189,190
, nicotinic 
191,192
, TrkB 
193
, estrogen 
194
, and testosterone 
receptors 
195
. Also a specific brain plasma membrane binding site for PPs 
has been proposed 
196
.  
Neuronal survival and differentiation  
Modulation of protein kinases and lipid kinases signaling cascades by PPs 
allows changes in caspase activity and/or alterations on gene expression, 
thus affecting neuronal survival 
171
. 
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Signaling pathways changes promoted by PPs are highly likely to underpin 
enhancements in spatial memory through the facilitation of changes in 
synaptic strength and the induction of morphological changes 
197
, in 
particular changes in neuronal spine density and morphology that are 
considered vital for learning and memory 
198
. Compounds or drugs that 
are capable of enhancing the activity of cAMP response element binding 
(CREB) may be capable of facilitating memory consolidation by promoting 
gene expression related with synaptic morphology and associated 
changes that are critical for long-term memory 
199,200
. Moreover, molecules 
that are capable of entering the brain and activate upstream regulators of 
CREB (e.g., extracellular-signal-regulated kinase (ERK) and protein kinase B 
(Akt)) may also be considered excellent candidates for memory-enhancing 
drugs. Flavonoids, due to their ability to localize in the brain 
201
 and their 
capacity to activate ERK– CREB and Akt–CREB circuitry 
170,202
 may be 
regarded as promising candidates for the enhancement of memory and 
aid patients suffering from AD, PD, stroke, or even normal age-associated 
memory deficits. 
2.1.2. Inhibition of neuropathological processes 
Flavonoids are also able to counteract the neuronal injury underlying 
these disorders and thus slowing the disease progression 
203,204
. Recent 
evidences suggests that nonsteroidal anti-inflammatory drugs are 
effective at delaying the onset of neurodegenerative disorders, particularly 
PD 
205
. As such, there has been an interest in the development of new 
compounds with an ability to counteract neuroinflammatory injury to the 
brain. Likewise, flavonoids have been shown to be effective at blocking 
oxidant-induced neuronal injury 
206
, although not via direct radical or 
oxidant-scavenging activity 
170,178,179,207-209
. 
‘Direct’ versus ‘indirect’ antioxidant activity 
Until recently the conventional wisdom was that the direct antioxidant 
activity of phytochemicals was the responsible to confer their health 
benefits 
210
. Phytochemicals have been considered able to modulate 
cellular responses to various stimuli interacting with RONS-mediated 
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intracellular signaling by scavenging RONS or suppressing their 
generation, either by inhibiting/activating enzymes or by chelating trace 
elements involved in free radical production 
211,212
.  More recently, the real 
impact of flavonoids and in general of PPs, as antioxidants has been 
reconsidered and questioned, opening up to the evidence that the 
molecular basis of their activity is much larger than originally  
considered 
213
. Diverse mechanisms have been proposed to explain the 
biological activity of PPs, including the capacity to bind protein and 
eventually affect enzyme activity by competitive or allosteric  
interactions 
174,214
; regulation of signal transduction; modulation of redox- 
-sensitive transcription factors, including nuclear factor erythroid 2-related 
factor 2 (Nrf2), NF-B, and activating protein-1 (AP-1) 215,216; GSH 
biosynthesis 
217
; and gene expression in general 
218-220
. Regarding 
phytochemicals concentrations, they are only effective as radical 
scavengers when they are present in supra-micromolar concentrations. 
Thus, it has been speculated that this antioxidant activity cannot account 
for the bioactivity of flavonoids in vivo, particularly in the brain, where 
they are found at only very low concentrations 
174
. Indeed, where 
examined, there is a biphasic dose-response relationship for many 
phytochemicals (low dose beneficial effects and high dose toxic effects), 
arguing against an exclusive antioxidant mechanism of action. Moreover, 
data from epidemiological studies and clinical trials have failed to 
demonstrate benefits of dietary supplementation with antioxidants such 
as vitamins C and E 
221,222
. 
It is becoming clear that many of the beneficial phytochemicals evolved as 
toxins (in which PPs are included), at subtoxic doses, activate adaptive 
cellular stress–response pathways, under control of genes defined as 
vitagenes, in a variety of cells including neurons. This mechanism defined 
as preconditioning, hormesis or neurohormesis, when applied to neurons, 
is an adaptive response of cells and organisms to a moderate stress 
223,224
. 
It is suggested that hormetic effects represent an adaptive responses to 
environmentally induced disruptions in homeostasis, such as ischemic 
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preconditioning, exercise, dietary energy restriction and exposures to low 
doses of certain phytochemicals (e.g. resveratrol and curcumin). Recent 
findings have elucidated the cellular signaling pathways and molecular 
mechanisms that mediate hormetic responses which typically involve 
enzymes such as kinases and deacetylases, and transcription factors such 
as Nrf2 and NF-B. As a result, cells increase their production of 
cytoprotective and restorative proteins including growth factors, phase II 
and antioxidant enzymes, and protein chaperones 
223,224
. By this way PPs 
can provide significant protection from oxidative stress at concentrations 
much lower than would be required for “chemical” antioxidant protection 
and by mechanisms other than radical scavenging. It appears that PPs act 
by maintaining upregulated levels of our endogenous antioxidant and 
other defenses, thereby minimizing the response time for the defense 
against stresses. Actions exerted through signaling cascades are likely to 
proceed at intracellular concentrations lower than those required for 
antioxidant actions. This is important as the accumulation of flavonoids in 
the brain and their potential bioactivity may be restricted by processes at 
the BBB in that it may aid or prevent the entry of such compounds to the 
brain 
225
. Results have demonstrated that flavonoids and their metabolites 
are able to cross the BBB but that its potential for permeation is 
dependent on compound lipophilicity and/or transporters
226,227
. 
2.1.3. Angiogenesis 
There is also strong evidence to suggest that flavonoids, in particular 
flavanols, are capable of promoting significant improvements in 
cardiovascular health after oral intake 
228-230
, facilitating more efficient 
cerebral blood flow (CBF). CBF is known to deteriorate with age, to be vital 
for optimal brain function and to be decreased in patients with  
dementia 
231,232
. Modulation of the cardiovascular risk factors by flavonoids 
may then result in lessening reductions in cognitive function. 
Epidemiological data suggest that this may be the case of flavonoids that 
could be capable of preventing many forms of cerebrovascular disease 
233,234
. As increased cerebrovascular function is known to facilitate adult 
Chapter 1: Introduction 
26 
 
neurogenesis in the hippocampus 
235
, appearing new hippocampal cells 
clustered near blood vessels and areas of angiogenesis and proliferate in 
response to vascular growth factors 
236
. The vascular effects of some 
flavonoids are partly mediated by their ability to induce nitric oxide 
production, a vasodilator, in the endothelium 
237,238
. 
2.1.4. Plants and phytochemicals with recognized 
neuroprotective effects 
Growing body of evidences have surged in the literature, showing pure 
PPs or PPs-enriched extracts as displaying neuroprotective activity  
(Table 1). Those evidences are coming from several types of studies: in 
vitro, in vivo, epidemiological and clinical. Each type of study presents 
different advantages and disadvantages, being the clinical ones more 
expensive but more reliable on the effects of compounds in the human 
organism and the in vitro the cheapest and the less physiological, 
however very important to unravel the molecular mechanisms underlying 
the effects observed on other models and useful for screenings . However, 
most of the in vitro studies rely on pure compounds, usually in the form 
as they occur in plants, being forgotten the possible synergisms between 
different compounds and their physicochemical alterations when they are 
orally administered. 
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Table 1- Neuroprotective effects of foods presenting high content of PPs, phenolic-enriched extracts and pure PPs. 
Compound Type of study Effect 
Ginkgo biloba 
(EGb 761) 
In vitro 
Scavenger of RONS 
239-241
 
Protection from A peptide neurotoxicity 242-245 
Protection mitochondria from H
2
O
2
, A toxicity 246 and APP overexpression 247 
In vivo 
Improvement of spatial learning and memory in AD mice model 
248
 
 Decreases APP levels in the cortex by 50 % in long-term treatment 
249
 
Decreases iNOS expression 
250
, up-regulates genes encoding antioxidant enzymes 
251
 and 
activates sirtuin 1 (SIRT1), which in turn suppresses A peptide-mediated NF- B activation 242 
Clinical 
Meta-analysis over 50 clinical studies indicates pharmacological effects controversy 
252
 
More recent meta-analysis indicate it more effective than the placebo in cognition scores, but 
no consistent results were obtained concerning the quality of life and neuropsychiatric 
symptoms 
253
 
Ongoing GuidAge study results, a 5-year double blind randomized trial for the prevention of AD  
will be available soon 
254
 
Green tea 
In vitro 
Direct scavenging of RONS 
255
 and induction of endogenous antioxidant systems, preventing 
oxidative DNA modifications 
255
 and inhibiting LPO 
256,257
 
Catechins contribute for neuronal viability through modulation of signal transduction pathways, 
cell survival/death genes and mitochondrial function 
258,259
 also reduce neurotoxins damages 
and A-induced toxicity either in established cell lines and primary cell cultures 257,260-263 
Epigallocatechin gallate (EGCG) prevents A fibril formation 264 and protects against A-induced 
apoptosis by inhibiting caspase activation 
257
 
In vivo 
Protection of proteins and lipids against oxidation, prevents the increase of lipofuscin 
deposition in hippocampal neurons of elderly rats 
265
 and improves the spatial learning  
abilities 
265
 
Improvement of cognitive and behavioural abilities during aging and neurodegenerative 
conditions 
259
. 
Catechins expand the life span in transgenic mouse and in Coenorhabditis elegans and prevent 
the spatial learning and memory decline in old rats 
266-270
 
EGCG improves age-related cognitive decline and protects against cerebral 
ischemia/reperfusion 
271,272
, brain inflammation 
273
, rescues memory impairments induced by A 
peptide 
264
 through inhibition of NF-B pathway and mitigation of induced oxidative stress in  
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Green tea 
In vivo 
the brains of rats 
274
 
Up-regulates genes and enhances activities of antioxidant protective enzymes (SOD, CAT and 
heme oxygenase (HO-1) 
259,275,276
), increases the activity and nuclear binding of Nrf1 and Nrf2 to 
the antioxidant regulatory element (ARE) 
259,277-279
 
EGCG treatment restores mitochondrial functions 50–85 % detected in mitochondria isolated 
from the hippocampus, cortex, and striatum 
280
 
EGCG supplemented diet rescues transgenic mice presenting phenotypes of brain 
morphogenesis defects, low brain-derived neurotrophic factor (BDNF) levels and mnemonic 
deficits 
281
 
Epidemiological 
Tea consumption inversely correlates with incidence of dementia, AD and PD 
282
 
Higher consumption is associated with lower prevalence of cognitive impairment in Japanese 
elderly people 
283,284
 
In Chinese elderly people the cognitive impairments were correlated with the lower prevalence 
of tea habits consumption 
285
 
In American, Finnish and Singaporean people, PD incidence was inversely correlated with the 
consumption of tea 
286-288
 
 
Clinical No obvious disease-modifying results were obtained 
289,290
 
Curcumin 
In vitro 
Exhibits intracellular direct and indirect antioxidant activities 
291-294
 anti-amyloid activities 
295
 and 
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) protective activity 
296,297
 
Anti-inflammatory through inhibition of lipoxygenase and cyclooxigenase-2 (COX-2) 
298,299
, 
suppression of iNOS and inhibition of NF-B and AP-1 activation 300-302 
Inhibits the formation and extension of A fibrils and destabilizes preformed A fibrils 303  
In vivo 
Reduces A levels and plaques, oxidized proteins and interleukin-1 (IL-1) in aged transgenic 
mice with advanced A accumulation 304 
Able to cross the BBB, targeting senile plaques and disrupting existing plaques 
305
 
Protects rat brain form MPTP-induced neurotoxicity 
296
 
Epidemiological Prevalence of AD in people aged 70-79 years in India is 4.4-fold less than in the United States 
306
 
Clinical 
Phase I clinical studies have demonstrated low systemic bioavailability following oral  
intake 
307,308
 
Rosemary 
phytochemicals 
In vitro 
Rosmarinic acid scavenges RNS, peroxynitrite, and various ROS 
309,310
  
Rosmarinic and carnosic acid protects human neurons from oxidative stress 
311,312
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Rosemary 
phytochemicals 
In vivo 
Rosmarinic acid alleviates memory impairment associated with A neurotoxicity, delays disease 
onset and prolongs lifespan in mouse models of AD and ALS 
313,314
 
Carnosic acid crosses the BBB and preserves GSH levels in the brain, protecting it against injury 
induced by middle cerebral artery ischemia/reperfusion 
312
 
Grape seed 
polyphenolic 
extract 
In vitro Inhibits A-protein aggregation, suppressing self-assembly of A peptide and cytotoxicity 315 
In vivo 
Rescues AD animal models from cognitive deteriorations with reduced high molecular weight 
soluble oligomeric A in the brain 173 and in serum 316, reduces formation of amyloid plaques 
and microglial activation 
316
 
Selectively decreases a 56 kDa A oligomer previously shown to induce memory impairment in 
rats, without alterations in the levels of transgenic APP, monomeric A peptide, or other A 
oligomers 
317
 
Attenuates of ERK 1/2 signalling in the brain of a mouse model of AD, suppressing the 
development of AD type tau neuropathology 
318
 
Red wine In vivo 
Attenuates deterioration of spatial memory performance and A neuropathology and A-related 
cognitive deterioration in AD transgenic mice 
319,320
 
Able to cross BBB 
321
 
Resveratrol 
In vitro Reduces A-induced intracellular accumulation of ROS and apoptotic death 322 
In vivo 
Reduces formation of amyloid plaques in the medial cortex, striatum and hypothalamus 
without affecting APP level in mice overexpressing APP 
323
 
Neuroprotective through modulation of the NF-B activity or NF-B/SIRT1 pathways 322,324,325 
Reduces neurodegeneration in the hippocampus and prevents learning impairment in a model 
of AD and tauopathies by intracerebroventricular injection 
326
 
Berries In vitro 
Blueberry extracts decreased production of proinflammatory cytokines and enzymes in murine 
microglial cells activated by LPS 
327
 
Blueberry extracts induced increase in A clearance, inhibition of its aggregation in fibres and 
suppression of microglia activation in murine cell culture 
328
 
Biotransformed blueberry juice activated molecular pathways promoting cell survival (p38 and 
c-Jun N-terminal kinase (JNK) pathways) and the blocking of cell death mediated by extracellular 
signal-regulated kinases in neuronal cultures submitted to H
2
O
2 
329
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Berries In vivo 
Pomegranate, strawberry, and blueberry ammeliorate several aspects of memory and learning: 
rapid and slow memory acquisition 
330-332
, short-term working memory 
201,333
, long-term reference 
memory 
334
 and memory retention/retrieval 
335
 
Strawberry, blueberry, and blackberry retard functional age-related CNS and cognitive 
behavioural deficits in rodent models 
331,332,336
 
Blueberries reverse age related deficits in spatial working memory 
201,333,334,336-339
 through: 
increases in CREB activity and BDNF 
201
; phosphorylation of hippocampal Akt, the activation 
downstream of mammalian target of rapamycin (mTOR), and the increased expression of 
activity-regulated cytoskeletal-associated protein (Arc/Arg3.1) 
201
; by acting indirectly on the 
dentate gyrus (DG), the hippocampal subregion most sensitive to the effects of aging 
340-342
 
Blueberry and blackberry effects are pronounced in terms of short-term memory 
336,343
 
Blueberries anthocyanins can cross BBB 
337,344
 
Pomegranate juice improves in cued and spatial learning tasks and has a significantly reduced 
burden of plaque load and soluble A in the hippocampus in transgenic mice expressing the 
APP 
330
 
Quercetin 
In vitro 
Increases cell survival in the presence of H
2
O
2
 
345,346
, linoleic acid hydroperoxide 
347
, tert-butyl 
hydroperoxide 
348
 and IL-1 349,350 
Protects cells against the PD toxins, such as 6-hydroxydopamine  (6-OHDA) and 1-methyl-4- 
-phenylpyridinium (MPP
+
 )
261
 
In vivo 
Improves memory and hippocampal synaptic plasticity after impairment induced by chronic 
lead exposure 
351
 
Neuroprotective against colchicine that induces cognitive impairments 
352
 
Decreases ischemic lesion 
353
 and suppresses hippocampal neuronal death in a rat ischemia 
model 
354
 
Improves motor function in a model of acute spinal cord injury 
355
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3. Strategy to deal with NDDs 
As already described NDDs are multifactorial diseases for which currently 
there are no cures. Licensed drugs for dementia are still few: 
cholinesterase inhibitors (four drugs developed to inhibit AChE), 
butyrylcholinesterase (BuChE) and memantine (a glutamate N-Methyl-D- 
-aspartic acid (NMDA) receptor antagonist). A range of other drugs often 
prescribed incidentally include antipsychotics, antidepressants, 
tranquillizers, and hypnotics 
356
. Afterwards, the development of new 
therapies aimed at halting or reversing the progression of these ailments 
is urgently needed. Moreover, most of PPs exhibit an immense natural 
diversity and  appear to have a number of different molecular targets, 
participating on several signaling pathways, and showing pleiotropic 
activity on cells 
357
. In addition, their occurrence in plants in complex 
mixtures make it possible to take advantages of additive or synergistic 
activities 
358,359
. Thus, PPs appear as promising candidate compounds to be 
explored in the treatment of NDDs. The uses of natural products (NPs) in 
pharmacological or nutritional approaches are two different strategies to 
supply PPs to humans that are described below. 
3.1. Natural products 
3.1.1. The current interest 
NPs are promising candidates for drug discovery and they still playing an 
important role in the development programs of future small organic 
compound drug 
360
. In the years 2000-2006, NPs produced or were 
involved in the production of 50 % of all small molecules 
360
. NPs play a 
dominant role in the discovery of leads for the development of drugs to 
be used in the treatment of human diseases. From 2005 to 2007, 13 NPs 
related drugs were approved 
361
. They include compounds from plants 
(including elliptinium, galantamine and huperzine), microbes (daptomycin) 
and animals (exenatide and ziconotide), as well as synthetic or semi-
synthetic compounds based on NPs (e.g. tigecycline, everolimus, 
telithromycin, micafungin and caspofungin). Over 100 NPs-derived 
compounds are currently undergoing clinical trials and a similar number 
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of projects are in preclinical development. Most are derived from leads 
obtained from plants and microbial sources 
361
. With the growing 
realization that the chemical diversity of NPs is a better match to that of 
successful drugs than the diversity of collections of synthetic  
compounds 
362
, the interest in applying natural chemical diversity to drug 
discovery appears to be increasing once again 
363
. NPs have inspired many 
developments in organic chemistry 
364,365
, leading to advances in synthetic 
methodologies and to the possibility of making analogues of the original 
lead compound with improved pharmacological or pharmaceutical 
properties 
366
. There are several examples of libraries based on alkaloids, 
polyketides, terpenoids 
367
 and flavonoids 
368
. Despite a period in which 
pharmaceutical companies cut back on their use of NPs in drug discovery, 
there are many promising drug candidates in the current development 
pipeline that are of natural origin. 
3.1.2. Lead versus multidrug approach 
Most NP drug discovery work is focused on single compounds with a 
particular biological activity (single target–single compound paradigm) 
tested at the molecular level (e.g. receptor binding inhibition or enzyme 
screening) 
369
. This approach is usual in Western medicine and has been 
responsible for the successful delivery of many potent drugs in the past, 
such as the huperzine A for AD 
370
. It is considered for some authors not 
the best approach for NP studies since the presence of synergism and pro-
drugs in an extract can be misleading 
369
. Recently, new approaches might 
help to get a better view of the mode of action of herbal or NPs and lead 
to the possibility of obtaining proof and guarantee of their 
pharmacological activity over different batches. These approaches are 
based on considering the NP holistically, i.e. on the bulk of chemical 
constituents rather than focusing on certain individual components or 
groups of compounds. Genomics, proteomics and metabolomics 
platforms, nowadays available, are crucial since they allow the 
identification of detectable protein/genes or compounds which might 
relate to the biological activity of complex extract 
371
. This may shift the 
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paradigm in the development and application of complex 
plant/phytochemical mixtures in modern medicine 
372
. Besides, new or 
unsuspected, mode(s) of action and targets might also be revealed in this 
approach 
369
. St John’s Wort extract is an example of holistic approach, 
since no single compound or even group of compounds has been found 
to be responsible for its activity, the possibility of synergism and pro-
drugs was evident 
369,371
.  
3.1.3. NPs challenges 
NP-based drug discovery projects also poses some challenges 
373
, such as: 
(a) dereplication, which is the rapid identification of known and unknown 
compounds from partially purified mixtures; (b) interaction between 
metabolites present in extracts, which could promote antagonism or 
synergism; (c) structure determination by spectroscopic methods;  
(d) sourcing of authenticated plants, a very important issue for quality 
control; (e) large scale production of the active component (as the 
identified NP lead might be a minor compound of the extract, or the 
supply of the material for extraction might be limited). 
3.1.4. NPs as neuroprotectants leads 
NPs are anticipated to play a significant role in the development of new 
therapeutic leads for NDDs, as exemplified by galanthamine and 
huperzine A, which have both proven to be potent inhibitors of AChE and 
are currently in clinical use for the treatment of AD 
374,375
. Some important 
properties for a CNS-active drug are present in NPs within the desired 
ranges, presenting chirality and structure rigidity and displaying 
privileged structures that make them able to interact with biological 
targets 
376,377
. Therefore, secondary metabolite leads should be regarded as 
generally compatible with the BBB penetration needs of CNS-active agents. 
Moreover, the chemical properties of the small-molecule NPs that have 
been recently developed into drugs, have been analyzed and it was found 
that half of them are more readily absorbed than synthetic drugs 
378
.  
As already described, a substantial number of cellular dysfunctions are 
shared among neurons experiencing NDDs. Accordingly, many research 
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groups have examined these non-specific disease targets in the hope of 
finding compounds that have broad applications to more than one 
neurodegenerative disorder. Several assays have been described for 
identifying generalized neuroprotective agents, including preventing 
glutamate-induced neurotoxicity 
374,379,380
, modulating neurotrophic  
activity 
381-383
, providing protection against inflammation 
384,385
, and 
inhibiting monoamine oxidases 
386
. Numerous flavonoids compounds  
(e.g. gossypin, quercetin, gnaphalin) have been associated with 
antiinflammatory activity 
387
 and may have potential in the management of 
inflammatory disorders. Among species with a range of relevant 
neurobiological activities, that have shown some promising effects on 
cognition in dementia patients it can be found Salvia officinalis L. 
(Lamiaceae), S. lavandulifolia Vahl. (Lamiaceae), Melissa officinalis L. 
(Lamiaceae), Crocus sativus L. (Iridaceae) and the extensively studied 
Ginkgo biloba L. (Ginkgoaceae) 
356
. 
The combination of the attractive chemical properties of NPs leads with 
the variety of druggable targets that have been identified for 
neurodegeneration, makes it clear that many opportunities remain for 
new discoveries in the area of NPs relevant to NDDs 
388
.  
3.2. Nutrition 
Compounds within plant foods may be considered as being more safe and 
healthy, compared to the ones isolated and presented in high doses, such 
as those in supplements. Two main factors contribute to the trust on 
beneficial activities of plant foods: (a) their general low concentration of 
nutrients and non-nutrients; (b) the additive or synergistic actions of 
complex mixture profiles of phytochemicals and nutrients.  
PPs are phytochemicals widespread in fruits, vegetables, cereals, dry 
legumes, chocolate, and plant-derived beverages (e.g. such as tea, coffee, 
and wine) and represent the most abundant “minor components” in the 
diet 
389
. Daily intake is estimated at 100–150 mg per day in Western 
populations 
389
 and their concentration in fruits and vegetables are around 
up to several 100 mg/100 g 
390
.  
 
Chapter 1: Introduction 
35 
 
3.2.1. Epidemiological/clinical evidences 
There is increasing evidence that plant-derived flavonoid-rich foods or 
supplements might delay the initiation/slow the progression of 
neurodegenerative disorders. Regular consumption of flavonoid-rich foods 
such as tea and wine has been associated with better performance on 
cognition and decreased risk of cognitive decline in elderly populations in 
Asia and Europe 
391,392
. The adherence to the Mediterranean diet has been 
associated to the lower risk of developing AD, mild cognitive impairment, 
the conversion of such impairment to AD 
393-395
 and to lower mortality in 
AD 
396
. Moreover, the consumption of polyphenolic-rich vegetables, fruit 
juices, and red wine has been shown to delay the onset of AD  
disease 
233,397,398
. One study, at a large-scale population level, negatively 
correlated intake of flavonoids with the years of life lost prematurely due 
to dementia and costs in disability 
399
 and evidencing flavonols as 
negatively correlated with dementia incidence. There are a number of 
studies that have indicated that the consumption of these foods and 
extracts may also be capable of inducing improvements in cognitive 
performance, human vascular function and on improving memory and 
learning, including in elderly people 
170,174,183,204,215,234,392,400-417
. Collectively 
these reports lend some support to the hypothesis that dietary 
intervention with plant-derived flavonoid-rich foods or supplements has 
an impact on the development of NDDs. 
3.2.2. The fate of phytochemicals supplied by nutrition 
Phytochemicals supplied by food ingredients are subjected to extensive 
alterations due to the gastrointestinal digestion, absorption and liver 
detoxification. The first step upon ingestion is the release of PPs from 
their matrix. Deglycosylation of flavonoid glycosides, the cleavage of 
polymeric proanthocyanidins, as well as the hydrolysis of esterified 
phenolic acids, are for most compounds a prerequisite for absorption 
through the intestinal barrier 
389
. These hydrolyses can be performed from 
the small intestine onward by either brush border or microbial enzymes. 
Aglycones, monomers to trimers of flavonols, and some intact glycosides 
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(anthocyanins) can rapidly be absorbed by enterocytes, most likely by 
passive diffusion. During intestinal absorption and passage in the liver, 
PPs are extensively glucuronidated and/or sulphated (phase II 
metabolism), whereas phase I metabolism (oxidation/reduction reactions) 
appears to be minor 
418
. As a result, circulating PPs are mainly 
glucuronides. Polyphenol suffer metabolization by colonic microflora, 
being posteriorly reabsorbed to the enterohepatic circulation. Although 
faecal excretion is low, urinary recoveries of the parent PPs account for 
only a small fraction of the ingested doses, suggesting a high degree of 
metabolization of phenolic compounds during digestion.  
 
4. Plants 
The chemical diversity of plants constitutes an immense and relatively 
untapped reservoir of molecules with potential 
pharmacological/nutraceutical value. The diversity of Portuguese plants 
represents a pool of phytochemicals as yet poorly characterized and 
explored.  
4.1. Juniper (Juniperus sp.) 
Juniperus sp. belong to Cupressaceae family and they are known a total of 
70 species and 27 varieties all around the world 
419
. The major part of 
these species are spread in Laurasia region, except J. procera that grows 
from the mountains of East Africa  until the south hemisphere and some 
mediterranean species such as J. oxycedrus, J. phoenicea, and J. thurifera 
that also grow in mountain regions of North Africa 
419
.  
Plants from the Juniperus genus have found application in different 
European cuisines as a spice, flavouring alcoholic drinks as well as in 
cosmetics 
420
. Furthermore, these plants have an extensively history of use 
in global folk medicine for various disorders, such as common colds, 
urinary and kidney infections and dermatological disorders 
421
. Many 
biological activities have been more recently reported for Juniperus sp.. In 
this work the species evaluated were J. navicularis Gand., J. oxycedrus 
badia H. Gay, J. phoenicea L. (= J. phoenicea phoenicea L.) e J. turbinata 
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Guss. (= J. phoenicea turbinata Guss.), all of them native from Portugal, 
being J. navicularis a Portuguese endemism. J. navicularis are usually 
found in sandy soils in the Portuguese coast,  pinewoods and deciduous 
woods in Baixo Alentejo, Estremadura and Ribatejo regions 
422,423
.  
J. oxycedrus badia can be found in xerophytic regions, plains, open hills 
or woods up to 1000 m high, especially in Portuguese inner regions: Beira 
Alta, Beira Baixa, Trás-os-Montes and also in Ribatejo 
422,423
. J. phoenicea 
and J. turbinata usually inhabit sandy areas such as dunes and xerophytic 
woods in central and southern parts of coastal area of the country, with  
J. phoenicea also colonizing cliffs and rocky areas 
422,423
. 
4.2. Blackberry (Rubus sp.) 
Fruits from Rubus sp. have long been collected and consumed worldwide, 
regardless of whether they were recognized for their possible health 
benefits from their natural phytochemicals 
424,425
 or simply because they 
have a good taste. The worldwide popularity of Rubus fruit has increased 
in part due to the repeated published accounts of highly colored berries/ 
fruit and their potential health benefits 
336,426-429
. The worldwide commercial 
production of blackberry is estimated to be approximately 154,578 tons 
annually 
430
, being wild blackberries also cultivated in considerable 
amounts in some regions, reaching 13,460 tons worldwide 
430
. 
Among the huge diversity of blackberries found in Europe, it is tough that 
the areas which were not covered with ice during the last two glaciations 
constituted refuges for the pre-glacial Rubus sp. 
431
. These areas found in 
Portugal, Pyrenees, Switzerland, Syria, Carpathian and Caucasus 
mountains should be the habitat of ancestral species, different from those 
found in the North countries of Europe 
431
. In Portugal it was already 
identified diverse species whose occurrence is relatively limited to some 
Iberian areas 
422
. Examples of these species are R. brigantinus Samp.,  
R. caesius L., R. castellarnaui Pau, R. genevieri Boreau, R. henriquesii 
Samp., R. lainzii H. E. Weber, R. praecox Bertol., R. radula Weihe in Boenn., 
R. sampaioanus Sudre ex Samp., R. vagabundus Samp., and R. vigoi R. 
Roselló, Peris & Stübing. These different species are potentially 
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constituted by a different combination of bioactive phytochemicals. 
Blackberries wild species are then a source of genetic variability to be 
explored.  
 
5. Aim 
This work envisages the study of plants as sources of phytochemicals with 
neuroprotective potential. Two different approaches will be described: the 
first utilizes juniper leaves for a potential pharmacological application; the 
second uses blackberries for a nutritional strategy. The two groups of 
plants chosen to be studied (junipers and blackberries) included 
species/cultivars with broader occurrences and others presenting a more 
restricted distribution, being in some cases endemic from some 
Portuguese regions. 
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Abstract  
The increase in population lifespan has enhanced the incidence of NDDs, 
for which there is, as yet, no cure.  
We aimed to chemically characterize phenolic-enriched fractions (PEFs) 
from four wild Juniperus sp. found in Portugal (Juniperus navicularis, 
Juniperus oxycedrus badia, Juniperus phoenicea and Juniperus turbinata) 
and address their potential as sources of natural products for treatment of 
NDDs.  
Leaves from the four Juniperus sp. evaluated contained a range of 
phenolic components which differed quantitatively between the species. 
The PEFs obtained were rich sources of phenolic compounds, exhibited 
AChE inhibitory activity and also displayed effective intracellular radical 
scavenging properties in neurons submitted to oxidative injury but 
showed a different order of effectiveness compared to AChE inhibition. 
These properties made them good candidates for testing in a 
neurodegeneration cell model. Pre-incubation with J. oxycedrus badia PEF 
for 24 h protected neurons from injury in the neurodegeneration cell 
model. 
 
Keywords 
Acethylcolinesterase inhibitor; intracellular antioxidant capacity; Juniperus 
sp.; natural products; neurodegeneration cell model; phenolic enriched 
fraction.
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1. Introduction 
In the developed world, the increase in population lifespan has been 
accompanied by an increase in the incidence of many age-related diseases 
such as neurodegenerative disorders 4. These diseases are associated with 
enormous economic and social costs 5,6: it has been estimated that the 
European healthcare costs of for AD in 2007 were €117 billion and that 
the number of cases are predicted to rise to 81.1 million by 2040 6. This, 
in conjunction with the lack of any cure, has made the development of 
new therapies for halting, retarding or reversing such disorders imperative. 
Research in recent years has provided substantial evidence supporting the 
theory that oxidative stress plays a major role in the pathogenesis of 
neurodegenerative disease 8-10. Oxidative stress is primarily caused by 
deviation of the cells redox balance from the norm and generally this is 
associated with an excessive accumulation of ROS in cells; a process 
previously implicated in the development of many NDDs including PD, HD, 
ALS and AD 8,11,12. Furthermore, a consistent neuropathological occurrence 
associated with memory loss is a cholinergic deficit, which has been 
correlated with the severity of AD. AChE inhibition has been reported to 
ameliorate the symptoms of some NDDs and has been used as a rationale 
to develop drugs to treat AD 14.  
NPs have made significant contributions towards the treatment of 
degenerative diseases 15. Since plants constitute a rich and diverse source 
of secondary metabolites they have long contributed to the development 
of small-molecule based therapeutics; the class of compounds called 
phenolics, which display a significantly diverse combination of chemical 
moieties, structures and associated potent bioactivities, are a good 
example of this. Indeed, before the advent of high-throughput screening 
and the post-genomic era around 80% of drugs were natural product 
derived and more recently natural product derivatives still accounts for 
more than half of the drugs approved since 1994 16. Several small 
molecules, including (poly)phenolics, have been reported to exhibit 
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neuroprotective properties 14,17,18. In addition, reports suggest that some 
phenolic compounds may target numerous pathways and protein kinases 
that underlie these conditions and that strengthen their utility in 
multifactorial diseases, such as neurodegeneration 17. 
Plants from the Juniperus genus have found application in different 
European cuisines as a spice, flavouring for alcoholic drinks as well as in 
cosmetics 19. Furthermore, these plants have an extensively history of use 
in global folk medicine for various disorders, such as common colds, 
urinary and kidney infections and dermatological disorders 20. Many 
biological activities have been reported for Juniperus sp. These include 
anti-inflammatory 3,21, diuretic, antiseptic (bacterial and fungal) 2,22-25, 
anthelmintic 26, hypoglycaemic 27, hypotensive, abortifacient, 
antinociceptive 21, antiviral 28, anticancer 29, antioxidant 2,3,30-32, 
anticholinesterase 31,32 and analgesic properties 33. They have also been 
found to be useful in the treatment of psoriasis 34 and neurasthenic 
neurosis 35. Although the chemical composition of the essential oil from 
diverse Juniperus sp. has attracted significant interest 36-42 much less 
attention has been paid to other components and there is paucity of detail 
on the phenolic characterization of Juniperus sp.. Previous reports have 
highlighted the presence of phenolic compounds including flavonoids, 
neolignans and phenylpropanoids 7,43-46, but also terpenoids 47-49. Studies on 
Juniperus species occurring in Portugal have been even more limited and 
the focus again was on essential oils 40-42. The aim of this work is to 
chemically characterize wild Portuguese Juniperus sp., in terms of 
phenolic compounds and address their potential as sources of NPs for 
treatment of NDDs. The rationale of this work is the search for AChE 
inhibitors as well as intracellular antioxidants as candidates to be tested 
in a neurodegeneration cell model. 
 
 
 
Chapter 2: The neuroprotective potential of phenolic-enriched fractions four from 
Juniperus species found in Portugal 
65 
 
2. Material and methods 
2.1. Plant material and extract preparation  
Leaves of Juniperus navicularis Gand., Juniperus oxycedrus subsp. badia 
(H. Gay) Debeaux, Juniperus phoenicea L. and Juniperus turbinata Guss. 
were collected, frozen and then freeze-dried. Juniperus navicularis is a 
Portuguese endemic and threatened plant and was sampled under a 
license for capture (11/2008/CAPT and 12/2008/CAPT). For all species, 
voucher samples were authenticated and deposited at the herbarium "João 
de Carvalho e Vasconcelos", Instituto Superior de Agronomia, Lisbon, 
Portugal. The herbarium numbers are: Juniperus navicularis (LISI 
1064/2007), J. oxycedrus subsp. badia (LISI 1/2008), J. phoenicea (LISI 
3/2008) and J. turbinata (1067/2007). Freeze-dried leaves were ground in 
a IKA M20 mill to pass a 0.5 mm sieve and stored at -80 ºC prior to 
extraction. Leaf extracts were prepared using a hydroethanolic solution 
(ethanol 50 % (v/v)) as previously described 50. Samples were dried, by 
centrifugal evaporation.  
2.2. Fractionation by solid phase extraction 
PEFs were obtained by fractionation by Solid Phase Extraction (SPE) using a 
Giga tubes 2 g 12 mL-1, C18-E units (Phenomenex®) as described before 50. 
PEFs were dried under vacuum, to suitable phenol contents for 
subsequent assays.  
2.3. Chemical characterization 
2.3.1. Total phenolic quantification 
Determination of total phenolic content (TPC) was performed by the Folin- 
-Ciocalteau method adapted to microplate reader 51. Gallic acid was used 
as the standard and the results were expressed as mg of gallic acid 
equivalents (mg GAE) per g of dry weight (DW).  
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2.3.2. Liquid chromatography-mass spectrometry (LC-MS) 
phenolic profile determination 
Dried extracts were redissolved and then applied to a C-18 column 
(Synergi Hydro C18 with polar end capping, 4.6 mm x 150 mm, 
Phenomonex Ltd.) and eluted over a gradient of  95:5 solvent A:B at 
time=0 minutes to 60:40 A:B at time=60 minutes at a flow rate of  
400 µL min-1. Solvent A was 0.1% (v/v) formic acid in ultra pure water and 
solvent B 0.1% (v/v) formic acid in acetonitrile. Samples were analysed on 
a LCQ-DECA system controlled by the XCALIBUR software (2.0, 
ThermoFinnigan), as reported by Tavares et al. 52. The LCQ-DECA system 
comprised a Surveyor autosampler, pump and photo diode array (PDA) 
detector and a Thermo Finnigan mass spectrometer iontrap. 
2.4. AChE inhibitory assay 
AChE inhibition was determined in 96-microtiter well plate, based on 
Ellman’s reaction, as described previously 53. Different concentrations of 
PEFs of the four species were tested (50, 100, 200, 400 and 800 µg  
GAE mL-1). The effect on AChE activity was calculated as percentage 
inhibition (%) of the control activity without inhibitor.  
2.5. Cell culture 
Human neuroblastoma SK-N-MC cells were obtained from the European 
Collection of Cell Cultures (ECACC) and cultured in Eagle Minimum 
Essential Medium (EMEM, Sigma) supplemented with 2 mM L-glutamine 
(Sigma), 10 % (v/v) heat inactivated foetal bovine serum (FBS, Gibco), 1 % 
(v/v) non-essential amino acids (Sigma), 1 mM sodium pyruvate (Sigma) 
and containing 50 U mL-1 penicillin and 50 µg mL-1 streptomycin. The cells 
were maintained at 37 ºC in 5 % CO
2
 and harvested at sub-confluence of 
70-80 % using 0.05 % trypsin/EDTA (Gibco). 
2.6. Cytotoxicity profile 
PEFs were dissolved in cell medium for measuring cell viability as 
previously described 52. Briefly, SK-N-MC neuroblastoma cells were seeded  
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in a 96-well plate using 1.25 x 105 cells mL-1 and grown for 48 h prior to 
addition of PEFs. Cytotoxicity was assessed using 24 h incubation with 
PEFs in the range 0-500 µg GAE mL-1 medium. Cell viability was assessed 
using the CellTiter-Blue® Cell Viability Assay (Promega), according to the 
manufacturer’s instructions. 
2.7. Intracellular ROS production  
To evaluate the ability of PEFs to reduce cellular ROS levels, the conversion 
of 2’,7’-dichlorofluorescein diacetate (H
2
DCFDA, Invitrogen) to fluorescent 
2’,7’-dichlorofluorescein (DCF) was monitored, as already described 52. 
Briefly, SK-N-MC neuroblastoma cells were seeded in a 96-well plate  
(1.25 x 105 cells mL-1),  grown for 24 h prior to treatment then pre-
incubated with PEFs prepared in medium (0.5% (v/v) FBS) for 2 h or 24 h. 
Cells were then incubated with 25 µM H
2
DCFDA for 30 min at 37 ºC, 
followed by addition of H
2
O
2
 (200 µM) and the fluorescence determined 
(λ
ex
: 485 nm, λ
em
: 530 nm) over 1 h at 37 ºC. ROS generation was 
calculated as an increase in fluorescent signal between control and H
2
O
2
- 
-treated cells.  
2.8. Determination of antioxidant enzyme activity  
Cells were seeded in 6-well plates and grown for 24 h before treatment 
with PEFs. After 24 h, cells were treated with H
2
O
2
 (200 µM, 1 h), which 
has been previously reported as inducing oxidative stress without cell 
death 52. Cells were washed with PBS and lysed with 200 µL of lysis buffer, 
containing 50 mM Tris-HCl pH 8.0, 120 mM NaCl, 0.5 mM EGTA and  
0.05 % (v/v) Triton X-100. Cells were incubated for 20 min on ice with 
vortexing every 5 min, then centrifuged 15 min at 9,000g. The 
supernatant was used to determine the activities of superoxide dismutase 
(EC 1.15.1.1) and catalase (EC 1.11.1.6). The activity of both enzymes was 
normalized for protein content determined by the Lowry method 54. 
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2.8.1. SOD assay 
SOD activity was measured based on the extent of inhibition of amino 
blue tetrazolium formazan formation and was adapted from Mockett  
et al. 55. Briefly, cell extracts were incubated in 100 mM PBS (pH 7.8) 
containing 0.1 mM EDTA, 0.1 mM xanthine, 100 µM nitro blue tetrazolium 
(NBT) and 2.5 nM xanthine oxidase (EC 1.1.3.22, CAS No: 9002-17-9, 
purified from bovine milk, Grade I, Sigma). The reduction of NBT was 
measured at 560 nm. One unit of SOD activity was determined as the rate 
of absorbance change per min. 
2.8.2. CAT assay 
CAT activity was measured by the method of Aebi 56 in which the rate of 
H
2
O
2
 decomposition was determined spectrophotometrically at 240 nm. 
The reaction mixture contained 30 mM of H
2
O
2
 in 50 mM potassium 
phosphate buffer, at pH 7.0. The reaction was initiated by adding 50 µL of 
cell lysate and the decrease in absorbance per min was calculated from 
the initial linear portion of the curve, using as molar extinction coefficient 
0.0394 cm-1 mM-1. The enzyme activity was expressed as U mg-1 protein, 
with 1 U being the amount of enzyme consuming 1 µmol of H
2
O
2
 per min. 
2.9. Neuroprotective effect against oxidative stress 
Fractions were evaluated for their neuroprotective effect in a 
neurodegeneration cell model previously described 52. The model involved 
the treatment of SK-N-MC neuroblastoma cells with H
2
O
2
 to induce cell 
death. Briefly, cells were seeded at 7.4 x 104 cells mL-1 and grown for 24 h. 
After 24 h of pre-incubation with medium supplemented with non-toxic 
concentrations of PEFs, cells were treated with medium containing H
2
O
2
 
(300 µM). After 24 h, the medium was removed and cells were washed 
with PBS and collected by trypsinisation. Cells were then incubated with 
two fluorescent probes for 30 min at 37 ºC. Mitochondrial transmembrane 
potential (∆Ψm) was assessed using 3,3’-dihexyloxacarbocyanine iodide 
(DiOC
6
(3), 20 nM, Invitrogen) and cell viability was determined by 
assessing plasma membrane integrity using propidium iodide (PI, 1 µg  
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mL-1, Invitrogen) 57. These parameters were analysed by flow cytometry 
using a blue solid state laser (488 nm) with FL1 green fluorescence 
channel for DiOC
6
(3) at 530 nm and a FL3 red fluorescence channel for PI 
detection at 650 nm. The acquisition and analysis of the results were 
performed with FlowMax® (Partec) software. 
2.10. Statistical analysis 
The results reported are the averages of at least three independent 
experiments and are represented as the mean ± SD. Differences among 
treatments were detected by analysis of variance with Tukey HSD (Honest 
Significant Difference) multiple comparison test (α = 0.05) using SigmaStat 
3.10 (Systat).  
 
3. Results 
3.1. Chemical characterization 
 Hydroethanolic extracts were obtained from the four Juniper species and 
chemically characterized (Table 1). The phenolic content was highest for 
the extract obtained from J. oxycedrus badia, followed by J. turbinata,  
J. navicularis and J. phoenicea, respectively. Following SPE fractionation, 
PEFs were obtained for all species with similar phenolic content. They 
were used at an equivalent phenolic load for all subsequent comparative 
bioactivity assessments. 
All four Juniperus sp. gave LC-MS-PDA profiles, in which some shared 
peaks presented quantitative differences (Fig. 1 and Table 2). Their 
phenolic composition is also in agreement with the phenolic 
identifications found in the literature for Juniperus sp.. Until now the 
identifications of Juniperus sp. compounds are spread across different 
reports, in which different species were used and for each only a few 
number of compounds were identified 2,3,7,13,31,44,45,58-61.  
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Catechins, procyanidins, flavonol derivatives, flavones and biflavones  
(Fig. 1 and Table 2) were putatively identified in the Juniperus sp.. Two 
major compounds that have been previously reported in J. communis as 
unknown 13 were present and identified as psydrin (peak 1) and 
procyanidin trimmer (peak 9). Psydrin was the major peak of J. oxycedrus 
badia, J. phoenicea and J. turbinata but significantly less prevalent in the 
J. navicularis LC-MS-PDA profile. Amongst the major compounds of 
Juniperus sp. were catechins, a range of flavonol derivatives (such as 
quercetin rutinoside and quercetin rhamnoside), flavones (such as 
isoscutellarein and luteolin glycosides) and biflavones. Procyanidins were 
present in all PEFs but in variable amounts. Some procyanidins 
components eluted as discrete peaks (e.g. peaks 2, 4, 5 and 7) but they 
were also presented as a poorly resolved smear across retention times 
(RTs) 17-25 mins (Fig. 1, annotated by bar). All four species contained 
flavonol derivatives mainly as quercetin, but also as myricetin, glycosides 
but they varied in content and composition between the species. For 
example, quercetin rutinoside (peak 13) was a major component of  
J. navicularis but it was present in much lower amounts in the other 
species. Another major difference between J. navicularis and the other 
species was the abundance of procyanidin trimer (peak 9, the unidentified 
phenolic component reported by Martz et al.13). Putative flavone 
derivatives were detected but whether these were isoscutellarein and/or 
luteolin glycosides could not be completely confirmed by LC-MS. However, 
Table 1- Total phenolic content of crude extracts and PEFs obtained from the four 
Juniperus sp.. Values are expressed as mg GAE g-1 of dried powder. Statistically 
significant differences at p<0.05 are denoted with different letters (a-c). All values 
are mean ± SD, n = 3. 
Species Crude extract PEF 
J. navicularis 247±28bc 310±40 
J. oxycedrus badia 354±10a 414±90 
J. phoenicea 221±5c 330±24 
J. turbinata 274±3b 401±55 
 
Chapter 2: The neuroprotective potential of phenolic-enriched fractions four from 
Juniperus species found in Portugal 
71 
 
these flavone derivatives (especially peaks 20 and 21) were more 
abundant in J. oxycedrus badia, J. phoenicea and J. turbinata. Such 
flavone derivatives have already been identified in J. communis var. 
depressa 44,45. Biflavone derivatives were putatively identified in all four 
species (peak 22, RT ~35 min). However, these apolar compounds eluted 
late in the gradient and were not sufficiently separated to allow us to 
distinguish between the three biflavones already identified in J. drupacea, 
amentoflavone, cupressuflavone and hinokiflavone 7. 
 
 
Fig.  1- Representative PDA profiles for J. navicularis (A), J. oxycedrus badia (B), 
J. phoenicea (C) and J. turbinata (D). Peak numbers correspond to their putative 
identifications based on MS fragmentation data presented in Table 2. The full 
scale deflection for each trace is shown in the top right corner. The area denoted 
by the bar is discussed in the text. 
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3.2. AChE inhibitory assay 
AChE inhibition by the PEFs was tested at the following concentrations: 50, 
100, 200, 400 and 800 µg mL-1 (Table 3). J. turbinata was the most potent 
species. Using 800 µg mL-1 of J. turbinata PEF the inhibition was 72.65 %. 
This species was followed by J. phoenicea, J. navicularis and J. oxycedrus 
badia. The last species was the only not able to inhibit more than 50 % at 
the concentrations tested. 
Table 2- Putative identities of major peaks in Juniper fractions 
Peak 
no. 
RT PDA m/z [M-H] MS2 Putative Identity 
1* 8.22 271 
275.1 [321.1] 
+277.1, 115.1 
161.1, 113.1 
+115.1, 87.1 
Psydrin,a furanone glycoside 1 
2 
11.23-
11.41 
280-310 
593.2, 425.4, 
289.8 
549.1, 289.1 
Epicatechin-epigallocatechin (EC-
EGC) 
3 12.54 285 305.1 179.1 Gallocatechin 
4 13.17 269 
896.7, 593.0, 
425.3, 289.1 
710.9, 593.1, 
425.0 
Procyanidin (EC-EGC-EGC) 
5 14.58 277 577.1, 289.2 
451.0, 407.1, 
289.1 
Procyanidin dimer (EC2) 
6 15.07 283-314 305.2 219.1, 179.0 Epigallocatechin 
7 15.87 275 577.0, 289.1 289.1 Procyanidin dimer (EC2) 
8 16.74 279 289.2 245.1, 179.2 Epicatechin 
9 17.32 275 865.1, 577.0 695.1, 577.1 Procyanidin trimer (EC3) 
10 18.14 275 881.2 593.1, 695.1 Procyanidin trimer (EC-EGC-EC) 
11 19.42 275, 378 479.2, 317.1 317.1 Myricetin hexose 2 
12 19.93 270, 357 625.3, 317.0 317.1 Myricetin rutinoside 
13 21.86 255, 354 609.2, 301.1 301.2, Quercetin rutinoside 3 
14 22.06 270- 365 449.2, 317.1 317.1 Myricetin pentose 
15 22.51 221, 269 755.0 569.0, 289.1 Proanthocyanidin derivative 
16 23.17 280-365 
181.5 
463.7, 301.2 
None 
301.2 
Unknown compound 
Quercetin hexose 
17 24.56 280-340 447.1, 285.0 285.1 Isoscutellarein hexoside 
18 24.81 276, 342 433.2, 301.2 301.2 Quercetin pentoside 
19 25.43 280-340 447.1, 301.1 301.1 Quercetin rhamnoside 
20 27.57 280-340 417.0, 285.2 285.2 Luteolin/isoscutellarein pentoside 
21 27.88 280-340 431.1, 285.1 285.1 Luteolin/isoscutellarein rhamnoside 
22 
35.06, 
35.34 
272, 329 537.9 375.2 
Amentoflavone or Cupressuflavone 
or Hinokiflavone 7 
Figures in bold are the main m/z or MS2 signals and were those used for MS2 fragmentation. 
Compound 1 is equivalent to the unknown compound as detected previously by Martz et al. 13. Figures in 
parantheses are formate adducts. + denotes [M + H] signals. 
Other m/z signals for larger proanthocyanidins (e.g. 1153 for epicatechins tetramers are present but do 
not elute as discrete peaks. 
* - Exact mass data obtained on the Orbitrap system supports this identification; molecular formula 
C
11
H
17
O
8 
in negative mode (RDB 4.5, delta amu 0.001). The difference in MS2 fragmentation pattern 
between positive and negative mode is also noted by Comte et al. 1. 
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3.3. Cytotoxicity profile 
Cell viability was determined for SK-N-MC neuroblastoma cells submitted 
to increasing concentrations of PEFs (0 to 500 µg GAE mL-1; Fig. 2). The 
four species presented different toxicity profiles. The less toxic species 
were J. navicularis and J. oxycedrus badia, which required more than  
100 µg GAE mL-1 to cause complete cell death. J. turbinata and  
J. phoenicea PEFs were more toxic, as they required less than 100 µg GAE 
mL-1 to drop cell viability to 0 %. The different toxicities were also reflected 
in the amount of PEFs required to attain 50 % of cell viability (around  
20 µg GAE mL-1 for J. phoenicea and 60-70 µg GAE mL-1 for J. navicularis). 
 
 
 
Fig.  2- Cytotoxicity profiles of Juniperus sp. PEFs. Cell viability was determined 
for SK-N-MC neuroblastoma incubated with Juniperus sp. PEFs (0 to 500 µg GAE 
mL-1) for 24 h. J. navicularis ( ), J. oxycedrus badia ( ), J. phoenicea
( ) and J. turbinata ( ). All values are mean ± SD, n = 3. 
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Table 3- AChE inhibitory capacity by Juniperus species. Results are reported as % 
inhibition compared to the control activity. Values are the average of at least three 
replicates ± SD. 
Fraction 
concentration 
(µg mL-1) 
J. navicularis 
J. oxycedrus 
badia 
J. phoenicea J. turbinata 
50 6.44±3.28 14.97±8.71 14.36±4.84 16.38±5.76 
100 14.31±6.46 14.26±3.60 15.93±4.71 29.33±3.90 
200 25.76±3.48 24.02±5.03 33.74±3.32 47.07±4.88 
400 30.69±7.60 27.03±8.47 53.44±3.02 83.84±7.90 
800 55.60±5.23 38.78±4.07 65.48±3.03 72.65±17.06 
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3.4. Intracellular ROS production  
The effect of pre-incubation with Juniperus PEFs on the production of ROS 
by neuroblastoma cells in the presence or absence of oxidative stress was 
evaluated (Fig. 3). PEFs were applied at concentrations demonstrated to be 
non-toxic for cells. In the absence of stress, all four Juniperus sp. PEFs 
reduced the basal production of ROS in cells exposed for 2 h or 24 h  
(Figs. 3A and B, respectively), and this reduction was more significant 
after 24 h incubation (Fig. 3B). When cells treated with PEFs for 2 h were 
exposed to a non-lethal stress (200 µM H
2
O
2
 for 1 h) 52, a significant 
decrease in ROS levels was recorded compared to the stress in the 
absence of PEFs but not for all PEF concentrations used (Fig. 3C). For 
example, the highest concentration of PEFs from J. phoenicea and  
J. turbinata (5 µg GAE mL-1) did not significantly reduce ROS production 
although lower concentrations did. Indeed, when cells were pre-incubated 
with PEFs for 24h, only J. navicularis and J. oxycedrus badia PEFs 
significantly reduced ROS production, for all three concentrations used 
(Fig. 3D).  
The 24 h pre-incubation with PEFs gives sufficient time that ROS levels 
may be affected through alterations in indirect antioxidant defences. 
Therefore we decided to evaluate the activities of two important 
endogenous antioxidant enzymes (SOD and CAT). Their activities were 
determined in neuroblastoma cells pre-incubated with PEFs for 24 h in the 
absence or presence of the non-lethal stress (200 µM H
2
O
2
 for 1 h). No 
differences were detected in SOD or CAT activities, when cells were 
stressed with H
2
O
2
 (results not shown). The lack of changes in SOD and 
CAT activities were also verified in cells pre-incubated with PEFs or pre- 
-incubated with PEFs followed by the oxidative challenge. 
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Fig.  3- Relative intracellular ROS production by SK-N-MC neuroblastoma cells pre-incubated with Juniperus PEFs. Neuroblastoma 
were pre-incubated with PEFs for 2 h (A) or 24 h (B) in the absence of stress or for 2 h (C) or 24 h (D) in the presence of stress 
(H
2
O
2
 200 µM, 1h). ROS were detected by fluorimetry using H
2
DCFDA as probe. Statistical differences in relation with untreated 
cells are denoted as * p<005 ** p<0.01 *** p<0.001; statistical differences in relation with stressed cells are denoted as  
# p<0.05 ## p<0.01 ### p<0.001. All values are mean ± SD, n = 3. 
 
2 h
24 h
J. 
navicularis
J. oxycedrus 
badia
J. phoenicea J. turbinata
Total phenolic
content (µg mL-1) 0 1.25 2.5 5 1.25 2.5 5 1.25 2.5 5 1.25 2.5 5
0
0.5
1
1.5
R
O
S
 r
e
la
ti
v
e
 p
ro
d
u
c
ti
o
n
* *
* ** **
*
*
*
A
0
0.5
1
1.5
R
O
S
 r
e
la
ti
v
e
 p
ro
d
u
c
ti
o
n
***
***
***
**
***
***
**
** ***
***
B
J. navicularis
J. oxycedrus 
badia
J. 
phoenicea
J. 
turbinata
Total phenolic 
content (µg mL-1) 0 0 1.25 2.5 5 1.25 2.5 5 1.25 2.5 5 1.25 2.5 5
H2O2 (200 µM) - + + + + + + + + + + + + +
2 h
24 h
0
0.5
1
1.5
2
R
O
S
 r
e
la
ti
v
e
 p
ro
d
u
c
ti
o
n ###
###
###
# # ##
##
C
0
0.5
1
1.5
2
R
O
S
 r
e
la
ti
v
e
 p
ro
d
u
c
ti
o
n
###
###
###
###
###
##
D
Chapter 2: The neuroprotective potential of phenolic-enriched fractions four from 
Juniperus species found in Portugal 
76 
 
3.5. Neuroprotective effect against oxidative stress 
PEFs were also tested in a neurodegeneration cell model for their 
protective effects. This model consists of neuroblastoma cells injured with 
300 µM H
2
O
2
 for 24 h, a condition that routinely reduces viability to 50 %. 
Two parameters were used to assess the protective effect of the PEFs: cell 
viability through the measurement of membrane integrity (Fig. 4A) and 
measurement of ∆Ψm (Fig. 4B).  
All Juniperus sp. PEFs were tested but only the J. oxycedrus badia PEF was 
able to protect cell viability and promote an increase in ∆Ψm (Fig. 4) at the 
concentrations used. The others Juniperus sp. PEFs did not improve these 
parameters over the stressed conditions (results not shown). The highest 
concentration of J. oxycedrus badia PEF (5 µg GAE mL-1) did not change 
viability, but decreased ∆Ψm in the absence of H
2
O
2
, suggesting that it 
may influence cellular metabolism. Under H
2
O
2
 stress, 2.5 µg GAE mL-1 PEF 
was the most effective cytoprotective concentration, in both parameters 
(viability and ∆Ψm). The use of 5 µg GAE mL-1 of PEF was not able to 
produce a better protection than 2.5 µg GAE mL-1 PEF. 
 
4. Discussion 
Previous work has attributed antioxidant activity and AChE inhibitory 
activity to extracts of some Juniperus sp. These properties along with 
their multiple aforementioned bioactivities (see section 1. Introduction) 
make Juniperus sp. interesting plants in the search for new NPs to treat 
NDDs. Despite this, diverse species of Juniperus, and in particular those 
growing in Portugal have not been characterized with respect to their 
phenolic composition; the proposed source of some of their bioactivities.  
Botanically, J. navicularis and J. oxycedrus badia belong to section 
Juniperus and J. phoenicea and J. turbinata belong to section Sabina and 
these inter-relationships might also underlie chemical diversity 62. 
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The four species yielded extracts with high TPCs when compared with 
extracts obtained in other works 31,32. After enrichment by SPE 
fractionation the fractions exhibited a higher phenolic content without 
organic acids, sugars and minerals which could confound any subsequent 
bioactivity analyses. 
This is the first time that the phenolic composition of these four Juniperus 
sp. has been described. Previous work on these species has mainly 
focused on essential oils composition 23,40,42 or have described biological 
properties without attempting to define or chemically characterise the 
derivation of the bioactivity 26,33,63. This work showed that the main 
polyphenolic compounds were common among the different species and 
some have been identified previously in various studies in different 
 
Fig.  4-   Cell viability and mitochondrial transmembrane potential (∆Ψm) for cells 
pre-incubated with J. oxycedrus badia PEF. (A) Cell viability, expressed as 
percentage of cells containing intact membrane, using PI as fluorochrome. 
(B) Percentage of cells presenting high ∆Ψm, using DiOC
6
(3) as probe. 
Neuroblastoma cells were pre-incubated with PEFs for 24 h and then injured by 
300 µM H
2
O
2
 for 24 h. Statistical differences comparatively with untreated cells 
are denoted as * p<0.05 *** p<0.001; statistical differences comparatively with 
injured cells are denoted as # p<0.05 ## p<0.01. All values are mean ± SD, n = 3. 
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Juniperus sp. 2,3,7,13,44,58-60. The main differences noted between the four 
species under study were in the relative amounts of certain compounds. 
For example, in J. oxycedrus badia, J. phoenicea and J. turbinata, psydrin 
was a major peak. However, in J. navicularis, this compound was not so 
dominant and other components, including the procyanidin trimmer  
(peak 9, RT= 17.32) and quercetin rutinoside (peak 13, RT = 21.86), were 
more abundant. On a equivalent phenolic basis, J. oxycedrus badia,  
J. phoenicea and J. turbinata were characterised by having greater levels 
of psydrin but also enhanced levels of procyanidins and certain individual 
peaks such as peak 7 (a procyanidin dimmer) as well as the flavone 
glycosides (peaks 20, 21). Indeed, on further examination, small 
differences in the flavonol and flavone composition of the species could 
be discerned which would not explain their different bioactivities, but 
could be used to distinguish them. However this would require more 
extensive examination. 
Among the phenolic compounds identified, biflavones such as 
amentoflavone, have already been described as useful in NDDs. It should 
be noted that the levels of these components were similar between the 
four PEFs. Amentoflavone have been reported as possessing inhibitory 
effect on the group II phospholipase A2 (PLA2) activity and also in 
inhibiting COX 64. Collective evidence from many recent studies suggests 
that increased PLA2 activity and PLA2-generated mediators play a central 
role not only in acute inflammatory responses in the brain, but also in 
oxidative stress associated with neurological disorders 65. PLA2 reportedly 
contributes to the pathogenesis of these disorders by attacking neural 
membrane phospholipids and releasing proinflammatory lipid mediators 
such as prostaglandins among others and also by generating  
4-hydroxynonenal, a well reported toxic product of lipid oxidation 66. Thus, 
inhibition of PLA2 activity provides an attractive approach for the 
treatment of inflammation and oxidative stress associated with acute 
neural trauma and some neurodegenerative disorders such as AD 67.  
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Among the possible strategies for the treatment of AD, PD, senile 
dementia, ataxia and myasthenia gravis is the enhancement of brain 
cholinergic activity by AChE inhibition 68-70. The principal role of AChE is 
the termination of nerve impulse transmission at the colinergic synapses 
by rapid hydrolysis of ACh. A variety of plants have been reported to show 
AChE inhibitory activity and constitute sources of potential new NPs in the 
treatment of neurodegenerative disorders 70 with diverse phytochemystries 
including alkaloids such as physostigmine and galantamine 71,  
ursolic acid 71, lignans 72, flavonoids, terpenoids and coumarins 14. Leaves 
of the Juniperus sp. used here caused similar levels of AChE inhibition as 
reported for other plants 70 and comparable to extracts from other 
Juniperus sp. leaves 31. In that work, J. excelsa extracts caused 45 % 
inhibition using 200 µg mL-1, whilst here J. turbinata extracts inhibited  
47 % of AChE activity at the same concentration of PEF. The remaining 
three species were less effective (causing 20 to 30 % inhibition at this 
concentration). Among the four species, the most effective AChE 
inhibition was caused by J. phoenicea and J. turbinata, which reached  
50 % of inhibition at ~400 and 200 µg mL-1 respectively. Since the PEFs, by 
definition, are enriched in phenolic components but free of sugars, 
organic acids and minerals, it is likely that AChE inhibitory activity was 
derived from phenolic compounds either singly or in combination. Psydrin 
and as well as quercetin derivatives have been identified as a good 
inhibitors of AChE 73,74. It has been demonstrated that quercetin inhibits 
AChE by a competitive mechanism 75,76.  However, other components must 
contribute to AChE inhibition since J. navicularis exhibited the highest 
amount of quercetin rutinoside (peak 13) but was the least effective PEF. 
The most effective PEFs for AChE inhibition (J. phoenicea and J. turbinata) 
had higher relative levels of procyanidins and lower levels of flavonols. 
Their higher effectiveness as AChE inhibitors could be related to their 
different composition. Due to the adverse side-effects and bioavailability 
problems of some AChE inhibitors already in use, there still is great 
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interest in finding better molecules 77,78. However, as the bioavailabilities 
of the juniper phenolics, are unknown, especially the unidentified 
components, their potential as effective agents remains to be discovered. 
Since many of the NPs exhibit an hormetic effect 79 it was necessary to 
confirm that the concentrations used were not cytotoxic before testing 
PEFs in neuroblastoma cells. Once again, there was a clear difference 
between the Juniperus sp., with J. navicularis and J. oxycedrus badia 
being the least toxic and J. turbinata and J. phoenicea more toxic. This 
difference in cytotoxicity must be related to differences in the polyphenol 
composition. 
Non-toxic concentrations of PEFs (0 and 5 µg GAE mL-1) from the four 
Juniperus sp. reduced basal ROS production (without H
2
O
2
 stress) at 2 and 
24 h incubation. When a non-lethal stress was imposed (200 µM H
2
O
2
 for 
1h), all PEFs retained the ability to reduce intracellular ROS following pre- 
-incubation for 2 h. However, at 24 h pre-incubation, only PEFs from  
J. navicularis and J. oxycedrus badia caused diminished ROS levels. 
Antioxidant activity in biological systems could be due to direct or indirect 
effects of compounds and the Juniperus PEFs could be acting by both 
direct as well as indirect antioxidant capacities. The direct antioxidant 
capacity could be achieved through a direct radical scavenging activity 
and the indirect antioxidant capacity through the induction of cellular 
defenses generally through the Nrf2 system, such as antioxidant  
enzymes 80. Therefore, at 2 h pre-incubation with PEFs, we assumed that 
changes in ROS levels were the consequence of a direct radical scavenging 
and at 24 h pre-incubation the changes were the consequence of the 
indirect antioxidant defenses. Thus, the direct scavenging that the four 
PEFs were able to mediate did not last for a longer time (Fig. 3 C and D). 
At 24 h pre-incubation other molecular events should take place, but they 
only should occur in cells pre-incubated with J. navicularis and  
J. oxycedrus badia PEFs. Since the amount of phenolic compounds used to 
determine the intracellular ROS production was equivalent for the four 
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species, the differences obtained must be the result of the differential 
composition/relative amount of each compound within species. 
Concerning the indirect antioxidant defences, the activities of SOD and 
CAT, considered primary antioxidant enzymes 81, were not altered as ROS 
production was decreased. Although both enzymes are responsible for 
protecting cells against ROS produced during normal metabolism and 
after an oxidative insult, these results suggest that alternative pathways 
could be regulated to cope with the imposed increase of ROS. These 
alternative pathways could be acting through the ARE and/or the 
xenobiotic response element (XRE) systems 82 with associated induction of 
induce genes for antioxidant and detoxification enzymes, such as NQO1 83. 
Only the PEF from J. oxycedrus badia could protect neurons against the 
injury caused by H
2
O
2
. This PEF enhanced values of viability and ∆Ψm, 
compared with cells treated with H
2
O
2
. A PEF concentration of 2.5 µg  
GAE mL-1 produced effective protection, enhancing viability by 51 % and 
∆Ψm by 57 % compared with cells only treated with H
2
O
2
. If considering at 
the same time the number of cells presenting adequate membrane 
integrity and a high ∆Ψm, the augmentation caused by 2.5 µg GAE mL-1 of 
J. oxycedrus badia PEF was about 70 %.  
These results, together with the data for SOD and CAT activities, suggest 
that reduction of intracellular ROS levels verified for 24 h pre-incubation 
with PEFs should be due to the induction of other intracellular antioxidant 
mechanisms. The involvement of ARE and XRE systems may be valid 
systems for investigation. 
 
5. Conclusions 
All four Juniperus sp. PEFs, and in particular J. oxycedrus badia, constitute 
potential sources of neuroprotective NPs. The four species are rich 
sources of phenolic compounds and contain molecules previously 
described with neuroprotective potentialities, such as quercetin 
derivatives (AChE inhibitor) and amentoflavone (effect on the group II 
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PLA2 inhibitor and cyclooxygenase inhibitor). Phenolic compounds from 
these species caused effective intracellular radical scavenging in neurons 
submitted to oxidative injury. Moreover, J. navicularis and J. oxycedrus 
badia PEFs induced mechanisms that reduced ROS formation induced by 
H
2
O
2
 treatment. Finally, J. oxycedrus badia PEF had a protective effect in 
the neurodegeneration cell model. The lack of impact of the components 
on the standard antioxidant enzymes CAT and SOD suggest alternative 
mechanisms underpin this bioactivity. Further research is merited to 
elucidate the source and mechanisms of these bioactivities, particularly if 
these are to be used in dietary-based neuroprotection strategies such as 
functional foods and/or functional food ingredients.  
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Abstract 
Phenolic enriched extracts from endemic Portuguese junipers were 
described as potential neuroprotective NPs. However, evaluation of plants 
for pharma/nutraceutical industry is based on secondary metabolites 
content, which is influenced by the environmental conditions. Therefore, it 
became important to elucidate the metabolic response of the junipers to 
seasonality and to stress conditions, concerning PPs production. 
Seasonal conditions modulated total phenolic and flavonoids contents of 
the four juniper species, being higher levels of phytochemicals obtained 
when plants were not actively growing. However, it was only register few 
differences in the relative contents of psydrin and a procyanidin dimer, 
accordingly to species. Salt stress and methyl jasmonate (MeJa) elicitation 
presented different susceptibilities within the species. They were effective 
in enhancing phenolic accumulation, with just few alterations in the 
relative contents of procyanidins, epicatechin and quercetin derivatives. 
These differences were also reflected in gene expression of important 
enzymes from biosynthetic pathway.  
 
Keywords 
Methyl jasmonate; phenolic content; polyphenols biosynthesis; salinity; 
season variability. 
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1. Introduction 
NPs are important sources of novel leads for therapeutic drugs 2. Between 
1981 and 2002, of the 877 novel medicines developed, 49 % were NPs, 
their derivatives or synthetic products developed with the natural product 
as a  basis 3. 
Among the diverse phytochemicals produced by plants, PPs are an 
important class. These compounds have many diverse functions in plants, 
such as colour of leaves, flowers and fruits, anti-microbial, anti-fungal, 
insect feeding deterrence, screening from damage by solar UV radiation, 
chelation of toxic heavy metals and anti-oxidant protection from free 
radicals generated during the photosynthetic process 4. Some have also 
been recognized as beneficial for human health since they exhibit 
activities such as anti-inflammatory, antioxidant, insulin-potentiating, anti-
carcinogenic, anti-viral, anti-ulcer, anti-apoptotic, cardiovascular and 
neurodegenerative protectant among others 5.  
Junipers (Juniperus sp.) are plants rich in secondary compounds, 
particularly terpenoids and phenolics 6-11. Common juniper extract is an 
important natural product used widely in many pharmaceutical and 
technical preparations, in cosmetic products and as a food additive. Some 
studies have emerged reporting on the diverse biological activities, such 
as: anti-inflammatory 12, diuretic, antiseptic 13,14, hypoglycaemic 15, 
hypotensive, analgesic, abortifacient, antinociceptive 16, antiviral 17, 
anticancer 18, antioxidant 19,20 and anticholinesterase 19,20. Recently phenolic 
enriched extracts from endemic Portuguese Juniperus sp. were described 
as potential NPs in the treatment of NDDs 1. 
The quality of plants intended for processing by the pharmaceutical 
industry is usually judged on the basis of secondary metabolites content 21. 
However, environmental conditions have an important effect on the 
secondary metabolisms 22. It has been reported that PPs levels can change 
in response to biotic (pest and pathogens) and abiotic (drought, hypoxia, 
high light intensity, low or high temperature) stresses 22,23. Therefore, it is 
critical to understand the metabolic response of the Juniperus sp. to 
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seasonality as well as to stress conditions, in terms of PPs production, if 
the species is to realise its full potential. 
 
2. Materials and methods 
2.1. Plant material and growth conditions 
2.1.1. Seasonal evaluation 
Five years old plants of J. navicularis Gand., J. oxycedrus badia (H. Gay) 
Debeaux, J. phoenicea L. and J. turbinata Guss were used for seasonal 
evaluation. As J. navicularis is a Portuguese endemic and threatened plant, 
a license for capture (11/2008/CAPT and 12/2008/CAPT) was required for 
sampling. For all species, voucher samples were authenticated and 
deposited at the herbarium "João de Carvalho e Vasconcelos", Instituto 
Superior de Agronomia, Lisbon, Portugal. The herbarium numbers are: 
Juniperus navicularis (LISI 1064/2007), J. oxycedrus subsp. badia  
(LISI 1/2008), J. phoenicea (LISI 3/2008) and J. turbinata (1067/2007). All 
plants were grown in pots, exposed to the same local (Lisbon area) 
environmental conditions of light, temperature and humidity. Plants were 
watered when necessary. Leaf samples were collected monthly through 
the year 2008, freeze-dried, ground to fine powder and stored at -80 ºC. 
2.1.2. Stress conditions 
For stress evaluation, two year old plants of J. oxycedrus badia,  
J. phoenicea and J. turbinata were used. Plants were maintained in 1 L 
pots, inside a growth chamber (Fitoclima 700 EDTU, Aralab, Lisbon, 
Portugal) with standard conditions: 30 ºC temperature, 60 % relative 
humidity, 800 µmol m-2 s-1 and 16 h/8 h (light/dark) photoperiod. All the 
plants, except the ones submitted to drought stress, were watered 
frequently with 300 mL of water. Plants were acclimatized for one week 
prior to stress initiation. For each condition tested five plants were used. 
Drought stress Plants were maintained in standard conditions but without 
watering for 20 days. Control plants were maintained under standard 
conditions for 20 days. 
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Salt stress Plants were kept in standard conditions but watered with  
300 mL of 250 mM NaCl for 15 days. Control plants were maintained in 
standard conditions for 15 days. 
Methyl jasmonate (MeJa) treatment Plants were sprayed with an aqueous 
solution containing 5 mM MeJa (Sigma-Aldrich) and 0.1 % (v/v) Tween 20 
(Sigma-Aldrich) at day 0 and effects followed for 120 h. Control plants 
were sprayed with aqueous solution of 0.1 % (v/v) Tween 20. 
2.1.3. Phenolic extracts preparation 
Phenolic compounds were extracted from leaves using a 50 % ethanol 
solution (v/v) in a ratio of 12 mL g-1 of freeze dried leaf powder, as 
previously described 24. 
2.2. Chemical characterization 
2.2.1. Total phenolic content (TPC)  
Determination of total phenolic compounds was performed by the Folin- 
-Ciocalteau method adapted to microplate reader 25. Gallic acid was used 
as the standard and the results were expressed as mg of GAE. 
2.2.2. Total flavonoid content (TFC)  
Measurement of total flavonoids was performed by a modification of the 
AlCl
3
 complexation method as described before 25 and expressed as mg 
catechin equivalents (CE). 
2.2.3. Phenolic composition  
Samples containing 20 µg GAE  were applied to a C18 column (Synergi 
Hydro C18 column with polar end capping, 4.6 mm x 150 mm, 
Phenomonex Ltd.) and analysed on a LCQ-DECA system controlled by the 
XCALIBUR software (2.0, ThermoFinnigan), as reported by Tavares et al. 26. 
The LCQ-Deca system comprised a Surveyor autosampler, pump and PDA 
detector and a Thermo Finnigan iontrap mass spectrometer. Samples were 
analysed in triplicate and in positive and negative mode to aid 
identification. Peak areas were assigned and quantified using the 
XCALIBUR software. 
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2.3. Relative accumulation of enzyme transcripts from 
phenylpropanoid biosynthesis pathway  
2.3.1. Achievement of specific RNA sequences from Juniperus sp. 
2.3.1.1. RNA isolation and cDNA synthesis  
Total RNA was isolated using an adaptation of the method described by 
Chang et al. 27. The extraction buffer contained 2 % (w/v) CTAB, 2 % (v/v) 
2-mercaptoethanol, 3 M NaCl, 25 mM EDTA, 100 mM Tris-HCl (pH 8.0), 2% 
(w/v) PVP-40 and 0.04 % (w/v) of spermidine. Briefly, leaf were ground 
with liquid nitrogen and each 1 g of leaf powder was incubated with  
20 mL of pre-heated extraction buffer for 30 min at 65 ºC with periodic 
shaking. Protein extraction was carried out using with chloroform:isoamyl 
alcohol (24:1) then RNA was precipitated with LiCl overnight at 4 ºC 27. The 
RNA obtained was dissolved in SSTE (1 M NaCl, 0.5% (w/v) SDS, 10 mM 
Tris-HCl pH 8 and 1 mM EDTA pH 8) and a second protein removal was 
performed followed by nucleic acid precipitation with absolute ethanol at  
-20 ºC. The pellet was dried and ressuspended in sterile water. RNA 
quantity and quality were measured spectrophotometrically (ND 1000, 
ThermoScientific) and checked by agarose gel electrophoresis. Afterwards, 
RNA was treated with Turbo DNA-free ™ kit from Applied Biosystems. 
Reverse transcription (RT)-PCR used 2 µg of total RNA in a 20 µL volume 
reaction, 25 µg mL-1 anchored oligo(dT)12-18 primer (Invitrogen) and 
SuperScript ™ II first-strand synthesis system for reverse transcription  
(RT)-PCR (Invitrogen). 
2.3.1.2. Gene Amplification, cloning and sequencing  
To determine the accumulation of transcripts that encode some of the 
most important phenylpropanoyd biosynthesis pathway enzymes, specific 
sequences of PAL, F3H, ANS, LAR and ANR for J. oxycedrus badia and  
J. phoenicea  were amplified. For Real-time RT-PCR normalization 
purposes, the sequences of actin (ACT), elongation factor 1α (EF1A) and 
glyceraldeide 3-phosphate dehydrogenase (GAPDH) were also determined. 
For each gene of interest, amino acid and nucleic acid sequences from 
diverse species, giving special attention to gymnosperm species, were 
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aligned and primers were designed for the most conserved regions. 
Primers were chosen in order to obtain PCR products with approximately 
200 to 500 bp size.  
Genes of interest were amplified in PCR reactions containing 0.1 to 2 µL of 
cDNA, 0.625 U Taq DNA Polymerase (Fermentas), 0.5 µM of each primer, 
2.5 mM MgCl
2
, 0.2 mM of each dNTP, 75 mM Tris-HCl (pH 8.8) and 20 mM 
(NH
4
)
2
SO
4
. The quality of PCR products was visually inspected by 
electrophoresis, and the generation of only one single band of the 
expected size was the criterion for specificity. The PCR products were 
then directly cloned using TA Cloning® Kit Dual Promoter (pCR®II) from 
Invitrogen, accordingly to the manufacturer’s instructions. One Shot® 
INVαF’ Chemically Competent E. coli (Invitogen) were transformed using 
the vector previously prepared. Transformed colonies grown in selective 
medium and the plasmids were purified using illustra plasmidPrep Mimi 
Spin Kit (GE Healthcare). 
The fragments were sequenced using the plasmid internal primers and 
their identity confirmed by comparison with sequences in database. 
Obtained sequences were also deposited in database with GenBank 
Accession numbers GQ389669 to GQ389686 (Table 1).  
2.3.2. Relative quantification of Juniperus sp. transcripts by 
quantitative Real Time RT-PCR 
Primers for Real Time RT-PCR were designed using the conserved regions 
of sequences previously obtained for both species. Beacon Designer™ 7.5 
(PREMIER Biosoft International) software was used and primers were 
designed to obtain products with size between 80 and 200 bp (Table 1). 
Total RNA isolation, DNase treatment and cDNA synthesis were performed 
as described above. 
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Real-time RT-PCR was performed using an iCycler iQ system (Bio-Rad). 
Each reaction contained 10 µL of 2X iQ™ SYBR® Green Supermix (Bio-Rad), 
1.0 µL of diluted cDNA sample, and 0.5 mM of each gene-specific primer 
in a final volume of 20 µL. The following program was applied: 95 °C,  
3 min; then 45 cycles at 94 °C, 10 s; 60 °C, 20 s; 72 °C, 30 s. All reactions 
were performed in triplicate. To check the specificity of the PCR reaction, 
melting curves were analyzed for each data point. Efficiency was 
determined by comparison of experimentally determined and theoretically 
expected threshold values, in cDNA mixtures using serial dilutions. ACT, 
EF1A and GAPDH were used for internal normalization. The expression 
rates were determined using Gene Expression Analysis for iCycler iQ® 
Real-Time PCR Detection System v1.10-©2004 (Bio-Rad). The calculation 
method took into account the different amplification efficiencies 
determined for each gene and also calculated a normalization factor 
which is the geometric mean of the relative quantities for all reference 
genes.  
 
 
Table 1- Enzymes transcripts from the phenylpropanoid biosynthetic pathway 
evaluated in J. phoenicea and J. oxycedrus badia by Real Time RT-PCR. For 
each are shown the geneGenBank accession numbers, gene sequence of 
primers used in Real Time RT-PCR and respective product length. 
Gene Species 
GenBank 
accession 
number 
Primers 
PCR product 
length (bp) 
PAL 
J. phoenicea GQ389685 Fwd:  ATGGCTTCTTACACCTCTGAG 
188 
J. oxycedrus badia GQ389686 Rev: TCCACCGCTTGACAAATCC 
F3H 
J. phoenicea GQ389679 Fwd: GGATTGGAAGCCGACGCGGT 
168 
J. oxycedrus badia GQ389680   Rev: TGGAGGAGCAGAGTGATG 
LAR 
J. phoenicea GQ389683 Fwd:  CCAGTTGAACCTGCTTTGAG 
190 
J. oxycedrus badia GQ389684   Rev: TGACAGTGCCATCACCATAG 
ANS 
J. phoenicea GQ389673   Fwd:  TCAGTGCTCTCACATTCC 
193 
J. oxycedrus badia GQ389674   Rev:  ATCCTTACTTTCTCCTTGTTC 
ANR 
J. phoenicea GQ389671 Fwd: ACTTGCCCTTAGCCTACTTACAG 
117 
J. oxycedrus badia GQ389672 Rev: AGTTGAGCACTACAAACATCATCC 
ACT 
J. phoenicea GQ389669 Fwd: CGGCGATGTATGTTGCTATTC 
157 
J. oxycedrus badia GQ389670   Rev:  CCAGCGAGATCCAACCTAAG 
EF1A 
J. phoenicea GQ389677 Fwd:  CTCTCAGGTTGCCACTTCAG 
131 
J. oxycedrus badia GQ389678   Rev:  TTCAGTTGTCAGCCCAGTTG 
GAPDH 
J. phoenicea GQ389681 Fwd: AACTAATTGTCTTGCTCCTCTTG 
200 
J. oxycedrus badia GQ389682   Rev:  CCTTTCCAACTGCCTTTGC 
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2.4. Statistical analysis 
The results reported in this work are the averages of at least three 
independent experiments and are represented as the mean ± SD. 
Differences among treatments were detected by analysis of variance with 
Tukey HSD multiple comparison test (α=0.05) using SigmaStat 3.10 
(Systat).  
 
3. Results 
3.1. Seasonal evaluation of phytochemicals  
To understand the seasonal dynamics of phytochemical compounds in the 
four different juniper species, plants were grown in the same 
environmental conditions to avoid differences in key growth drivers such 
as soil, moisture, temperature, solar exposure amongst others parameters. 
The highest value of TPC was obtained for J. turbinata and the lowest for 
J. phoenicea (Table 2). These were also the two species where the highest 
differences between the minimum and the maximum value attained 
through the year were observed. These differences were ~ 235 %, 118 %, 
82 % and 78% for J. phoenicea, J. turbinata, J. oxycedrus badia and  
J. navicularis, respectively. The highest TPC were usually registered in the 
winter (months of October to January) and for J. navicularis and  
J. turbinata also in August and September. The lowest values were noted 
at beginning of spring (Feb/Mar to Apr/May) depending on the species 
and also in July, except for J. turbinata. A similar pattern was observed 
across the species for the TFC (Table 2). However, the highest TFC was 
exhibited by J. oxycedrus badia and the lowest in J. phoenicea. Selected 
samples were analysed for phytochemical composition using LC-MS. The 
months chosen were April, May, July and December.  The rationale was to 
analyze junipers at the stage of active growth (April), the stage when they 
stop growing (May), the months when most of junipers register low levels 
of TPC and TFC (July) and high TPC and TFC (December). The main 
phytochemicals were then identified (Fig. S1 on Supplementary material) 
and their levels quantified relative to each other (Fig. 1).  
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Table 2- Total phenol content and total flavonoid content for the four juniper 
species (J. navicularis, J. oxycedrus badia, J. turbinata and J. phoenicea) 
across different months. Different letters (a-f) denote significantly different 
samples at p<0.05. 
Species Months 
Total phenolic content 
(mg GAE g-1 DW) 
Total flavonoid content  
(mg CE g-1 DW) 
J.
 n
a
v
ic
u
la
ri
s 
Jan 80.84 ± 1.32 a 37.50 ± 0.98 a 
Feb 45.66 ± 1.30 f 20.52 ± 0.38 g 
Mar 57.91 ± 0.23 de 24.80 ± 0.47 f 
Apr 56.75 ± 1.67 d 24.92 ± 0.65 ef 
May 69.48 ± 2.41 bc 33.14 ± 0.89 b 
Jun 63.07 ± 2.56 cd 29.83 ± 1.06 d 
Jul 54.26 ± 0.97 e 27.20 ± 0.33 e 
Aug 65.52 ± 4.05 b 30.81 ± 0.87 cd 
Set 65.30 ± 5.59 bcd 30.24 ± 1.25 d 
Oct 68.43 ± 1.35 b 31.88 ± 0.68 bcd 
Nov 71.61 ± 0.36 b 32.68 ± 0.66 bc 
Dec 81.24 ± 2.77 a 36.10 ± 0.67 a 
J.
 o
x
y
c
e
d
ru
s 
b
a
d
ia
 
Jan 94.37 ± 7.68 ab 54.18 ± 1.02 b 
Feb 72.91 ± 2.73 d 43.96 ± 0.99 f 
Mar 57.06 ± 2.20 f 35.71 ± 0.51 g 
Apr 55.86 ± 0.89 e 37.71 ± 0.38 g 
May 56.30 ± 2.81 f 38.32 ± 0.58 g 
Jun 80.61 ± 2.35 cd 50.91 ± 0.79 cd 
Jul 60.89 ± 2.94 f 37.60 ± 2.01 g 
Aug 77.68 ± 3.80 d 48.44 ± 1.55 de 
Set 74.65 ± 5.78 d 47.23 ± 1.21 ef 
Oct 83.52 ± 2.22 bcd 52.07 ± 0.73 bc 
Nov 90.86 ± 0.62 bc 54.70 ± 0.49 b 
Dec 102.55 ± 6.29 a 62.01 ± 2.26 a 
J.
 p
h
o
e
n
ic
e
a
 
Jan 61.42 ± 0.69 d 25.94 ± 1.57 bc 
Feb 41.30 ± 0.43 e 16.90 ± 1.32 e 
Mar 26.56 ± 1.34 f 9.95 ± 0.46 f 
Apr 44.68 ± 1.75 e 16.95 ± 0.09 e 
May 31.32 ± 0.67 f 10.67 ± 0.18 f 
Jun 60.18 ± 0.61 d 23.89 ± 0.74 cd 
Jul 43.52 ± 0.81 e 15.30 ± 0.92 e 
Aug 69.75 ± 1.14 c 25.75 ± 0.83 bc 
Set 71.65 ± 3.69 bc 23.17 ± 0.15 d 
Oct 77.65 ± 2.81 b 27.27 ± 1.10 ab 
Nov 74.61 ± 2.64 b 26.92 ± 0.47 b 
Dec 89.07 ± 3.85 a 29.73 ± 0.67 a 
J.
 t
u
rb
in
a
ta
 
Jan 90.90 ± 1.84 b 34.50 ± 1.05 b 
Feb 62.89 ± 2.15 de 23.20 ± 0.84 d 
Mar 51.94 ± 1.57 e 19.88 ± 0.11 e 
Apr 91.66 ± 4.03 b 34.25 ± 0.70 b 
May 75.67 ± 0.23 cd 29.83 ± 0.80 c 
Jun 73.05 ± 1.27 d 28.60 ± 0.73 c 
Jul 86.67 ± 2.25 bc 33.40 ± 0.71 b 
Aug 94.11 ± 2.55 b 33.88 ± 1.98 b 
Set 95.07 ± 3.73 b 34.63 ± 1.47 b 
Oct 70.31 ± 2.39 d 25.00 ± 0.50 d 
Nov 113.52 ± 12.66 a 38.44 ± 0.90 a 
Dec 95.74 ± 10.15 b 33.69 ± 0.76 b 
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Analysed on the basis of equivalent phenol content, LC-MS identified that 
only two compounds showed differentially significant quantitative 
changes across the seasons; psydrin (5-methyl-4-O-(β-D-glucopyranosyl)- 
-3(2H)-furanone; peak 1, RT 8.22 in Fig. S1; Fig. 1A) and a procyanidin 
dimer (peak 7, RT 15.87 in Fig. S1; Fig. 1B). Psydrin exhibited significant 
changes in J. navicularis, J.oxycedrus badia and J. phoenicea but not in  
J. turbinata. Levels of psydrin increased in May, July and December in 
comparison with the levels in April. This increase was ~50 % for  
J. navicularis (July) and J. phoenicea (May and July). The exception was in 
May for J. navicularis, when psydrin levels slightly decreased. Only  
J. phoenicea showed statistically significant alterations in the levels of the 
procyanidin dimer, being its levels increased in May and decreased in July 
and December. 
 
Fig.  1- Relative quantification of psydrin (A) and procyanidin dimer (B) for the 
four Juniperus sp. in April (■), May (■), July (■) and December (□). 
Phytochemicals were quantified by LC-MS and normalized against the April 
values, which was the month generally presenting the lowest TPC contents. 
Statistical differences relative to April values are denoted by * p<0.05,  
** p<0.01 and *** p<0.001. 
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3.2. Changes in polyphenol composition in response to stress 
Young plants from J. oxycedrus badia, J. phoenicea and J. turbinata were 
submitted to drought and salinity stresses as well as MeJa elicitation. 
These stresses are reported to induce changes in phenolic content in 
plants 28-32. We selected young plants because these are normally more 
responsive to stress treatment. However, drought stress did not 
significantly alter TPC and TFC (results not shown). Different Juniperus 
species responded differently to salt stress and MeJa treatment.  
J. oxycedrus badia was the only species that responded to salt stress  
(Fig. 2) and J. phoenicea the only species that responded to MeJa 
treatment (Fig. 3). In response to salt stress, J. oxycedrus badia showed 
increased TPC and TFC (Fig. 2A). These increases were noted 2 days after 
stress application and persisted until day 7. Then, levels of TPC and TFC 
returned to initial levels, with only a slight increase in TPC on day 15. To 
assess if changes in total phenol content were accompanied by qualitative 
changes in composition, the samples were analysed by LC-MS.  Based on 
an equivalent amount of phenols, the profiles were very similar and only 
the levels of epicatechin (Fig. 2B) and a procyanidin trimer were altered 
significantly by the salt treatment (Fig. 2C). In comparison with control 
plants, both epicatechin and the procyanidin dimer decreased between 
the 2nd and the 7th day of salt stress. 
Following MeJa application, TPC and TFC changed significantly (Fig. 3A). 
The response was biphasic, with an initial increase at 12 h after treatment, 
which was accompanied by a non-significant increase in TFC, followed by 
a decrease. At 72 h, both parameters (TPC and TFC) showed significant 
increases which persisted until 96 h. LC-MS analysis revealed that the only 
compounds that were differentially altered in response to the treatment 
were a procyanidin dimer, epicatechin and quercetin-rhamnoside (Fig. 3B, 
C and D, respectively). In comparison with control plants that were only 
sprayed with Tween 20, MeJa induced increases in a procyanidin dimer  
72 h after treatment (Fig. 3B). Epicatechin also clearly increased from 12 
to 72 h after treatment (Fig. 3C).  
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Fig.  3- Changes in total phenol content and total 
flavonoid content in J. oxycedrus badia subjected to salt 
stress. TPC (■) and TFC (■) were evaluated (A). Significant 
statistical changes in total phenolic content in 
comparison with plants at 0 days are denoted by  
* p<0.05, ** p<0.01 and *** p<0.001; significant 
statistical changes in total flavonoid content in 
comparison with control plants are denote by # p<0.05, 
## p<0.01 and ### p<0.001. LC-MS also noted that the 
contents of epicatechin (B) and procyanidin trimer (C) 
were the only two compounds that changed due to salt 
stress. Values of control plants are represented by the 
grey line and at black values for the salt stressed plants. 
Significant statistical changes in metabolites levels in 
comparison with control plants are denoted by* p<0.05, 
** p<0.01 and *** p<0.001 
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Fig.  2- Changes in total phenol content and total flavonoid 
content in J. phoenicea subjected to MeJa treatment. TPC (■) 
and TFC (■) were evaluated (A). Significant statistical changes 
in total phenolic content in comparison with plants at 0 h are 
denote as * p<0.05, ** p<0.01 and *** p<0.001; significant 
statistical changes in total flavonoid content in comparison 
with control plants are denoted by # p<0.05, ## p<0.01 and 
### p<0.001. LC-MS also noted that the contents of  
procyanidin dimer (B), epicatechin (C) and quercetin- 
-rhamnoside (D) were the only three compounds that changed 
due to MeJa treatment. Values of control plants are 
represented by the grey line and at black values for the 
elicited plants. Significant statistical changes in metabolites 
levels in comparison with control plants are denoted by  
* p<0.05, ** p<0.01 and *** p<0.001 
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Quercetin-rhamnoside levels decreased compared to control at 12h after 
methyl jasmonate application, recovered to control levels at 48h then 
were reduced at 72 to 96 h (Fig. 3C). 
3.3. Transcription regulation of enzymes from phenylpropanoid 
biosynthetic pathway as response to stresses 
To verify the transcriptional regulation of the synthesis of metabolites 
affected by stresses, the mRNA levels of some crucial enzymes of the 
phenylpropanoid biosynthetic pathway were determined by Real Time RT- 
-PCR. For that, specific nucleotide sequences of J. oxycedrus badia and J. 
phoenicea were determined. Relative quantification of transcripts was 
determined for each enzyme using a normalization factor calculated using 
the relative quantities of the reference genes ACT, EF1A and GAPDH. 
Transcript levels of reference genes were monitored for all conditions 
tested and it was verified that their levels did not vary significantly. 
In response to salt stress, the levels of PAL and ANR transcripts increased 
in J. oxycedrus badia (Fig. 4A). For both enzymes, their transcript 
accumulation was enhanced two days after stress initiation and persisted 
until day 5. The relative accumulation of F3H and LAR transcripts were not 
significantly changed in response to salt stress. 
On the other hand, MeJa treatment induced changes in the accumulation 
of PAL, ANS, F3H and ANR transcripts in J. phoenicea (Fig. 4B) but with no 
change in transcript level for LAR. The level of PAL transcripts increased  
8 h after treatment and stayed high until 96 h. ANS and F3H also showed 
a biphasic response with increases within 12h and a second peak at 96h. 
The expression of ANR was slightly different as it was increased at 8h 
compared to control, reduced at 12h, increased at 48h then was 
maintained to 96h.  
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Fig.  4- Schematic representation of the main alteration in expression of enzymes 
of phenylpropanoid biosynthetic pathway under stress conditions. J. oxycedrus 
badia subjected to salt stress (A) and J. phoenicea subjected to MeJa treatment (B). 
Direct reactions are denoted with solid arrows and indirect with dashed arrows. 
Enzymes whose mRNA levels were analyzed are written in bold. Reactions 
mediated by enzymes whose mRNA showed significant differences due to stress 
are highlighted with block arrows. Graphical representations of mRNA fold change 
are shown in the respective balloon. Results were obtained from three 
independent replicates and significant statistical changes are denoted as * p<0.05, 
** p<0.01 and *** p<0.001. Legend: ACC- Acetyl-CoA carboxylase (EC 6.4.1.2), 
ANR- anthocyanidin reductase (EC 1.3.1.77), ANS- anthocyanidin synthase or 
leucocyanidin oxygenase (EC 1.14.11.19 ), C3H- p-coumarate 3 hydroxylase  
(EC 1.14._._), DFR- dihydroflavonol-4-reductase (EC 1.1.1.219), F3GT- flavonoid-3- 
-glucosyltransferase or anthocyanidin/flavonol 3-O-glucosyltransferase  
(EC 2.4.1.115 ), F3H- flavanone 3-hydroxylase or flavanone 3-dioxygenase  
(EC 1.14.11.9), FLS- flavonol synthase (EC 1.14.11.23), FS- flavone synthase  
(EC 1.14.11.22), LAR- leucoanthocyanidin reductase (EC 1.17.1.3),  
PAL- phenylalanine ammonia-lyase (EC 4.3.1.5). 
 
4. Discussion 
4.1. Seasonal evaluation of phytochemicals  
Juniperus sp. have been widely used in the cosmetic industry, gastronomy, 
and many uses and biological properties have been attributed to these 
plants 12,16,18. The Juniper species are rich in secondary metabolites, 
compounds well described as greatly affected by environmental 
conditions 33. Since the industrial quality (and relevance) of plants to the 
pharma/nutraceutical industries are valorised based on their content in 
secondary metabolites, it is imperative to understand secondary 
metabolite content, diversity and dynamics. Phytochemicals from some 
Portuguese Juniperus sp. have recently been described as exhibiting 
potential in the development of therapies for the prevention of NDDs 1. 
Therefore, to translate this to practical application it is important to 
understand the seasonal dynamics of phytochemical compound 
production. Here, four Portuguese juniper species were evaluated and 
grown under the same environmental conditions to eliminate any growth 
condition differences. Although some differences in TPC and TFC amongst 
the different species were found (Table 2), some general trends were 
found. The highest TPC were obtained in the winter months of October to 
January and the lowest values in the beginning of spring (February/March 
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to April/May) and in July. A similar tendency was verified for TFC. In the 
literature, the seasonal dynamics of polyphenolic compounds have been 
reported. For example, in Salix species 34, phenolic glycoside levels 
decreased over the growing season, with the highest contents detected 
during plant dormancy (winter). A similar trend was also seen for 
Apocynum venetum and Poacynum species 35, where the influence of 
environment (geolocation and climate) was also shown to be significant 
with respect to polyphenol content.  
To identify and quantify phytochemicals that may be preferentially 
affected due to environmental factors varying during the seasons, extracts 
were evaluated by LC-MS based on the same amount of phenol content. 
The phytochemical profile of Juniperus sp. gives a characteristic LC-MS 
profile and is relatively similar within species 1. Consequently, our focus 
was in the relative quantification of compounds that changed significantly 
with respect to the different conditions. The chemical profile of junipers 
species only presented small differences. The compounds that were 
significantly altered between species (Fig. 1) were psydrin (peak 1,  
RT 8.22 in Fig. S1) and a procyanidin dimer (peak 7, RT 15.87 in Fig. S1). 
Psydrin exhibited seasonal changes in J. navicularis, J. oxycedrus badia 
and J. phoenicea. For all these species psydrin levels are higher after the 
phase of active growth (April). The content of the procyanidin dimer only 
changed in J. phoenicea in May, the month after active growth, when its 
levels were highest.  
Resource allocation hypotheses such as the carbon-nutrient balance 36 and 
growth differentiation balance 37 have been proposed that changes in 
carbon source-sink relationships may be a consequence of carbon 
availability. That availability determines variations in the relative 
partitioning of carbon to growth and production of carbon based 
secondary metabolites.  Secondary metabolite production has been found 
in diverse species [such as Zingiber officinale 38, Digitalis lanata 39, 
Brassica oleracea 40 and Hypericum perforatum 41] to increase as a result 
of primary metabolism enhancement, for instance, through CO
2
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modulation. The shikimic acid pathway is able to convert simple 
carbohydrate precursors derived from glycolysis and the pentose 
phosphate pathway into aromatic amino acids 38, such as phenylalanine, 
the precursor compound in phenylpropanoid biosynthetic pathway. 
In Mediterranean conditions, temperatures and water availability in winter 
and summer are more extreme for plants, which may decrease 
photosynthetic efficiency 42,43. In spring and autumn, conditions that allow 
a high photosynthetic yield are exploited and active growth occurs. Thus, 
it is reasonable to hypothesise that during periods of growth inactivity 
(winter and summer), available carbon may be reallocated to secondary 
metabolites. Under conditions favourable to growth, the opposite may 
occur. Our results fit this hypothesis as maximum TPC and TFC were 
found in winter and minimum values in spring. The production of 
secondary metabolites was modulated across the seasons but the main 
differences where in the total levels of phenolics, not in their composition. 
Any enrichment in a few metabolites (psydrin and a procyanidin dimer) 
was mostly observed after the period of active growth. 
4.2. Influence of stress on PPs production 
To assess the influence of stresses on secondary metabolite production, 
young plants from J. oxycedrus badia, J. phoenicea and J. turbinata were 
submitted to drought, salinity and MeJa elicitation. However, only  
J. oxycedrus badia changed its phenolic content as response to salt stress 
and J. phoenicea as consequence of MeJa elicitation. The fact that  
J. oxycedrus badia was the only species that exhibited enhanced TPC and 
TFC contents in response to salt stress (Fig. 2A) is likely to be associated 
with the adaptation of this species to mountainous environments rather 
than the saline coastal regions, favoured on the other species. In the 
literature, contradictory effects of salinity on phenolic contents can be 
found, depending on the plant and salinity levels applied 28,44,45. Although 
there was a general trend of increasing TPC and TFC with salt treatment, 
there were also changes in the relative amounts of specific compounds 
(Fig. 2B and 2C) as determined by LC-MS. However, changes in the relative 
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amounts were only significant for epicatechin (peak 8, RT 16.74 in Fig. S1) 
and a procyanidin trimer (peak 9, RT 17.32 in Fig. S1). The relative 
contents of these two particular metabolites were decreased by salt 
treatment. Other phenolics showed increases in their relative amounts 
(without reaching significance) were quercetin rutinoside (peak 13,  
RT 21.86 in Fig. S1) and luteolin/isoscutellarein rhamnoside (peak 21,  
RT 27.88 in Fig. S1). It appears that the salt stress produced a general 
increase in polyphenol content per se and that a differential response in 
specific polyphenolics is minor. These alterations in metabolites were 
accompanied by increase in transcripts of PAL and ANR enzymes (Fig. 4A). 
The significant enhancement of PAL transcripts corroborates the 
hypothesis of a general enrichment in phenolic compounds, without 
specific enhancement/reduction of any particular class of compounds. 
Induction of PAL transcripts and activity by salt stress is well reported in 
the literature for other plants 46,47. However, enhancements in ANR 
transcript levels were accompanied by decreases in epicatechin and 
procyanidin trimer levels. These results may suggest that post- 
-transcriptional/translational regulation is evident, limiting the translation 
of those transcripts and/or the activity of those enzymes. Alternatively, 
reductions in epicatechin or the procyanidin dimers may have associated 
with enhanced levels of higher molecular weight oligomers and therefore 
unextractable procyanidins 48. That regulation should be theme of future 
studies to elucidate the specific mechanisms of stress responses in 
junipers. 
Endogenous MeJa is a signaling compound that modulates various 
physiological processes in plants 49. Under stresses such as wounding and 
pathogen attack, volatile MeJa can be released into the air from the 
wounded plants 50 and can induce plants to increase secondary (defense) 
metabolite production and consequentially enhance their defensive 
systems. Therefore, exogenous MeJa has been used to usefully induce 
secondary metabolites such as alkaloids, terpenoids, and phenolics in 
some plants and plant cell cultures 51,52. In the present work J. phoenicea 
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was the only species that responded to MeJa by increasing TPC and TFC 
levels (Fig. 3A). The TPC response showed a biphasic pattern which was 
reflected in the increase of the relative amounts of the procyanidin dimer 
(peak 7, RT 15.87 in Fig. S1) and epicatechin (peak 8, RT 16.74 in Fig. S1) 
(Figs. 3B and C). Conversely, the relative amount of quercetin-rhamnoside 
(peak 19, RT 25.43 in Fig. S1) was reduced, also in a biphasic manner  
(Fig. 3D). These results are corroborated by the transcriptomic analysis 
(Fig. 4B). MeJa induced the gene expression of PAL from 8 h to 96 h, 
which would drive a generalized augmentation of phenolic compounds. 
Induction of PAL transcripts by MeJa is well reported in literature 52,53. 
Increases in F3H, ANS and ANR transcripts were also registered and this 
was reflected in the levels of some of their associated metabolic end 
points (procyanidin dimer, epicatechin). The increase in transcripts of this 
branch could lead to metabolic flux deviation to the synthesis of 
proanthocyanidin and epi-flavan-3-ol, thus disfavoring flavonol 
biosynthesis.  
 
5. Conclusion 
Overall, the four juniper species presented a common pattern of 
phytochemicals production with higher levels in periods when plants were 
not actively growing and lower levels in the remaining periods. Therefore, 
seasonal conditions modulated the total content of phenolics and 
flavonoids. However, qualitatively, phytochemical composition was not 
greatly changed with only the relative contents of psydrin and a 
procyanidin dimer enhanced in some months and this varied accordingly 
to species.  Salt stress and MeJa elicitation were effective in enhancing 
phenolic accumulation, however different susceptibilities were exhibited 
by the different species. In addition to the increase of total phenolic and 
flanvonoids content, both stresses caused alterations in the relative 
phytochemical composition. Procyanidins, epicatechin and quercetin 
derivatives were the most responsive to stresses, being altered their 
relative amounts in both stresses. Salt stress reduced procyanidin and 
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epicatechin contents in J. oxycedrus badia extracts and enrichment in 
quercetin derivatives, while the opposite effect was noted after MeJa 
elicitation in J. phoenicea. This suggests differential metabolic regulation 
in response to those stresses between species. The mechanisms 
underlying these responses are important considering juniper a viable and 
sustainable source of compounds/extracts for end-user industries such as 
pharmaceuticals/nutraceuticals. 
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8. Supplementary material 
 
 
Figure S1- Representative PDA profiles for J. navicularis (A), J. oxycedrus badia 
(B), J. phoenicea (C) and J. turbinata (D). Peak numbers correspond to their 
putative identifications based on MS fragmentation, already published 1. The 
full scale deflection for each trace is shown in the top right corner. The area 
denoted by the bar contain some procyanidins components that are poorly 
resolved  across RTs 17-25 mins. Legend: 1- Psydrin; 2- Procyanidin dimer;  
3- Gallocatechin; 4- Procyanidin trimer; 5- Procyanidin dimer;  
6- Epigallocatechin; 7- Procyanidin trimer; 8- Epicatechin; 9- Procyanidin 
trimer; 10- Procyanidin trimer; 11- Myricetin hexose; 12- Myricetin rutinoside; 
13- Quercetin rutinoside; 14- Myricetin pentose; 15- Proanthocyanidin 
derivative; 16- Unknown compound + Quercetin hexose; 17- Isoscutellarein 
hexoside; 18- Quercetin pentoside; 19- Quercetin rhamnoside;  
20- Luteolin/isoscutellarein pentoside; 21- Luteolin/isoscutellarein 
rhamnoside; 22- Amentoflavone or Cupressuflavone or Hinokiflavone. 
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Abstract  
Blackberry ingestion has been demonstrated to attenuate brain 
degenerative processes in rodents with the benefits ascribed to the 
(poly)phenolic components. The aim of this work was to assess the 
efficacy of blackberry polyphenolics in a neurodegeneration cell model 
before and after simulated gastrointestinal digestion. 
Digested blackberry metabolites protected neuroblastoma cells from H
2
O
2
- 
-induced death at low, non-toxic levels that approaches physiologically- 
-relevant serum concentrations. However, the undigested extracts were 
not protective even at five-fold higher concentrations. This potentiation 
may reflect alterations in the polyphenolic composition caused by the 
digestion procedure as detected by LC-MS analysis. This protection was 
not caused by modulation of the intracellular antioxidant capacity or 
through alteration of glutathione levels, although the undigested extract 
influenced both these parameters. This work reinforces the importance of 
evaluating digested metabolites in disease cell models and highlights the 
possible involvement of other mechanisms beyond antioxidant systems. 
 
Keywords 
Blackberry; In vitro digestion model; Neurodegenerative diseases; Phenolic 
compounds.  
 
 
 
 
 
 
 
 
 
Chapter 4: Neuroprotective effect of blackberry (Rubus sp.) polyphenols is 
potentiated after simulated gastrointestinal digestion 
117 
 
1. Introduction 
Epidemiological studies have shown that dietary habits can influence the 
incidence of AD and PD 1-4. Foods and food ingredients, in particular, 
components chemically classified as antioxidants have been described to 
exert a beneficial effect in neurodegeneration 5-8. 
In the developed world, the population lifespan is increasing with a 
concomitant increased incidence of many age-related diseases such as 
cancer, cardiovascular and neurodegeneration 9. The impact of this at the 
financial and social level is immense with the health care costs in 2008 for 
Alzheimer’s disease and other forms of dementia recently estimated at 
€160 billion for the EU27 and €177 billion for the whole of Europe 10. 
Clearly it is paramount that preventative, amelioration and/or, ideally, 
inhibition strategies are developed to retard or reverse neuronal and 
behavioral deficits that occur in aging 9. Indeed, these foci are areas of 
intense research effort but the delivery of (pharma) products 11,12 and 
therapeutic strategies 13 have been limited. Furthermore the mechanisms 
involved in the behavioral deficits during aging remain to be discerned 14,15. 
Substantial evidence supports the hypothesis that oxidative stress plays a 
major role in neurodegenerative disease pathogenesis 16-18. Oxidative 
stress is generally caused by the excessive accumulation of ROS in cells 
and has been implicated in the development of many NDDs including PD, 
HD, ALS and AD 16,19,20. In tissues from patients with neurodegenerative 
disorders, an increase in markers of ROS damage has been found 5,21. In 
the affected regions of brain, these markers are elevated levels of lipid 22, 
protein 23,24 and DNA 24,25 oxidation products.  
Behavioral studies in rodents have revealed an attenuation of brain aging 
when strawberries, blueberries or blackberries are ingested 26-29 and the 
authors propose that the benefits are due to the presence of 
(poly)phenolic compounds. These phytochemicals, and by association the 
foods, are accruing a significant evidence base for beneficial effects on 
human health and the reduction of risk of cardiovascular disease 30,31, 
cancer 32,33 and type II diabetes 34.  Driving these beneficial endpoints are 
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the numerous pathways and protein kinases that have been reported as 
being targets for phenolic compounds, thereby demonstrating the broad 
spectrum of targets and strengthen their usefulness in addressing 
multifactorial diseases 5. 
In many of the in vitro studies focused on PP-derived health benefits, the 
doses used are significantly higher than those to which humans are 
exposed through the diet or that could be found in the blood 35.  On 
average, and depending on the PP class, plasma bioavailabilities in healthy 
humans are in the range of 0.5-1.6 µM 36. Furthermore, it was concluded 
from an analysis of 97 bioavailability studies that total PP-derived 
metabolite concentration in plasma after an intake of 50 mg of aglycone 
equivalents ranges from 0 to 4 µM 37.  However, the majority of in vitro 
studies use PP concentrations ranging from 10 to 100 µM 38: around 2-25 
fold difference. Additionally, most of in vitro cell-based studies evaluate 
metabolites “as they are in food”, ignoring the chemical alterations 
occurring during digestion, absorption and metabolism with the 
consequential impact on bioavailability and bioefficacy. Moreover, many 
studies have evaluated the effect of single purified phenolic compounds, 
thereby losing possible synergic/cooperative or competitive activities 
between phenolic compounds 38. Thus, in order to evaluate the potential 
role of fruit phytochemicals in human body, we should take into account 
the physiochemical changes occurring in the gastrointestinal tract 38. 
The aim of this work is to compare the neuroprotective effect of non-
digested blackberry extract against digested blackberry metabolites. This 
work encompasses a more physiological approach which takes into 
account: i) the chemical changes occurring during digestion; ii) the effects 
of phytochemical mixtures found in authentic foods; iii) treatment of cell 
models with relevant in vivo concentrations of phytochemical metabolites.  
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2. Materials and methods 
2.1. Plant material and extract preparation  
Blackberry (Rubus L. subgenus Rubus Watson) cv. Apache was grown in 
Fataca experimental field (Odemira, Portugal) and berries were harvested 
at full ripeness. Berries were harvested (yield approx. 500 g), frozen and 
then freeze-dried. After, fruits were ground without seed separation in an 
IKA M20 mill to pass a 0.5 mm sieve and stored at -80 ºC prior to 
extraction. Fruit extracts were prepared as previously described 39. Briefly, 
to each 1 g of lyophilized powder, 12 mL of hydroethanolic solvent (50 % 
(v/v) ethanol/water) was added and the mixture was shaken for 30 min at 
room temperature in the dark. The mixture was then centrifuged at  
12,400 g for 10 min at room temperature. The supernatant was filtered 
through paper filter and then through 0.2 µm cellulose acetate membrane 
filters. The resulting extracts were stored frozen at –80 °C. 
2.2. In vitro digestion (IVD) 
Phytochemical alterations during digestion were mimicked using the IVD 
model previously described by McDougall et al. 40. Briefly, the undigested 
extract (final volume 20 mL) was adjusted to pH 1.7 with 5 M HCl, then 
pepsin (Sigma Product number P6887) was added at 315 units mL-1 and 
incubated at 37 °C in a heated water bath for two hours with shaking at 
100 rpm. Aliquots (2 mL) of the post-gastric digestion were removed and 
frozen. The remainder was placed in a 250 mL glass beaker and 4.5 mL of 
4 mg mL-1 pancreatin, 25 mg mL-1 bile salts mixture added. A segment of 
cellulose dialysis tubing (molecular mass cut-off 12 kDa) containing 
sufficient 0.1 M NaHCO
3
 to neutralise the sample's titratable acidity was 
added and the beaker sealed with parafilm. The NaHCO
3
 diffused out of 
the dialysis tubing and the pH reached neutrality within 45 min. After two 
hours incubation at 37 °C, the solution inside the dialysis tubing (fraction 
IN) and the solution outside the dialysis tubing (fraction OUT) were taken. 
Small samples (2 mL) were immediately frozen. The digested fractions IN 
and OUT were acidified until 0.5 % (v/v) by slow addition of 10 % formic 
acid. 
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After centrifugation (2,500 g, 10 min, 5 °C),  the soluble material from 
fractions IN and OUT were applied to C18 solid phase extraction columns 
(GIGA tubes, 1000 mg capacity, Phenomenex Ltd) which had been pre-
equilibrated in ultra pure water (UPW) containing 0.25 % (v/v) formic acid 
(FA). After a wash with 2 volumes of FA/ultra pure water, the bound 
material was eluted by the addition of 0.25 % (v/v) FA in 25 % (v/v) 
acetonitrile. This afforded complete separation of total phenolics from the 
bile salts present in samples 41. The fractions were then concentrated in a 
Speed-Vac to suitable phenol concentrations. 
2.3. Chemical characterization 
2.3.1. Total phenolic quantification  
Determination of total phenolic compounds was performed by the Folin- 
-Ciocalteau method adapted to microplate reader 42. Gallic acid was used 
as the standard and the results were expressed as mg GAE. 
2.3.2. Peroxyl radical scavenging capacity determination 
Peroxyl radical scavenging capacity was determined by the ORAC (Oxygen 
Radical Absorbance Capacity) method as described by Tavares et al. 39. 
The final results were calculated using the differences in area under the 
fluorescence decay curves between the blank and the sample, and were 
expressed as µM Trolox equivalents (µM TE). 
2.3.3. Phenolic Profile Determination by LC-MS 
Extracts and digested fractions were applied to a C-18 column (Synergi 
Hydro C18 column with polar end capping, 4.6 mm x 150 mm, 
Phenomonex Ltd.) and analysed on a LCQ-DECA system controlled by the 
XCALIBUR software (2.0, ThermoFinnigan), as reported by Tavares et al. 39. 
The LCQ-Deca system comprised a Surveyor autosampler, pump and PDA 
detector and a Thermo Finnigan mass spectrometer iontrap. 
2.4. Cell culture 
Human neuroblastoma SK-N-MC cells were obtained from the ECACC and 
cultured in EMEM (Sigma) supplemented with 2 mM L-glutamine (Sigma), 
10 % (v/v) heat inactivated FBS (Gibco), 1 % (v/v) non-essential amino acids 
(Sigma), 1 mM sodium pyruvate (Sigma) and containing 50 U/mL penicillin 
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and 50 µg/mL streptomycin. The cells were maintained at 37 ºC in 5 % 
CO
2
 and split at sub-confluence of 70-80 % using 0.05 % trypsin/EDTA 
(Gibco). 
2.5. Cytotoxicity profile  
The undigested blackberry extracts and fraction IN were concentrated 
under vacuum and dissolved in cell medium for the cytotoxicity tests 43. 
The cell viability assay was performed in a 96-well plate cell and employed 
the neuroblastoma human cell line SK-N-MC to identify the non-toxic 
range of extract concentrations. Cells were seeded at 1.25 x 105 cells mL-1 
and grown for 48 h prior to incubation with extracts. Toxicity tests 
involved 24 h incubation in the range of 0 to 500 µg GAE mL-1 medium. 
Cell viability was assessed using the CellTiter-Blue® Cell Viability Assay 
(Promega), according to the manufacturer’s instructions. Non-viable cells 
rapidly lose their metabolic capacity and thus do not generate the 
fluorescent signal. 
2.6. Neuroprotective effect against oxidative stress 
To evaluate the neuroprotective effect of extracts, SK-N-MC 
neuroblastoma cells were incubated in the presence of H
2
O
2
. Cells were 
seeded at 7.4 x 104 cells mL-1 and 24 h after seeding, growth medium was 
removed and wells washed with PBS. Cells were pre-incubated with 
medium containing 0.5 % (v/v) FBS supplemented with non-toxic 
concentrations of blackberry extracts. After 24 h pre-incubation, cells 
were washed again with PBS and medium replaced by medium containing 
0.5 % (v/v) FBS and H
2
O
2
 at a final concentration of 300 µM. After 24 h, 
medium was removed, cells were washed with PBS, collected by 
trypsinisation and incubated with two fluorescent probes for 30 min at  
37 ºC. DiOC
6
(3) (20 nM, Invitrogen) was used to evaluate the ∆Ψm and PI 
(1 µg mL-1, Invitrogen) was used to determine cell viability, based on 
plasma membrane integrity 44. Cells were then analyzed by flow cytometry. 
A flow cytometer (Partec) containing a blue solid state laser (488 nm) with 
FL1 green fluorescence channel for DiOC
6
(3) at 530 nm and a FL3 red 
fluorescence channel for PI detection at 650 nm was used. The acquisition 
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and analysis of the results were performed with FlowMax® (Partec) 
software. 
2.7. Intracellular ROS production  
To evaluate the ability of extracts to reduce ROS levels produced by cells, 
the conversion of H
2
DCFDA (Invitrogen) to fluorescent DCF was  
monitored 45,46. SK-N-MC neuroblastoma cells were seeded in a 96-well 
plate at 1.25 x 105 cells mL-1. Cells were grown for 24 h and then they 
were washed with PBS and then pre-incubated with extracts prepared in 
medium (0.5 % (v/v) FBS) for 2 h or 24 h. After pre-incubation, cells were 
washed with PBS and incubated with 25 µM H
2
DCFDA in PBS for 30 min at 
37 ºC. Cells were washed and H
2
O
2
 (200 µM) in PBS, added. Fluorescence 
was measured (λex: 485 nm, λem: 530 nm) using a FLx800 Fluorescence 
Microplate Reader (Biotek) during 1 h at 37 ºC. ROS generation was 
calculated as an increase in fluorescent signal between control and H
2
O
2
- 
-treated cells.  
2.8. Glutathione and glutathione disulphide (GSSG) quantification 
To quantify GSH and GSSG, cold 10 % (v/v) metaphosphoric acid was 
carefully added to samples or standards. After incubation (4 ºC, 10 min) 
and centrifugation (16,000 g, 20 min, 4 ºC) supernatants were transferred 
into 1.5 mL propylene tubes (50 µL for determination of GSH and 200 µL 
for determination of GSSG). 
Derivatization was performed accordingly to Kand’ar et al. 47, adapted 
from Hissin and Hilf 48. Briefly, for GSH analysis 1 mL of 0.1 % (w/v) EDTA 
in 0.1 M sodium hydrogen phosphate, pH 8.0, was added to 50 µL of 
supernatant. To 20 µL portion of this mixture, 300 µL of 0.1 % (w/v) EDTA 
in 0.1 M sodium hydrogen phosphate, and 20 µL of 0.1 % 
orthophthalaldehyde (OPA) (w/v) in methanol, was added. Tubes were 
incubated at 25 ºC for 15 min in the dark. The reaction mixture was then 
stored at 4 ºC until analysis. For GSSG analysis, a 200 µL of supernatant 
was incubated at 25 ºC with 200 µL of 40 mM N-ethylmaleimide for 25 
min in dark. To this mixture, 750 µL of 0.1 M NaOH was added. A 20 µL 
portion was taken and mixed with 300 µL of 0.1 M NaOH and 20 µL of  
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0.1 % OPA. Tubes were incubated at 25 ºC for 15 min in dark and stored 
at 4 ºC until analysis. 
Chromatographic analysis was accomplished using isocratic elution on 
C18 analytical column (Supelcosil ABZ+Plus HPLC Column 15 cm x 4.6 
mm, 3 µm (Supelco)) at 40 ºC on an AcquityTM Ultra Performance LC 
system (Waters). The mobile phase consisted of 15 % methanol in 25 mM 
sodium hydrogen phosphate (v/v), pH 6.0. The flow rate was kept constant 
at 0.7 mL min-1. The excitation and emission wavelengths were set at 350 
and 420 nm, respectively. The amount of GSH and GSSG was quantified 
from the corresponding peak area using Empower® Pro 2.0 software. The 
concentration of GSH and GSSG in the samples was determined from 
standard curves with ranges 0-100 µM for GSH and 0-5 µM for GSSG. 
Values were normalized for total protein content, determined by Lowry 
method 49. 
2.9. Statistical analysis 
The results reported in this work are the averages of at least three 
independent experiments and are represented as the mean ± SD. 
Differences among treatments were detected by analysis of variance with 
Tukey HSD multiple comparison test (α=0.05) using SigmaStat 3.10 
(Systat).  
 
3. Results 
3.1. Chemical characterization 
Blackberry fruits are well known to be a rich source of PPs and to exhibit 
high antioxidant capacity. However, after ingestion blackberry 
phytochemicals undergo many modifications or even degradation by the 
processes of gastrointestinal (GI) digestion. In the present work, an IVD 
model was used to mimic the effect of GI digestion on blackberry phenolic 
extract. IVD produces different digested fractions: post gastric digest (PG) 
and two pancreatic digested fractions (IN and OUT). There was a large 
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reduction in both TPC and antioxidant capacity (AC) following digestion, 
in particular for the pancreatic digest fractions IN and OUT (Table 1).  
 
Interestingly, IVD increased the relative antioxidant capacity (expressed as 
a ratio of total phenolic content) of fraction IN by three-fold and by two- 
-fold in fraction OUT (AC/TPC in Table 1). There were substantial 
alterations in phytochemical composition caused by IVD as assessed by 
LC-MS (Fig. 1; Table 2). The major anthocyanins, cyanidin-3-O-glucoside 
(CyGlc), cyanidin-3-O-xyloside (CyXyl) and cyanidin-3-O-dioxayl-glucoside 
(CyDAGlc) were greatly reduced by pancreatic digestion with recoveries in 
fractions IN and OUT at around 10 % of the undigested extract (Fig. 2). 
Quercetin derivatives were more highly recovered after digestion with 
recoveries ranging from 40 to >80 %. The recovery of the major 
ellagitannin components was substantial in the PG fraction but much 
lower in the pancreatic digests, around 30-40 % for fraction OUT and 
essentially zero for IN. It was also notable that new peaks were identified 
after IVD. For example, after gastric digestion, a major new peak was 
present (G1, Fig. 1B) but the MS properties did not permit identification. 
After pancreatic digestion, a number of new peaks appeared in fractions 
IN and OUT (Fig. 1 C and D, peaks P1-P3). Peak P3 gave PDA and MS  
 
Table 1- Total phenolic content (TPC) antioxidant capacity (AC) and ratio 
antioxidant capacity per total phenolic content (AC/TPC) of undigested extract 
of blackberry and IVD fractions. Values are reported as means ± SD (n=3) and 
percentage in comparison to the undigested extract. Statistical differences 
compared to the undigested extract are denoted as * p<005 ** p<0.01 *** 
p<0.001. PG – Post gastric; IN – post pancreatic; OUT - post pancreatic. 
Undigested 
extract
PG IN OUT
Total phenolic 
content (TPC) 
mg GAE 16.7 ± 0.2 15.5 ± 0.4 0.9 ± 0.2 4.6 ± 0.2
% 100.0 93.0 5.5 27.5
significance * *** ***
Antioxidant 
capacity (AC)
µmol TE 544.2 ± 26.9 268.6 ± 71.1 91.7 ± 6.2 294.3 ± 23.5
% 100.0 49.4 16.9 54.1
significance ** *** **
AC/TPC 32.6 17.3 101.9 64.0
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Fig. 1- Analysis of blackberry samples by liquid 
chromatography-mass spectrometry (LC-MS). A- Undigested
extract; B- Post gastric; C- IN post pancreatic; D- OUT post 
pancreatic. All figures are representative traces recorded at 
280 nm. The full scan deflection is shown in the upper right 
corner of each panel. Peaks are labelled as described in 
Table 2 with components appearing in the PG or the 
pancreatic digests, IN and OUT, labelled, e.g. G1 and P1, 
respectively.  
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Table 2- Identification of indicated phenolic components from 
blackberries. 
There was also evidence for cyanidin-3-O-rutinoside which co-eluted with the main 
anthocyanin peak. Assignments are supported by previous work. Peak numbers refer 
to Fig. 1. Compounds 1-12 were identified in the undigested extract; compound G1 
was more apparent in PG and compounds P1-P3 were more apparent in the IN and 
OUT. + denote detection in the positive mode MS only. In bold are denote the most 
abundant ions. 
 
Peak 
No. 
RT PDA m/z MS2 Putative ID 
1 18.46 515, 280 +449, 287 287 Cyanidin-3-O-glucoside 50 ,51 
2 21.14 515, 208 +419, 287 287 Cyanidin-3-O-xyloside 
50,5 1
 
3 22.18 520, 280 +593, 287 287 Cyanidin-3-O-dioxayl-g lucoside 
50
 
4 23.03 240-300 
1401, 1250, 
934, 301 
1869, 1567, 1250, 
1235, 934, 633 
Lambertianin C 
5 1-5 3
 
5 23.63 240-300 
1869, 935, 
301 
1567, 1265, 1235, 
1103, 933, etc. 
Sanguiin H6 51-54 
6 24.06 240-300 1103 multiple Unidentified ellagitannin 
7 24.47 355 433, 301 301 Quercet in-xyloside 
55
 
8 25.39 355 433, 301 301 Quercet in-xyloside 
55
 
9 25.83 355 609, 301 301 Quercet in-rutinoside 
50 ,53,56
 
10a 26.64 355 463, 301 301 Quercet in-glucoside 50,51,5 3,5 6 
10b 26.86 355 477, 301 301 Quercet in-glucuronide 
51 ,56
 
11 27.61 355 
607, 505, 463, 
301 
545, 505, 463 , 
301 
Quercet in-HMG-glucoside 
56
 
12 28.50 365 447 315 Methyl ellagic acid derivative 
51 ,53
 
G1 14.61 
250-300, 
270 max 
none - Unknown 
P1 11.21 
220-300, 
260 max 
282, 150 150, 133 Unknown 
P2 17.32 290 none - Unknown 
P3 17.47 265 153 109 Dihydroxy benzoic acid 
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properties consistent with assignment as dihydroxybenzoic acid, perhaps 
derived from the breakdown of cyanidin anthocyanins at pH > 7 40,50. 
3.2. Cytotoxicity profile determination 
Prior to the assessment of the 
neuroprotective potential, 
cytoxicity assays were 
performed using the 
assessment of cell metabolism 
of SK-N-MC neuroblastoma 
cells. Fraction IN which 
presented a higher relative 
antioxidant capacity, was more 
toxic than the undigested 
extract (Fig. 3). Non-toxic 
concentrations of the 
Fig.  3- Cytotoxicity profile obtained for 
undigested extract (solid line) and IN (dashed 
line). Cell viability was determined by 
CellTiter-Blue® Cell Viability Assay (Promega) 
after cells being incubated with phenolic 
compounds for 24 h. 
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Fig.  2- Recovery of selected blackberry phenolics after in vitro digestion. The 
main metabolites identified in undigested blackberry extract were relatively 
quantified and values reported as percentage of recovery based on the peak 
area of the mass spectrometer response for each m/z. ■- PG (Post gastric); ■- 
IN post pancreatic; □- OUT post pancreatic. Metabolites analyzed: CyGlc- 
Cyanidin-3-O-glucoside; CyXyl- Cyanidin-3-O-xyloside; CyDAGlc- Cyanidin-3-O-
dioxayl-glucoside; ET 1401- Lambertianin C; ET 1869- Sanguiin H6; ET 1103- 
Unidentified ellagitannin; QXyl1- Quercetin-xyloside 1; QXyl2- Quercetin-
xyloside 2; Qrut- Quercetin-rutinoside; QGlc- Quercetin-glucoside; QGlcA- 
Quercetin-glucuronide; QHMGGlc- Quercetin-HMG-glucoside; MEAD- Methyl 
ellagic acid derivative. 
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undigested extract and fraction IN were selected for further assays.  
To evaluate if the effect of the PPs was due to interactions with 
extracellular receptors or to uptake, we took advantage of the intrinsic 
autofluorescence properties of polyphenolic compounds51. 
Cells incubated for 1 h with increasing concentrations of blackberry 
extract showed a concentration-dependent autofluorescent signal within 
the cytoplasm (see column A in Fig. S1 in Supplementary material). This 
suggests cellular uptake of, at least, part of the PPs.  
3.3. Evaluation of neuroprotective effect  
Concentrations of blackberry extract and IN fraction, which were non-toxic 
as assessed by cellular metabolism, were tested in an H
2
O
2
-stress 
neurodegeneration cell model. Neuroblastoma cells were treated with  
300 µM H
2
O
2
 for 24 h, which reduced cell viability to around 50 % (based 
on cells with an intact cell membrane, negative for PI in flow cytometry 
assay; Fig. 4A). Only fraction IN was able to significantly protect 
neuroblastoma cells from H
2
O
2 
injury (Fig. 4A). The greatest protection 
was achieved when higher metabolite concentrations were used (0.5 and  
1 µg GAE mL-1) and pre-incubation with IN fraction (0.5 µg GAE mL-1) 
resulted in an increase in viability to 78 % (Fig. 4A). However, in this 
neurodegeneration cell model, neither the undigested extract nor fraction 
IN could prevent the dissipation of the ∆Ψm (Fig. 4B).  
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3.4. Intracellular ROS production determination 
The same concentrations were also tested for intracellular antioxidant 
capacity (Fig. 5). Two different pre-incubation times were tested, at 2 h 
and 24 h (Fig. 5A and 5B, respectively).  
At both time points and in the absence of an imposed oxidative stress, 
both undigested extract and IN fraction significantly reduced the basal 
ROS production. H
2
O
2 
 was used to promote an oxidative stress in cells 
and doubled ROS production compared with the control (Fig. 6) without 
promoting cell death. With a 2 h pre-incubation, neither the undigested 
extract nor IN fraction reduced intracellular ROS caused by H
2
O
2
 stress. 
With a 24 h pre-incubation followed by H
2
O
2
 stress, the undigested extract 
but not IN fraction reduced intracellular ROS production. Conversely, the 
 
Fig.  4- Cell viability and mitochondrial transmembrane potential (∆Ψm) 
assessed by flow cytometry. A) Cell viability, expressed as percentage of cells 
containing intact membrane, using PI as fluorochrome. B) Percentage of cells 
presenting high mitochondrial transmembrane potential, using DiOC
6
(3) as 
probe. Neuroblastoma cells were pre-incubated with blackberry undigested
extract or IN fraction for 24 h and then injured by 300 µM H
2
O
2
 for 24 h. 
Statistical differences between treatments are denoted as * p<005 ** p<0.01 
*** p<0.001. All values are mean ± SD, n = 3. 
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Fig.  6- Characterization of stress conditions used to 
determine intracellular ROS production. □- Cell viability; 
■-ROS production. Values are reported as percentage 
relative to the control condition. Cells were incubated in 
presence/absence of an oxidative stress (200 µM H
2
O
2
for 1 h), cell viability determined by FACS with PI as 
probe and ROS production determined by fluorimetry 
with DCF as probe. Statistical differences between 
treatments are denoted as * p<005 ** p<0.01 
*** p<0.001. All values are mean ± SD, n = 3. 
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Fig.  5- Relative intracellular ROS production by SK-N-MC 
neuroblastoma cells in presence/absence of oxidative stress.
Oxidative stress (200 µM H
2
O
2
) was applied for 1 h. Cells were pre-
incubated with undigested blackberry extract or fraction IN for A) 2 h; 
B) 24h. ROS were detected by fluorimetry using DCF as probe. 
Statistical differences between treatments are denoted as * p<005 
** p<0.01 *** p<0.001. All values are mean ± SD, n ≥ 3. 
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undigested extract was able to promote ROS scavenging, although not 
enough to protect cells from death.  
3.5. GSH and GSSG quantification 
To verify the alterations induced by metabolites pre-treatment and post 
application of H
2
O
2
 stress, the redox pair GSH/GSSG was quantified. GSH 
and total thiols (GSH+2xGSSG) are presented in Fig. 7. Cells subjected to 
H
2
O
2
 (300 µM, 24 h) exhibited a reduction in the level of total thiols as a 
result of GSH depletion. Conversely, cells subjected to a 24 h pre-
treatment with blackberry extract at 1.25 and 2.5 µg GAE mL-1 showed an 
increase in GSH and total thiols. Pre-treatment with IN fraction did not 
prevent the H
2
O
2
-dependent depletion of GSH levels.  
 
 
4. Discussion 
Blackberry fruits are well known to be a rich source of PPs and to exhibit 
high antioxidant capacity 52,53. Besides that, like many fruits of the Rubus 
genus they are increasingly been attributed with a significant potential for 
 
Fig.  7- Quantification of GSH and total thiols. - GSH and - total thiols levels 
in SK-N-MC neuroblastoma cells pre-treated with undigested blackberry extract 
and fraction IN. After pre-treatment for 24 h, cells were subjected to 300 µM 
H
2
O
2
 for 24h. Cells were harvested and analyzed for their content in GSH and 
GSSG by UPLC. Total thiol content was calculated as GSH+2xGSSG and values 
are expressed in nmol GSH mg-1 protein. Statistical differences between 
treatments are denoted as * p<005 ** p<0.01 *** p<0.001. All values are mean 
± SD, n ≥ 3. 
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human health benefits 54-56 and, in particular, blackberries have been 
reported to enhance short-term memory performance in animal models 27. 
After ingestion, blackberry phytochemicals undergo many modifications 
or even degradation by the processes of GI digestion. Although transport 
and metabolic mechanisms cannot be effectively reproduced, in vitro 
studies can provide a simple predictive instrument to investigate the 
potential bioavailability under conditions mimicking the GI tract. In the 
present work, an IVD model was used to mimic the effect of GI digestion 
on blackberry phenolic extract. This model was first described by Miller et 
al. 57 and then adopted to evaluate secondary metabolites 50,58. In the 
present study, following digestion, blackberries presented a large 
reduction in both TPC and AC, in particular for IN and OUT (Table 1). 
Gastric digestion reduced the antioxidant capacity by 50.6 %, although the 
total phenolic content was reduced by no more than 7 %. The results for 
total phenolic content of PG digest are in accordance with other studies 
performed with pomegranate, red cabbage and chokeberry 50,59,60. The TPC 
of IN fraction was reduced to 5.5 % and the AC to 16.9 % compared to the 
undigested blackberry extract. In OUT, these values were 27.5 % and  
54.1 % respectively. Both TPC and AC values are in the same range as 
those obtained for grapes by Tagliazucchi et al. 61 (55.5 % for TPC and 
62.4 % for AC).  
There were substantial alterations in phytochemical composition caused 
by IVD as assessed by LC-MS (Fig. 1; Table 2). 
 The major anthocyanins were greatly reduced by pancreatic digestion 
(recoveries at around 10 % of the undigested extract; Fig. 2). These low 
recoveries are concordant with the values reported after IVD of 
pomegranate juice 59 and raspberry 58. Anthocyanins are generally stable in 
the acidic conditions of the stomach, but less stable at the higher pH of 
the small intestine 40,59,62. Quercetin derivatives were more highly recovered 
after digestion (40 to >80 %). In some cases, the total recovery in fractions 
IN plus OUT was greater than 100 %, which may be due to interconversion 
of quercetin components during digestion or enhanced detection of 
Chapter 4: Neuroprotective effect of blackberry (Rubus sp.) polyphenols is 
potentiated after simulated gastrointestinal digestion 
132 
 
quercetin derivatives due to reductions in other components. Increased 
relative recovery of flavonols was also noted after IVD of green tea 63.  The 
recovery of the major ellagitannin components was around 30-40 % for 
fraction OUT and essentially zero for IN. Ellagitannins are more stable to 
pH changes than anthocyanins but degrade to smaller components 64. 
Additionally, after IVD some new peaks were identified (Fig. 1). As 
mentioned in section 3.1, fraction IN had approximately three-fold higher 
antioxidant capacity than the undigested extract when expressed as a 
ratio of phenolic content. This increased antioxidant capacity may result 
from its greatly altered phenolic composition (lower levels of anthocyanins 
and ellagitannins but relatively enhanced levels of quercetin derivatives 
and evidence of accumulation of breakdown products) (Fig. 2) and made it 
the obvious choice for further studies on neuroprotective effects. 
Fraction IN also revealed more toxic than the undigested extract (Fig. 3), 
presumably as a result of digestion-induced chemical modifications. 
Interestingly, the non-toxic range of fraction IN (maximum 1 µg GAE mL-1 
corresponding to 6 µM) was similar to that reported for dietary 
polyphenolic-derived metabolites in plasma at 0 to 4 µM 37, which is 
physiologically relevant with respect to polyphenolic-load. The maximum 
non-toxic concentration for the undigested extract was higher, 5 µg  
GAE mL-1 (equivalent to 30 µM). It should be noted that these 
concentrations of total PPs do not refer to specific chemical moieties, 
rather it is a value for the total mix of PPs obtained from fruits or their 
simulated digestion. Non-toxic concentrations of blackberry extract and 
IN fraction were then tested in an H
2
O
2
-induced neurodegeneration cell 
model. Production of H
2
O
2
 is related with age-related diseases and more 
particularly with neurodegeneration 65,66. Only fraction IN was able to 
significantly protect neuroblastoma cells from H
2
O
2 
injury (Fig. 4A) even 
though the undigested extract was applied at five-fold higher 
concentration. The lowest concentration of IN fraction (0.25 µg GAE mL-1 
equivalent to 1.5 µM) was able to exert a protective effect and this 
concentration is in the same range as the serum bioavailability reported 
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for individual PPs (maximum 4 µM 37) which reinforces the biological 
significance of this neuronal protection. Furthermore, higher protection 
was achieved for pre-incubation with higher metabolite concentrations of 
IN fraction (0.5 µg GAE mL-1) resulting in an increase in viability to 78 % 
(Fig. 4A). However, in this neurodegeneration cell model, blackberry 
metabolites before and after digestion were not able to prevent the 
dissipation of ∆Ψm (Fig. 4B). This dissipation reflects the earlier stage 
H
2
O
2
-induced cytotoxicity associated with its diffusion into the 
mitochondrial matrix and with subsequent loss of integrity, ability to 
generate ATP and finally cell death 67,68. Therefore, although not able to 
completely protect neuroblastoma cells, digested metabolites in fraction 
IN were able to modulate molecular mechanisms of survivability in 
response to the imposed oxidative stress. The same concentrations were 
tested for intracellular antioxidant capacity (Fig. 5), using two different 
pre-incubation times (2 h and 24 h; Fig. 5A and 5B, respectively), to cover 
different timescale events. We presumed that the 2 h pre-incubation 
would evaluate the direct scavenging events caused by the phenolic 
compounds. As it turned out, as mentioned above (section 3.2), we 
verified that 1 h should be enough for compounds presented in 
blackberry extract to be taken up by cells (column A in Fig. S1 in 
Supplementary material). We presumed that 24 h pre-incubation with PP-
derived metabolites could influence ROS levels via indirect effects on 
endogenous antioxidant systems. At both time points and in the absence 
of an imposed oxidative stress, both undigested extract and IN fraction 
significantly reduced the basal ROS production. This suggests that the 
undigested extract and IN fraction could alter the oxidative environment 
of cells.  Contrary happened with a 2 h pre-incubation, neither the 
undigested extract nor IN extract reduced intracellular ROS caused by 
H
2
O
2
 stress. With a 24 h pre-incubation followed by H
2
O
2
 stress, the 
undigested extract but not IN fraction reduced intracellular ROS 
production. Comparison of this data with that derived from the 
neuroprotection assay suggests that the neuroprotection exhibited by 
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fraction IN was not mediated by ROS scavenging. Indeed, similar results 
were obtained by Cilla et al. 69 who reported that intracellular ROS 
production was not diminished by pre-incubating cells with an in vitro 
digested fruit beverage. Conversely, the undigested extract was able to 
promote ROS scavenging, although not enough to protect cells from death. 
Protection from ROS over a 24 h time scale may be indicative of priming 
of the endogenous antioxidant systems via events like nuclear receptor 
modulation, gene expression and enzyme activity regulation, subcellular 
signaling pathways modulation and involvement in mechanisms of DNA 
protection/repair among others 70-72. Phenolic compounds present in the 
undigested blackberry extract could be modulating some endogenous 
antioxidant defenses and consequently reducing the intracellular ROS, as 
suggested for grape derived PPs 73,74. Indeed, recent work by Xiao 75 
showed that fruit PPs stimulated the expression and production of 
mammalian detoxification/antioxidant enzymes via Nrf2 transcription 
factor. Compounds responsible for decreasing ROS levels may have been 
removed during digestion, since the same response was not observed 
with IN. These results suggest that neuronal protection caused by IN 
fraction is produced by other mechanisms than modulating ROS levels. 
GSH is the major antioxidant within cells and is involved in maintaining a 
tight control of redox status 76. To verify the alterations in GSH/GSSG 
homeostasis induced by metabolites pre-treatment and post application of 
H
2
O
2
 stress, the redox pair GSH/GSSG was quantified. Contrarily to cells 
subjected pre-treated with blackberry extract that exhibited an increase in 
GSH and total thiols, pre-treatment with IN fraction did not prevent the 
H
2
O
2
-dependent depletion of GSH levels. These changes in GSH levels are 
in accordance with ROS levels observed after 24 h pre-treatment followed 
by oxidative stress (Fig. 6). The augmentation in GSH following pre-
treatment with blackberry extract and induction of oxidative stress could 
contribute to the reduction in ROS levels detected. Although IN fraction 
did not prevent GSH depletion, it promoted cell protection, unlike the 
undigested blackberry extract. Again, these results reinforce the 
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differences noted between cell model studies performed with metabolites 
obtained from food digestion rather than the direct food components.   
 
5. Conclusion 
The potential of blackberry to contribute to dietary strategies to prevent 
or retard neurodegeneration was evaluated. The present work clearly 
compares and distinguishes the neuroprotective effect of non-digested 
blackberry extract (undigested extract) and digested blackberry 
metabolites (IN fraction) at concentrations approaching physiological 
levels. 
The undigested blackberry extract, although exhibiting a significant 
antioxidant capacity in vitro, was not able to protect neurons in a 
neurodegeneration cell model, but enhanced GSH levels and reduced ROS 
production. However, enhancing intracellular antioxidant capacity per se 
was not enough to effectively protect neurons. 
Conversely, digested PP metabolites were able to maintain cell membrane 
integrity, protecting neurons from death. Interestingly, this protection was 
not related to enhanced intracellular antioxidant capacity, since the IN 
fraction did not directly/indirectly reduce ROS levels. In addition, there 
were no alterations in GSH redox status after IN pre-incubation. This 
highlights the involvement of other mechanisms beyond antioxidant 
systems and the complexity of how, what may be thought of as a simple 
food, fruit, can interact at the fundamental level with our cells. Overall, 
this work illustrates the importance of evaluating the effect of digested 
metabolites in disease cell models.  
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8. Supplementary material 
 
 
Fig. S1- Polyphenol uptake by SK-N-MC neuroblastoma cell line. 
Cells were treated with increasing concentrations of blackberry undigested extract 
for 1 h. Slides were prepared and nuclei were stained with DAPI. Cells were 
visualized using a fluorescence microscope (Leica DM RB) with two different filters. 
Column A: Images were obtained using a filter with excitation range on UV λex 
515-560 nm, LP 590 nm to detect the intrinsic autofluorescence of the PPs. 
Column B: Images were obtained using a filter with excitation range on green λex 
340-380 nm, LP 425 nm to detect DAPI-stained nuclei. Column C: Merged images 
of A and B columns using ImageJ software. 
 
0
30
60
120
240
Total phenols content
(µg GAE mL-1)
A B C
 
Chapter 5: Neuroprotective effects of digested polyphenols 
from wild blackberry species 
 
Lucélia Tavares 1, Inês Figueira 1, Gordon J. McDougall 2, Helena L.A. Vieira 1, 3, 4, 
Derek Stewart 2, 5, Paula M. Alves 1, 3, Ricardo B. Ferreira 1,6, Cláudia N. Santos 1, 3 
 
1  Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Av. da 
República, 2780-157 Oeiras, Portugal. 
2 Environmental and Biochemical Science Group, Enhancing Crop Productivity and 
Utilisation Theme, The James Hutton Institute, Dundee, DD2 5DA, Scotland, UK. 
3 Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2781-901 Oeiras, 
Portugal.  
4 CEDOC@IGC, Faculdade de Ciências Médicas, UNL, 1169-056 Lisboa.  
5 School of Life Sciences, Heriot Watt University, Edinburgh, EH14 4AS, Scotland, 
UK 
6 Departamento de Botânica e Engenharia Biológica, Instituto Superior de 
Agronomia, Universidade Técnica de Lisboa, Tapada da Ajuda, 1349-017 Lisboa, 
Portugal. 
 
Adapted from: 
Tavares, L. et al., Neuroprotective effects of digested polyphenols from 
wild blackberry species. Eur J Nutr, DOI:10.1007/s00394-00012-00307-
00397 (2012). 
 
Author contribution: 
LT performed the majority of the experiments presented in this chapter 
(except in vitro digestion and GSH and GSSG quantification, performed in 
collaboration) and wrote the manuscript cited above. 
Chapter 5: Neuroprotective effects of digested polyphenols from wild blackberry 
species 
142 
 
Abstract 
Blackberry ingestion has been demonstrated to attenuate brain 
degenerative processes with the benefits ascribed to the (poly)phenolic 
components. The aim of this work was to evaluate the neuroprotective 
potential of two wild blackberry species in a neurodegeneration cell model 
and compare them with a commercial variety.  
This work encompasses chemical characterization before and after an IVD 
and the assessment of neuroprotection by digested metabolites. Some 
studies targeting redox/cell death systems were also performed to assess 
possible neuroprotective molecular mechanisms. 
The three blackberry extracts presented some quantitative differences in 
PP composition that could be responsible for the different responses in 
the neurodegeneration cell model. Commercial blackberry extracts were 
ineffective but both wild blackberries, R. brigantinus and R. vagabundus, 
presented neuroprotective effects. It was verified that a diminishment of 
intracellular ROS levels, modulation of glutathione levels and activation of 
caspases occurred during treatment. The last effect suggests a 
preconditioning effect since caspase activation was not accompanied by 
diminution in cell death and loss of functionality. 
This is the first time that metabolites obtained from an in vitro digested 
food matrix, and tested at levels approaching the concentrations found in 
human plasma, have been described as inducing an adaptative response.  
 
Keywords 
Caspase activity; Glutathione balance; In vitro digestion; 
Neurodegenerative diseases; Wild blackberries. 
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1. Introduction 
In the developed world, the population lifespan is increasing with a 
concomitant increase in the incidence of age-related diseases such as 
neurodegeneration 1.  Due to the high impact at both financial and social 
levels 2,3, strategies to retard or reverse neuronal and behavioral deficits 
that occur in aging are urgently required. Indeed, these foci are areas of 
intense research effort but the therapeutic strategies 4 and delivery of 
(pharma) products 5,6 have been limited. Epidemiological evidence 
indicates that antioxidant supplementation may provide neuroprotection 
against age-related neurodegenerative disorders, including PD, ALS and 
AD 7-9. Increased dietary intake of antioxidant fruits, in particular berry 
fruits, may cause positive and profound impacts on human health, 
performance, and disease 10. Their biological properties are attributed to 
the wide diversity and high levels of phenolic compounds, frequently 
associated with a high antioxidant capacity. Due to the multitude of 
phytochemicals found in these fruits, instead of a single compound, they 
can promote complementary, additive, and/or synergistic effects 10,11.  
In vitro studies have revealed blackberries as possessing potent 
antioxidant, antiproliferative and anti-inflamatory activities 12,13. Moreover, 
in aged rats these fruits were capable of improving performance on motor 
tests, which relied on balance and fine motor coordination, and on 
measures of spatial working memory 14. However, these effects were not 
accompanied by an improvement in dopamine release 14, and 
consequently by an improvement of receptor sensitivity, events usually 
related with the observed effects 15,16. A large number of pathways and 
protein kinase cascades, such as protein kinase C, Nrf2/ARE antioxidant 
pathway, pro-survival mitogen-activated protein kinase kinase (MEK)/ERK 
and PI3K/AKT pathways among others, have been reported as targets for 
phenolic compounds; nevertheless the target pathways affected remain 
unknown 17. 
The chemical diversity of plants constitutes an immense and relatively 
untapped reservoir of molecules with potential 
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pharmacological/nutraceutical value. The diversity of Portuguese plants 
represents a reservoir of phytochemicals as yet poorly characterized and 
explored. In particular, in the north of Iberian Peninsula there are endemic 
Rubus species, such as Rubus brigantinus Samp. and Rubus vagabundus 
Samp. 18, of which chemical diversity could be further explored. 
The aim of this work is to evaluate the neuroprotective potential of two 
endemic blackberry species in a neurodegeneration cell model. This work 
encompasses an IVD to mimic some alterations in metabolites that fruits 
are submitted to when ingested. Some studies targeting redox and cell 
death systems were performed to illustrate molecular mechanisms by 
which blackberry metabolites could exert beneficial effects. 
 
2. Methods and Materials 
2.1. Plant material 
Fruits of wild blackberry species (Rubus brigantinus Samp. and Rubus 
vagabundus Samp.) were collected in September 2009 in Bragança region 
(northeast region of Portugal) and frozen. Fruits were collected from 
several populations, growing in different locations in order to be 
representative of species. For both species, voucher samples were 
authenticated and deposited at the herbarium "João de Carvalho e 
Vasconcelos", Instituto Superior de Agronomia, Lisbon, Portugal (voucher 
number 716/2010 and 722/2010). For comparison purposes, the 
commercial blackberry cv. Apache (Rubus L. subgenus Rubus Watson) 
produced in Fataca experimental field (Odemira, Portugal) was also used. 
The samples were freeze-dried, ground without separation of seeds in an 
IKA M20 mill to pass a 0.5 mm sieve and stored at -80 ºC prior to 
extraction. 
2.2. Extract preparation 
Fruit extracts were prepared using an hydroethanolic solution (ethanol  
50 % (v/v)) as previously described 19. Briefly, 12 mL of ethanol 50 % were 
added for each gram of blackberry freeze-dried powder. Homogenate was 
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shaken for 30 min and filtered. Extracts obtained were dried under 
vaccum. 
2.3. In vitro digestion  
Phytochemical alterations during digestion were mimicked using the IVD 
model already described 20. Briefly, the undigested extract was submitted 
to conditions that mimic the gastric digestion such as adjusted to pH 1.7, 
the addition of pepsin and incubation at 37 ºC with shaking at 100 rpm 
for 2 h. After, small intestine conditions were mimicked by the addition of 
pancreatin and bile salts, followed by dialysis with a cellulose tube 
containing NaHCO
3
 to neutralize titratable acidity. After 2 h incubation at 
37 °C, the solution inside the dialysis tubing (IN) and the solution outside 
the dialysis tubing (OUT) were taken. 
2.4. Chemical characterization 
2.4.1. Total phenolic quantification 
Determination of total phenolic compounds was performed by the Folin- 
-Ciocalteau method adapted to microplate reader 21. Gallic acid was used 
as the standard and the results were expressed as mg GAE. 
2.4.2. Peroxyl radical scavenging capacity determination 
Peroxyl radical scavenging capacity was determined by the ORAC method 
as described by Tavares et al. 19. The final results were calculated using 
the area differences under the fluorescence decay curves between the 
blank and the sample, and were expressed as µM TE. 
2.4.3. Determination of Phenolic Profile by LC-MS 
Extracts and digested fractions, containing 500 mg GAE mL-1 were applied 
to a C18 column (Synergi Hydro C18 column with polar end capping,  
4.6 mm x 150 mm, Phenomonex Ltd.) and analyzed on a LCQ-DECA 
system controlled by the XCALIBUR software (2.0, ThermoFinnigan), as 
reported by Tavares et al. 19. The LCQ-Deca system comprised a Surveyor 
autosampler, pump and PDA detector and a Thermo Finnigan iontrap 
mass spectrometer. 
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2.5. Animal cell culture 
Human neuroblastoma SK-N-MC cells were obtained from the ECACC and 
cultured in EMEM (Sigma) supplemented with 2 mM L-glutamine (Sigma), 
10 % (v/v) heat-inactivated FBS (Gibco), 1 % (v/v) non-essential amino acids 
(Sigma), 1 mM sodium pyruvate (Sigma) and containing 50 U penicillin and 
50 µg streptomycin per mL of medium. The cells were maintained at 37 ºC 
in 5 % CO
2
 and split at sub-confluence of 70-80 % using 0.05 % 
trypsin/EDTA (Gibco). 
2.6. Cytotoxicity evaluation 
Digested fractions were dried under vacuum and dissolved in cell medium 
for the cytotoxicity tests by measuring cell viability as previously 
described 20. Briefly, SK-N-MC neuroblastoma cells were seeded in a  
96-well plate using 1.25 x 105 cells mL-1 and grown for 48 h prior to 
incubation with the IN fractions. Toxicity tests involved 24 h fractions 
incubation in the range 0-100 µg GAE mL-1 medium. Cell viability was 
assessed using the CellTiter-Blue® Cell Viability Assay (Promega), 
according to the manufacture instructions. 
2.7. Neuroprotective evaluation 
To evaluate the neuroprotective effect of fractions, a neurodegeneration 
cell model already described was used 20. The model described the 
treatment of SK-N-MC neuroblastoma cells with H
2
O
2 
to induce cell
 
death. 
Briefly, cells were seeded at 7.4 x 104 cells mL-1, grown for 24 h, then after 
24 h of pre-incubation with medium supplemented with non-toxic 
concentrations of blackberry fractions, the cells were treated with medium 
containing H
2
O
2
 (300 µM). After 24 h, the medium was removed and cells 
were washed with PBS and collected by trypsinisation. Cells were then 
incubated with two fluorescent probes for 30 min at 37 ºC.  
3,3’-Dihexyloxacarbocyanine iodide (DiOC
6
(3), 20 nM, Invitrogen) was 
used to evaluate the ∆Ψm and PI (1 µg mL-1, Invitrogen) was used to 
determine cell viability, based on plasma membrane integrity 22. A flow 
cytometer (Partec) was used to analyze parameters. This cytometer 
contains a blue solid state laser (488 nm) with FL1 green fluorescence 
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channel for DiOC
6
(3) at 530 nm and a FL3 red fluorescence channel for PI 
detection at 650 nm. The acquisition and analysis of the results were 
performed with FlowMax® (Partec) software. 
2.8. Intracellular ROS production determination 
To evaluate the ability of fractions to reduce ROS levels produced by cells, 
the conversion of H
2
DCFDA (Invitrogen) to fluorescent DCF was monitored 
23,24. SK-N-MC neuroblastoma cells were seeded in a 96-well plate  
(1.25 x 105 cells mL-1), grown for 24 h, then washed with PBS and pre- 
-incubated with fractions prepared in medium (0.5 % (v/v) FBS) for 2 h or 
24 h. After pre-incubation, cells were washed with PBS and incubated for 
30 min at 37 ºC with 25 µM H
2
DCFDA prepared in PBS. Cells were washed 
with PBS then H
2
O
2
 (200 or 300 µM) was added. Fluorescence was 
measured (λex: 485 nm, λem: 530 nm) using a FLx800 Fluorescence 
Microplate Reader (Biotek) over 1 h at 37 ºC. ROS generation was 
calculated as an increase in fluorescent signal compared with cells not 
treated with H
2
O
2
. 
2.9. GSH and GSSG quantification 
GSH and GSSG were quantified by HPLC after derivatization with 
orthophthalaldehyde, performed accordingly to Kand’ar et al. 25 as already 
described in Tavares et al. 20.  
Chromatographic analysis was accomplished using isocratic elution on a 
C
18
 analytical column (Supelcosil ABZ+Plus HPLC Column 15 cmx4.6 mm, 
3 µm (Supelco)) at 40 ºC on an AcquityTM Ultra Performance LC system 
(Waters). The mobile phase was 15 % (v/v) methanol in 25 mM sodium 
hydrogen phosphate, pH 6.0. The flow rate was kept constant at 0.7 mL 
min-1. The excitation and emission wavelengths were set at 350 and 420 
nm, respectively. The amount of GSH and GSSG was quantified from the 
corresponding peak areas using Empower® Pro 2.0 software. The 
concentration of GSH and GSSG in the samples was determined from 
standard curves with ranges 0-100 µM for GSH and 0-5 µM for GSSG. 
Values were normalized for total protein content, determined by Lowry 
method 26. 
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2.10. Caspase 3/7 activity determination 
Caspase activity was determined using the Caspase-GloTM 3/7 assay 
(Promega). SK-N-MC neuroblastoma cells were seeded in a 96-well plate  
(1 x 104 cells mL-1). Cells were grown for 24 h, then washed with PBS and 
pre-incubated with fractions prepared in medium (0.5% (v/v) FBS) for 24 h. 
After this period, cells were washed again with PBS and medium 
containing 300 µM H
2
O
2
 was added. Cells were incubated for 24 h and 
then 100 µL of proluminescent caspase 3/7 substrate was added to each 
well. Cells were incubated at room temperature for 3 h and luminescent 
signal was recorded. Values were normalized for cell viability, determined 
by flow cytometry, as described above. 
2.11. Statistical analysis 
The results reported in this work are the averages of at least three 
independent experiments and are represented as the mean ± SD. 
Differences among treatments were detected by analysis of variance with 
Tukey HSD multiple comparison test (α=0.05) using SigmaStat 3.10 
(Systat).  
 
3. Results  
3.1. Characterization of the blackberry extracts 
Characterization of the three blackberry extracts was performed and, 
although the TPC of the three blackberries was very similar, their AC was 
different (Table 1). The wild blackberries had a higher AC compared to the 
commercial variety, especially R. brigantinus which had 60 % higher 
antioxidant capacity than the commercial blackberry.  
The IVD model provided two fractions (IN and OUT) after pancreatic 
digestion. The fraction that passes through the dialysis membrane 
constitutes the IN fraction and contains metabolites that equate to those 
that should be able to reach serum by paracellular transport. The material 
that remains outside the dialysis tubing constitutes the OUT fraction and 
contains metabolites that equate to those that reach colon after digestion. 
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After IVD, the TPC and AC were greatly changed (Table 1) and the TPC of 
the IN fractions as reduced to less than 10 % of the original content. The 
AC values were also reduced in all samples, but since the reduction was 
lower than in the values of TPC, the ratio AC/TPC became higher in the IN 
fractions comparatively to the undigested extracts  
(Table 1). Concerning these ratios for the IN fraction, R. brigantinus was 
the most potent (222 µmol TE mg-1 GAE) followed by the commercial 
blackberry (100 µmol TE mg-1 GAE) then R. vagabundus (44 µmol TE  
mg-1 GAE; Table 1). Moreover, IN fractions had a higher ratio of AC/TPC 
than the respective OUT fractions (results not shown). Since IN fraction 
equates to the compounds that could potentially reach the serum through 
paracellular transport and at the same time, this fraction seems to be the 
most chemically reactive (higher AC/TPC), these factors led us to choose 
the IN fraction to be tested in neuroprotective studies.  
LC-MS analysis (Fig. S1 and Table S1 on Supplementary material) showed 
that the PP profiles of the wild blackberries before digestion were similar 
to that of the commercial blackberry (Fig. S1A on Supplementary material 
and Fig. 1A).  
 
The main differences were in the amount of anthocyanins (cyanidin-3-O- 
-glucoside, -xyloside and -hydroxymethyl-glutaroyl glucoside), which were 
lower for the endemic species and in the quantity of ellagitannins 
Table 1- Chemical characterization of commercial blackberry and two wild 
blackberry species (R. brigantinus and R. vagabundus) extracts before and after in 
vitro digestion. For undigested extracts and IN fractions the total phenolic content 
(TPC) and antioxidant capacity for peroxyl radical (AC) were determinate and the 
ratio AC/TPC was calculated. Values of TPC, AC and AC/TPC in the undigested 
extract wre expressed as mg GAE g-1 dw, µmol TE g-1 dw and µmol TE mg-1 GAE, 
respectively. Values in the IN fraction were expressed as % of the values 
determined for the undigested extract. Statistical significant differences for 
p<0.05 are denote with different letters (a-c). All values are mean ± SD, n = 3.
Undigested extract IN fraction
TPC AC AC/TPC TPC AC AC/TPC
(mg GAE g-1 dw) (µmol TE g-1 dw) (µmol TE mg-1 GAE) (% of undigested extract)
Commercial 
blackberry
27.51±0.98a 221±22c 33±2a 5.5 17 307
R. brigantinus 28.17±3.65a 357±10a 21±3b 0.5 5 1040
R. vagabundus 31.07±1.47a 274±57b 15±3b 1.7 5 292
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(sanguiins H-2, C, H-6 and H-10), which were particularly high in  
R. vagabundus (approx. 3.5-fold the amount detected in commercial 
blackberry). In addition, the endemic species had higher levels of certain 
flavonols (quercetin pentoside) and ellagic acid or ellagic acid derivatives 
(methyl ellagic acid glucuronide). After IVD (Fig. 1B), the amounts of 
anthocyanins and ellagitannins detected in the IN fractions were 
considerably reduced while, conversely, quercetin derivatives were present 
in higher levels in fractions from the wild species than those from the 
commercial blackberry (especially quercetin pentoside; Fig. 1B). The most 
obvious difference between the R. brigantinus, R. vagabundus and the 
commercial blackberry IN samples was the presence of a component with 
properties that suggest a methyl ellagic glucuronide structure (compound 
10 in Fig. S1A on Supplementary material).  
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3.2. Cytotoxicity evaluation 
Cytotoxicity of digested blackberry metabolites was evaluated by 
conversion of resazurin into resorufin by viable cells (Fig. 2).  
 
Fig.  1- Relative quantification of PPs in blackberries. A) Undigested extract before 
in vitro digestion, B) IN samples. All values are expressed as relative to the 
commercial blackberry variety (■), R. brigantinus (■) and R. vagabundus (□). 
Values were calculated as peak area of the mass spectrometer response for the 
m/z characteristic of each component. Quantified metabolites: cyanidin-3-O-
-glucoside (CyGlc), cyanidin-3-O-xyloside (CyXyl), cyanidin-3-O-malonylglucoside 
(CyMalG), cyanidin-3-O-hydroxymethyl-glutaroyl glucoside (CyHMGG), methyl 
ellagic acid glucuronide (MeEAGlcA), methyl ellagic acid pentose (MeEApent), 
quercetin-glucoside (QGlc), quercetin-glucuronide (QGlcA), quercetin-HMG-
-glucoside (QHMGG), quercetin pentose 1 (Qpent1), quercetin pentose 2 (Qpent2), 
quercetin-rutinoside (Qrut), ellagic acid (EA), sanguiin H-2 (Sang H-2), 
lambertianin C (Lamb), sanguiin H-6 (Sang H-6), sanguiin H-10 (Sang H-10). 
Lambertianin C, sanguiin H-2 and sanguiin H-10 were not identified in IN 
samples. 
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R. brigantinus
and R. vagabundus 
these profiles, ranges of non
1 µg mL-1 GAE for commercial blackberry and 
µg mL-1 GAE for 
Fig.  2- Cytotoxicity evaluation of digested fractions of the three 
SK-N-MC neuroblastoma cells were incubated for 24 h with digested fractions 
(0-100 µg GAE mL
by CellTiter-Blue® Cell Viability Assay (Promega). Values are expressed as 
percentage relatively to control (without extract):  Commercial blackberry (
R. brigantinus
3.3. Neuroprotective evaluation
SK-N-MC neuroblastoma cells were 
or absence of IN fractions and then challenged with H
Neuroprotection was then evaluated by monitoring cells that maintained 
both high ∆
Incubation with all IN fractions in the absence of H
cellular responses compared to the controls (Fig. 3A), which confirmed the 
absence of toxicity previously detected on n
cells were challenged with H
commercial blackberry did not cause a protective effect (Figs. 3B and 3C).
However,
 
IN fractions from wild species simultaneously increased 
and cell membrane integrity (Figs. 3B and 3C).
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Fig.  3- Cell viability assessed by flow cytometry. Cell viablility was assessed in Q4, showing cells presenting membrane integrity 
(negative for PI) and high mitochondrial potential (∆ψm; positive for DiOC
6
(3)) and expressed as percentage. A) Cell viability for 
cells incubated with IN digested fractions without oxidative stress (0 µM H
2
O
2
). Statistical differences of pre-incubated cells in 
comparison with cells not treated with H
2
O
2
 are denote as * p<0.05 ** p<0.01 *** p<0.001. All values are mean ± SD, n ≥ 3.
 B) Flow cytometry outputs obtained with PI and DiOC
6
(3) allow the assessment of the percentage of viable cells, represented in 
quadrant Q4 (cells presenting membrane integrity and high mithocondrial potential). C) Cell viability for cells incubated with IN 
digested fractions with oxidative stress (300 µM H
2
O
2
).  Neuroblastoma cells were pre-incubated with digested fractions for 24 h 
and then injured by 300 µM H
2
O
2
 for 24 h. Graphic representation of flow cytometry panels and respective statistical evaluation. 
Statistical differences of pre-incubated cells in comparison with cells only treated with H
2
O
2
 are denote as * p<0.05 ** p<0.01 
*** p<0.001. All values are mean ± SD, n ≥ 3 
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3.4. Intracellular ROS production 
Intracellular ROS levels were monitored (Fig. 4) at two different times of 
pre-incubation, 2 h and 24 h, to cover different time events. All blackberry 
digested extracts at 2 h and/or 24 h pre-incubation (Fig. 4A) reduced 
basal ROS production.   
 
3.5. GSH and GSSG quantification 
GSH and GSSG were measured after pre-incubation with digested 
metabolites and after application of H
2
O
2
 stress (Fig. 5).  The commercial 
blackberry fraction caused a decrease in GSH content (Fig. 5A), contrarily 
to R. brigantinus and R. vagabundus fractions that augmented GSH with  
R. vagabundus being more effective (Fig. 5A).  
 
Fig.  4- Relative intracellular ROS production by SK-N-MC neuroblastoma cells 
pre-incubated with digested fractions for 2 h or 24 h. A) In absence of an 
oxidative stress B) In the presence of an oxidative stress (200 µM H
2
O
2
 for 1 h). 
ROS were detected by fluorimetry using H
2
DCFDA as probe. Statistical differences 
in relation to cells not treated with blackberries metabolites (0 µg GAE mL-1) are 
denote as * p<0.05 ** p<0.01 *** p<0.001. All values are mean ± SD, n = 3 
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H
2
O
2
 insult (300 µM for 24 h) induced a GSH depletion (Fig. 5A). Pre- 
-treatment with commercial blackberry metabolites could not maintain 
GSH levels under H
2
O
2
 insult. Conversely, pre-incubation with the IN 
fractions from the wild blackberries prevented GSH depletion, maintaining 
GSH levels at around control levels. However, analysis of the GSH/GSSG 
did not highlight any detectable any significant alteration due to H
2
O
2
 
stress or pre-incubation with digested metabolites (Fig. 5B). 
 
 
 
 
Fig.  5- Quantification of GSH and ratio GSH/GSSG. SK-N-MC neuroblastoma cells 
pretreated with digested blackberries extract for 24 h, in the absence of stress () 
and in cells subjected to stress (300 µM H2O2 for 24h) () A) GSH; B) ratio 
GSH/GSSG. Cells were harvested and analyzed for their content in GSH and GSSG 
by HPLC. Statistical differences between treatments in relation to control were 
determined for p<0.01 and are denoted as ** p<0.01 *** p<0.001. All values are 
mean ± SD, n ≥ 3 
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3.6. Caspase 3/ 7 activity determination 
Pre-incubation with IN 
metabolites in the absence 
of H
2
O
2
 injury enhanced 
caspase activity up to 
twofold (Fig. 6A). When cells 
were challenged with  
300 µM H
2
O
2
, caspase 
activation was augmented 
by around fourfold 
compared to the control  
(Fig. 6B). Indeed, the same 
augmentation in caspase 
activity was verified when 
cells were pre-incubated 
with any of the blackberry 
IN samples and submitted 
to stress. Curiously, lower 
levels of endemic 
metabolites (0.1-0.25 µg 
GAE mL-1) strongly promote 
caspase activation. 
 
4. Discussion 
Wild species represent a rich source of phytochemicals that can be 
explored with nutritional, nutraceutical or pharmaceutical purposes.  
R. brigantinus and R. vagabundus are two Rubus sp. endemic from the 
North of Iberia Peninsula with a very restrict occurrence 18. These two 
species have, until now, not been chemically characterized. The 
occurrence of different (quantities of) phenolic compounds could promote 
different bioactivities, thereby identifying this germplasm as sources of 
compounds to be further explored and exploited. Blackberries are berries 
 
Fig.  6- Caspase 3/7 relative activity in SK-N-MC 
cells pre-treated with digested fractions for 
24 h. A) In the absence of H
2
O
2
 injury. B) In the 
presence of H
2
O
2
 (300 µM, 24 h) injury. Values of 
caspase 3/7 activity were normalized by cell 
viability determined by flow cytometry. 
Statistical differences are denote as * p<0.05 
** p<0.01 *** p<0.001. All values are mean ± 
SD, n = 3 
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with a recognized high phenolic content 27. However, although the TPC of 
the three blackberry extracts was very similar, the wild blackberries 
exhibited higher ACs compared to the commercial variety, especially R. 
brigantinus (Table 1). LC-MS analysis of blackberry extracts before IVD 
showed some quantitative differences among species concerning 
anthocyanins, ellagitannins, flavonols and ellagic acid (Fig. 1A and Fig. S1 
on Supplemmentary material). However, the physical-chemical alterations 
during GI digestion have a major impact on the quantity and diversity of 
the phenolic compounds present in fruits 20. After IVD, the TPC of the IN 
fractions was reduced to less than 10 % of the original content (Table 1). 
These values are in accordance with recoveries obtained in previous work 
on red wine and red cabbage 28,29. The AC was also greatly reduced (Table 
1). Nevertheless, the IN fractions presented relatively higher AC/TPC ratio 
than the undigested extracts (Table 1).  IN fractions from R. brigantinus 
were the most potent followed by the commercial blackberry and then by 
R. vagabundus. These differences, relecting the different chemistries, 
could be reflected in different biological potencies and/or effects. After 
IVD, the amounts of anthocyanins and ellagitannins detected in the IN 
fractions were considerably reduced (Fig. 1B). Total anthocyanin content 
was reduced to 12.8 % in commercial blackberry and to around 5 % in the 
endemic species; these recoveries are in agreement with other work on 
red cabbage, red wine and pomegranate juice 28-30. Anthocyanins are stable 
in acidic conditions of the stomach, but less stable at elevated pH of the 
small intestine 28,30,31. Also ellagitannins, a characteristic group of 
metabolites in the Rosaceae, were extensively reduced in all species. A 
proportion of the “missing ellagitannins” was recovered in the OUT sample 
having been unable to pass through the dialysis tubing presumably as a 
result of their larger size or binding to proteins and/or bile acids 32. The 
increased levels of ellagic acid in the IN fractions is indicative of 
ellagitannin breakdown. After IVD, quercetin derivatives were present in 
higher levels in extracts from the wild species than those from the 
commercial blackberry. These higher recoveries reflect the greater 
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stability of flavonols to IVD 29 as other components were degraded during 
IVD but also reflect higher levels in the undigested extracts. The most 
obvious difference between the R. brigantinus,  
R. vagabundus and the blackberry IN samples was the presence of a 
component with properties indicating a methyl ellagic glucuronide 
structure. Methyl ellagic glycosides have been identified in blackberry and 
raspberry 33,34, and methyl ellagic glucuronides have been identified in 
other plants 35. However, further work is required to confirm this putative 
identification. Although this component appeared greatly enriched in the 
IN samples after digestion compared to the commercial blackberry IN 
sample, it still only comprised a small proportion of the total phenolic 
content. The IN samples contained many peaks, presumably breakdown 
products, that could not be identified, and these metabolites may also 
have important biological properties.  
Based on the cytotoxicity profiles, ranges of non-toxic concentrations of 
IN fractions were selected as 0- 1 µg mL-1 GAE for commercial blackberry 
and R. vagabundus and 0-0.4 µg mL-1 GAE for R. brigantinus. These 
ranges correspond to 0-6 µM GAE and 0-2.4 µM GAE, respectively. These 
levels are near to the physiological concentrations of certain phenolic 
components noted in human plasma (0-4 µM) 36. Then, these non-toxic 
physiological concentrations were tested on a neurodegeneration cell 
model. 
SK-N-MC neuroblastoma cells were pre-incubated for 24 h in the presence 
or absence of IN fractions and then challenged with H
2
O
2
. Neuroprotection 
was then evaluated by monitoring cells that maintained both high ∆Ψm 
and cell membrane integrity (Q4 positive cells; Fig. 3B). Unlike the 
commercial blackberry variety, the wild species were able to recover both 
parameters, ensuring cell viability and functionality (high cell membrane 
integrity and high ∆Ψm). Therefore, R. brigantinus and R. vagabundus, 
but not the commercial blackberry, extracts contain phytochemicals with a 
potential to be explored in a neuroprotective perspective. However, the 
mechanism(s) by which those metabolites are exerting a beneficial effect 
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are unknown. In order to unravel possible mechanisms behind the 
neuroprotection detected, some cellular redox/death mechanisms were 
tested. 
Intracellular ROS levels were monitored (Fig. 4) at two different times of 
pre-incubation, 2 and 24 h, to cover different time events. Within 2 h, 
direct scavenging effects from metabolites can be determined, and at  
24 h, indirect scavenging resulting from activation/modulation of other 
molecular mechanisms can be assessed. Diverse phytochemicals can act 
directly through scavenging properties or indirectly through modulation 
of thiol-containing molecules (such as glutathione), ROS-inactivating 
enzymes (e.g. SOD, CAT) or phase II detoxifying enzymes (e.g. glutathione 
S-transferases, HO-1) 37. All blackberry extracts at 2 h and/or 24 h pre- 
-incubation (Fig. 4A) reduced basal ROS production. This effect suggests a 
possible preventive role in oxidative stress-associated diseases, such as 
neurodegeneration. These results agree with previous work on various 
phenolic components (e.g. naringin, nobiletin, luteolin, quercetin,  
gingerol) 38-40. Following the application of a stress of 200 µM H
2
O
2 
for 1 h 
(Fig. 4B), R. brigantinus was the only species that maintained reduced ROS 
levels after 24 h pre-incubation. The different composition of  
R. brigantinus digested metabolites could activate indirect antioxidant 
systems more effectively than the other species. Digested metabolites 
from commercial blackberry, as already described 20, and from  
R. vagabundus lost part of their intracellular antioxidant capacity 
especially against H
2
O
2
-induced stress. 
GSH and GSSG were determined after pre-incubation with blackberry 
fractions and after application of H
2
O
2
 stress (Fig. 5).  Different IN 
fractions caused different responses. The commercial blackberry fraction 
caused a GSH depletion (Fig. 5A), while conversely, R. brigantinus and  
R. vagabundus fractions augmented GSH levels with R. vagabundus being 
more significant (Fig. 5A). Intracellular GSH depletion is an early hallmark 
in the progression of cell death in response to different apoptotic  
stimuli 41.  H
2
O
2
 insult induced a GSH depletion (Fig. 5A). Pretreatment with 
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commercial blackberry metabolites could not maintain GSH levels under 
H
2
O
2
 insult, which corresponds to the lack of neuroprotection by 
commercial blackberry digests (Fig. 3B). However, no significant changes 
were detected in GSH/GSSG ratio, induced by H
2
O
2
 stress or IN fraction 
pre-incubation (Fig. 5B). This redox homeostasis is due to changes in GSH 
that are accompanied by changes in GSSG. Pre-incubation with the IN 
fractions from the wild blackberries, although not changing GSH/GSSG 
ratio, increased GSH levels (Fig. 5A) which could occur via de novo 
synthesis of GSH by γ-glutamylcysteine ligase. This increase should 
contribute to the cellular protection, since after imposition of oxidative 
stress, levels of GSH were maintained around control levels (Fig.5B) and 
cell death was prevented (Fig. 3C). The decrease in GSH and GSSG levels 
after pre-incubation with wild blackberries fractions followed by the 
oxidative stress could be due to their mobilization by other molecules, 
such as proteins. This mechanism denominated S-glutathionylation is an 
important post-translational modification that provides protection of 
proteins against irreversible modifications and protein damage in 
response to higher levels of oxidative stress 42. 
Acute and chronic neurodegenerative conditions have been associated 
with both apoptotic and necrotic cell death, and caspases can play a role 
in both mechanisms 43. A range of pure phenolics have been shown to 
cause caspase inhibition and reduce cell death 38,39,44. However, pre- 
-incubation with IN metabolites in the absence of H
2
O
2
 injury enhanced 
caspase activity up to twofold (Fig. 6A) without reducing cell viability  
(Fig. 3A). When cells were challenged with H
2
O
2
, caspase activation was 
augmented by comparison with the control (Fig. 6B). The same augment 
in caspase activity was verified when cells were pre-incubated with any of 
the blackberry IN samples and submitted to stress. However, for the 
fractions from wild blackberries, this caspase activation was not 
accompanied by a decrease in cell viability, in contrast to cells only 
challenged with H
2
O
2
 (Fig. 3C). This protective effect was not verified for 
the commercial blackberry fraction. Again, differences in PP composition 
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must be responsible for these observed differences. Curiously, although 
lower levels of endemic metabolites (0.1-0.25 µg GAE mL-1) strongly 
promote caspase activation, they did not diminish cell death in stressed 
cells (Fig. 3C). Results suggest that the existing mechanism of death in 
the presence of metabolites is not caspase-dependent. Different levels of 
caspases-3 and -7 activation by metabolites pre-incubation (Fig. 6A) did 
not lead to different levels of death (Fig. 3A). Also, similar caspases-3 and 
-7 activation by metabolites (Fig. 6B) led to reduced levels of death after 
oxidative injury (Fig. 3C). Exposure to components in the digests from 
wild blackberries could be an initiating event that leads to protection 
against subsequent, potentially lethal stimuli. This mechanism, also 
known as preconditioning or hormetic effect, has been reported as an 
effective neuroprotective mechanism, where activation of caspase-3 could 
be involved 45-47. In those cases where caspase-3 is activated, arrest of cell 
death can be triggered by downstream mechanisms like defense against 
apoptossome assembly and cleaved caspases. This protection can be 
mediated by factors such as calbindin, inhibitors of apoptosis (IAPs), B-cell 
lymphoma 2 (Bcl-2) family and HSPs, induced by sub-lethal insults 46,47. 
The evaluation of (in vitro) digested metabolites, as opposed to the 
common approach employing undigested/pure compounds, revealed a 
differential metabolic response indicating that considering dietary PPs 
metabolism is crucial to effectively assess and determine physiological 
bioefficacy 20. In fact, the metabolism of these compounds is quite 
complex. PPs can be absorbed in the stomach and small intestine, by 
diffusion or transport 36. Once absorbed, they are biotransformed through 
phase II enzymatic conjugation in both the small intestine and liver. 
Flavonoids not absorbed in the upper GI tract reach the colon and are 
subjected to colonic microflora action and their catabolites absorbed into 
the circulatory system.  
Once we aim to study digestion-derived metabolites in neurodegenerative 
disorders, we should also take into account that circulating metabolites 
must cross and/or interact with BBB. There are numerous studies 
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reporting PP-mediated neuroprotection. However, there is paucity of 
information regarding the interaction of PPs metabolites with the brain 
endothelial cells forming the BBB, which has complicated identification of 
PPs compounds entering the central nervous system. Among PPs found in 
berries, there are some reports indicating the presence of anthocyanins 
and flavanols in brain tissues  48-52. 
 
5. Conclusions 
In summary R. brigantinus and R. vagabundus were revealed to be 
promising sources of metabolites with neuroprotection capabilities. 
Digested metabolites from these blackberries, at levels that could be 
found in human plasma, activated adaptative cellular stress response 
pathways such as caspase activation, GSH modulation and also ROS 
diminishment. These effects protected neuronal cells against oxidative 
injury, one of the most important features of neurodegeneration. This is 
the first report highlighting a neuroprotective effect by a digested food 
matrix involving activation of caspases, suggesting a preconditioning 
effect. It has been already described for some isolated phytochemicals 
that beneficial effects could be achieved thought neurohormesis pathways, 
such as stimulating the vitagene system, the production of antioxidant 
enzymes, protein chaperons and other proteins that help cells to 
withstand stress 53. Therefore, these molecular targets should be a goal 
for future studies into the neuroprotection mediated by digested 
metabolites from wild blackberries.  
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8. Supplementary material 
 
 
Figure S1- HPLC profile of the three blackberries recorded at absorption maximum wavelength for each peak A) Undigested 
extracts and B) IN samples. The full scan deflection is shown in the upper right corner of each panel. Numbers in some peaks 
correspond to their putative identifications based on MS fragmentation pattern presented in Table S1. Peaks under the bracket 
are covered by peaks 9-16 (mainly quercetin and ellagic acid derivatives) which are enriched in the wild species and survive 
digestion. The arrows denote unknown components which are enriched in only the wild species. 
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Table S1- Identification of phenolic components from blackberry extracts 
Peak 
No. 
RT PDA m/z MS2 Putative ID 
Blackberry extracts 
1 18.46 515, 280 +449, 287 287 Cyanidin-3-O-glucoside 33,54 
2 21.11 515, 280 +419, 287 287 Cyanidin-3-O-xyloside 33,54 
3 21.77 240-300 
1567, 783, 
301 
1265, 1103, 
933 
Sanguiin H-10 33,54,55 
4 21.85 520, 285 +535, 287 287 
Cyanidin-3-O-malonyl 
glucoside 54 
5 
 
22.16 520, 280 +593, 287 287 
Cyanidin-3-O-
hydroxymethyl-glutaroyl 
glucoside 55  
6 22.98 240-300 
1401, 
1250, 934, 
301 
1869, 1567, 
1250, 1235, 
934, 633 
Lambertianin C 33,34,56 
7 23.58 240-300 
1869, 935, 
301 
1567, 1265, 
1235, 1103, 
933, etc. 
Sanguiin H-6 34,56 
8 24.00 240-300 1103 multiple Sanguiin H-2 57 
9 24.43 355 433, 301 301 Quercetin pentose 1 58 
10 24.83 365 
491, 315, 
301 
315, 301 
Methyl ellagic acid 
glucuronide 35 
11 25.25 355 433, 301 301 Quercetin-pentose 2 58 
12 25.40 355 609, 301 301 Quercetin-rutinoside 34,54,58 
13a 26.63 355 463, 301 301 Quercetin-glucoside 33,34,54,58 
13b 26.83 355 477, 301 301 Quercetin-glucuronide 33,58 
13c 27.00 355 477, 301 301 Quercetin-glucuronide 33,58 
14 27.57 370 301 301, 275 Ellagic acid 59 
15 27.95 355 
607, 505, 
463, 301 
545, 505, 
463, 301 
Quercetin-HMG-glucoside 58 
16 28.50 365 447, 315 315 
Methyl ellagic acid pentose 
33,34 
IN fractions 
P1 11.22 
230-300, 
250 max 
779, 667, 
281, 267 
737, 547, 
397, 265 
Unknown 
P2 17.32 260, 290 611 
575, 465, 
285 
Unknown 
P3 17.47 270 443 
237, 219, 
163 
Unknown 
P4 17.85 260, 290 1057, 471 869 Unknown 
P5 18.06 275 
855, 715, 
552, 519 
757, 739, 
713, 695 
Unknown 
P6 20.48 335, 285 465 303, 285 Unknown 
P7 20.74 280 
767, 565, 
463, 445 
731, 587, 
551 
Unknown 
P8 22.24 235 881 ND Unknown 
Assignments are supported by previous work. Peak numbers refer to Fig. S1. 
Compounds 1-14 were identified in the original extract; compounds P1-P8 were 
more apparent in the IN samples. + denote detection in the positive mode MS only. 
In bold are denote the most abundant ions. ND- not detected. 
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Abstract 
Clinical and preclinical research has identified neurological benefits 
associated with the consumption of berry fruits in relation to reducing the 
risk of incidence of age-related neurodegeneration. Signaling mechanisms 
and protein kinases cascades have been reported as affected by phenolic 
compounds; however the impact upon pathways affected remain unknown. 
The aim of this study is to unravel the neuroprotective pathways mediated 
by extracts of Rubus vagabundus, a wild blackberry species, in 
comparison with a commercial variety, which have already been proven to 
promote different neuroprotective actions. In model systems To facilitate 
the achievement of this aim a transcriptomic approach will be exploited. 
Blackberry extracts subjected to IVD were able to differentially impact 
upon gene expression alterations induced by oxidative stress. However,  
R. vagabundus was more effective in reducing the number of genes 
altered. Potential pathways differentially affected by stress and blackberry 
metabolites were mainly related with functions of transport, cell cycle and 
DNA repair. Complementary biochemical studies are necessary to evaluate 
possible further post-translational regulation and validate the differential 
protective role of blackberry metabolites on those pathways. Pathways 
involving small GTP-binding proteins were also highlighted as 
differentially regulated. This impact upon several cellular pathways with 
the effect on those pathways could be interesting to follow. Moreover, 
study of small GTP-binding proteins could reveal them as important 
regulators. 
 
Keywords 
Cell cycle; DNA repair mechanism; Microarrays; Neurodegeneration cell 
model; Rubus sp.; Small GTP-binding proteins; Transport. 
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1. Introduction 
The increase in life expectancy in populations from developed countries 
has increased the incidence of aging related diseases, such as NDDs 1. 
These diseases are becoming a major problem in terms of health and well- 
-being with an associated high impact in health and welfare care costs. 
Dietary supplementation with berry fruits is reported to have direct and 
beneficial effects on the brain 2.  There is a growing body of preclinical 
and clinical research identifying neurological benefits associated with the 
consumption of berry fruits, preventing age-related neurodegeneration, by 
mediating cognitive and motor functions 3. Recent clinical trials have 
extended the findings of the model systems identifying antioxidant, anti- 
-inflammatory, and cognition sparing effects to humans 3. In cell and 
animal models, berry fruits have been shown to mediate signaling 
pathways involved in inflammation and cell survival in addition to 
neuroplasticity and neurotransmission enhancement, leading to 
attenuation of age- and pathology-related deficits in behavior 2,4. A large 
number of signaling pathways and protein kinase cascades, such as 
protein kinase C, Nrf2/ARE antioxidant pathway, pro-survival MEK/ERK 
and PI3K/AKT pathways among others, have been reported to be affected 
by phenolic compounds; nevertheless the specific details of the mode and 
site of action of these phenolic compounds remains unclear 5. Recently, 
wild blackberries, with a slightly different chemical composition from a 
commercial blackberry cultivar, were shown to exhibit a better 
neuroprotective capacity than the commercial cultivar 6. Therefore, as well 
as understanding the target pathways affected it become also important 
to understand the differential regulation mediated by the different 
blackberries.  
Many reports on the effects of PPs are based on in vitro cell assays that 
have studied single compounds at relatively high doses and in the form as 
they occur in food 7. Although these studies are import to unravel the 
potential mechanisms involved, the experimental conditions are largely 
non-physiological. PPs are normally ingested as mixtures of different 
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compounds immersed in a complex food matrix that undergoes a 
digestion process and then must pass several barriers before reaching the 
target organ. 
Dietary interventions generally results in small effects on a large number 
of genes compared to a pharmaceutical intervention which may targets a 
specific biomarker 8. Transcriptional profiling using DNA microarrays has 
become an essential technology to conduct a broad survey of the changes 
in gene expression that accompany specific cellular responses such as 
those triggered by food or food components on cells. It can also highlight 
the combined effect of several genes belonging to a similar biological 
pathway and to identify gene products of potential significance that can 
be examined further thereby giving a feel for the global cell response to a 
specific treatment. Moreover, it can identify modulations of multiple gene 
networks, in the form of the expression of thousands of genes, within a 
single experiment. 
The aim of this work is to use a transcriptomic approach to unravel the 
mechanism/pathways mediated, at the gene expression level, by Rubus 
vagabundus, a wild blackberry species, in comparison with a commercial 
variety, which have already been shown to promote different 
neuroprotective actions.  
 
2. Material and Methods  
2.1.  Preparation of in vitro digested fractions 
Fruits of wild blackberry (Rubus vagabundus Samp.) were collected in 
September 2009 in Bragança region (northeast region of Portugal) and 
frozen. Fruits were collected from several populations, growing in 
different locations in order to be representative of the species. Voucher 
samples were authenticated and deposited at the herbarium "João de 
Carvalho e Vasconcelos", Instituto Superior de Agronomia, Lisbon, 
Portugal (voucher number 722/2010). The commercial blackberry cv. 
Apache (Rubus L. subgenus Rubus Watson) was produced in Fataca 
experimental field (Odemira, Portugal). The samples were freeze-dried, 
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ground without separation of seeds in an IKA M20 mill to pass a 0.5 mm 
sieve and stored at -80 ºC prior to extraction. In vitro digested fractions 
were obtained as previously described 6. Fruit extracts were prepared 
using a hydroethanolic solution (ethanol 50 % (v/v)). Briefly, 12 mL of 
ethanol 50 % were added for each gram of blackberry freeze-dried powder. 
Homogenate was shaken for 30 min and filtered. Extracts obtained were 
dried under vacuum. Phytochemical alterations during digestion were 
mimicked using the IVD model and a fraction which contains metabolites 
that equate to those that should be able to reach serum by paracellular 
transport were evaluated.  
2.2. Animal cell culture 
Human neuroblastoma SK-N-MC cells were obtained from the ECACC and 
cultured in EMEM (Sigma) supplemented with 2 mM L-glutamine (Sigma), 
10 % (v/v) heat inactivated FBS (Gibco), 1 % (v/v) non-essential amino acids 
(Sigma), 1 mM sodium pyruvate (Sigma) and containing 50 U penicillin and 
50 µg streptomycin per mL of medium. The cells were maintained at 37 
ºC in 5 % CO
2
 and split at sub-confluence of 70-80 % using 0.05 % 
trypsin/EDTA (Gibco). SK-N-MC cells were seeded at 5 x 104 cells cm-2 and 
grown for 24 h. Afterwards, medium was replaced and in vitro digested 
fractions that contains metabolites that could reach serum by paracellular 
transport supplied to cells (0.5 µg GAE mL-1) dissolved in medium 
containing 0.5 % (v/v) FBS. Cells were incubated for 24 h, then medium 
was removed, replaced by medium (0.5 % (v/v) FBS) containing 300 µM 
H
2
O
2 
and cells incubated for 3 h.  
2.3. Cell sorting 
After incubations cells were washed with PBS, tripsinized, collected to a 
tube and 0.05 volumes of FBS added, to inactivate trypsin. Two 
fluorescent probes (DiOC
6
(3), Invitrogen and PI, Invitrogen) were then 
added, in PBS, to final concentrations of  20 nM and 1 µg mL-1, 
respectively. Cells were then incubated with the probes for 30 min at  
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37 ºC. DiOC
6
(3) was used to evaluate the ∆Ψm and PI to determine cell 
viability, based on plasma membrane integrity, as previously described 6. 
Cells were then sorted in a FACSAria High Speed Cell Sorter (Becton 
Dickinson), using a 100 µm nozzle with 206.8 kPa (30 psi) sheath 
pressure. A 488 nm laser was used for DiOC
6
(3) and PI excitation and 
detection was performed using a 530/30 nm and a 695/40 nm HQ band 
pass filter, respectively. Only cells that presented cellular membrane 
integrity and high mitochondrial transmembrane potential were collected 
in tubes containing PBS. 
2.4. RNA isolation, quality control and labeling and hybridization 
Followed centrifugation 10 min at 500 g, total RNA extraction of sorted 
cells was performed using AxyPrep Multisource Total RNA Miniprep 
(Axygen), accordingly to manufacturers and as previously described 9. 
Total RNA was treated with Turbo™ DNase I (Ambion), accordingly to the 
manufacturer’s instructions. RNA quantity was assessed through Nano- 
-Drop® ND-1000 spectrophotometer (NanoDrop Technologies) and quality 
using an Agilent 2100 Bioanalyser with an RNA 6000 Nano Assay (Agilent 
Technologies). The RNA, in biological triplicates, was processed for use on 
Affymetrix (Santa Clara, CA, USA) GeneChip HuGene 1.0 ST Arrays, 
according to the manufacturer’s Whole Transcript Sense Target Labeling 
Assay. Briefly, 100 ng of total RNA containing spiked in Poly-A RNA 
controls (GeneChip Expression GeneChip Eukaryotic Poly-A RNA Control 
Kit; Affymetrix) was used in a reverse transcription reaction (GeneChip® 
WT cDNA Synthesis Kit; Affymetrix) to generate first-strand cDNA. After 
second-strand synthesis, double-stranded cDNA was used in an in vitro 
transcription (IVT) reaction to generate cRNA (GeneChip® WT cDNA 
Amplification Kit; Affymetrix). Fifteen µg of this cRNA was used for a 
second cycle of first-strand cDNA synthesis (GeneChip® WT cDNA 
Synthesis Kit; Affymetrix). From the single stranded cDNA 5.5 µg was 
fragmented and end-labeled (GeneChip® WT Terminal Labeling Kit; 
Affymetrix). Size distribution of the fragmented and end-labeled cDNA, 
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respectively, was assessed using an Agilent 2100 Bioanalyzer with a RNA 
6000 Nano Assay. 
Five µg of end-labeled, fragmented cDNA was used in a 100-µL 
hybridization cocktail containing added hybridization controls. 80 µL of 
mixture was hybridized on arrays for 17 h at 45°C. Standard post 
hybridization wash and double-stain protocols (FS450_0007; GeneChip 
HWS kit, Affymetrix) were used on an Affymetrix GeneChip Fluidics Station 
450. Arrays were scanned on an Affymetrix GeneChip scanner 3000 7G. 
Scanned arrays were analyzed first with Affymetrix Expression Console 
software for quality control. GeneChip datasets for the eighteen arrays 
used in this study will be available in a MIAME-compliant format through 
Gene Expression Omnibus. 
2.5. Data Analysis and Gene Functional Classification 
Absent and present calls were generated using Chipster 2.0 platform as 
24 of January 2012 (http://chipster.csc.fi/ 10). Array data were normalized 
using Robust Multi-array average (RMA) and statistical differences 
evaluated by a two groups test (empirical Bayes), for p<0.01. 
The DAVID gene functional classification tool 11,12 was used to condense 
the list of genes detected in our sample set into functionally-related 
groups. We used an agglomeration method (Functional Annotation 
Clustering) to cluster the three main gene ontology charts (Biological 
Process, Molecular Function and Cellular Component) in a meaningful 
network context. The following parameters were used: classification 
stringency (medium), similarity term overlap (3), similarity threshold 
(0.50), initial group membership (3), final group membership (3), and 
multiple linkage thresholds (0.50). Only clusters presenting an enrichment 
score higher than 1.3 (equivalent to p<0.05) were considered. To identify 
the canonical pathways involved in the protection by berry metabolites, 
differentially-expressed genes were analyzed using a manually curated 
proprietary database (MetaCoreTM, GeneGo, by Thomson Reuters, St. 
Joseph, MI). Analysis involves in the enrichment of matching gene IDs of 
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possible targets for the sets with gene IDs in functional ontologies in 
MetaCore. The probability of a random intersection between a set of IDs 
the size of target list with ontology entities is estimated in p-value of 
hypergeometric intersection. The lower p-value means higher relevance of 
the entity to the dataset, which shows in higher rating for the entity. 
Pathways identified were sorted using the criterion “Statistically significant 
Maps”. 
 
3. Results 
Transcript levels were determined in neuroblastoma cells pre-incubated 
with blackberry metabolites and/or subjected to oxidative insult, a model 
for neurodegeneration. Cells were subjected to control (C) conditions, 
oxidative stress [subjected to 3 h H
2
O
2
 300 µM (S)], incubated with 
blackberry metabolites for 24 h (BB and RV for commercial blackberry and 
R. vagabundus, respectively) and pre-incubated with blackberry 
metabolites for 24 h followed by oxidative stress  (BB+S and RV+S). All the 
results were obtained by comparison with C conditions. 
3.1. General characterization 
Oxidative stress (S treatment; Table 1) resulted in the differential 
expression 967 genes compared with control treatment, which 
corresponds to 4.8 % of the total genes covered by the array. Of those, 
495 were up-regulated and 472 down-regulated. BB and RV treatments 
induced the differential expression of 524 and 85 genes, respectively 
(Table 1). In the BB+S treatment, 844 (4.2 % of total) genes were 
differentially-expressed. Fewer genes were differentially-expressed by the 
RV+S treatment, 441 (2.2 % of total) genes, compared with the C cells. 
Within the differentially-expressed genes, some were commonly 
differentially regulated as result of H
2
O
2
 treatment and pre-incubation with 
blackberry metabolites (78 and 19 genes for BB and RV, respectively;  
Fig. 1). When cells were pre-incubated with metabolites followed by 
oxidative stress, some genes that were differentially-expressed by the 
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stress itself (S) remained changed (42 % and 29 % of the genes altered by 
S remain altered in BB+S and RV+S, respectively).  
 
 
 
3.2. Gene enrichment  
Using term enrichment algorithms it was possible to associate biological 
relevance and consequences to some sample comparisons (Table 2). After 
S treatment, differentially-expressed genes were mostly grouped by terms 
 
Fig.  1- Venn diagram illustrating differential gene expression. Numbers 
correspond to differentially-expressed genes in comparison with the control. 
S– oxidative stress (300 µM H
2
O
2
, 3h); BB- incubation with commercial 
blackberry (0.5 µg GAE mL-1, 24 h); BB+S- pre-incubation with commercial 
blackberry pre-incubation followed by stress imposition; RV- incubation with  
R. vagabundus incubation (0.5 µg GAE mL-1, 24 h); RV+S- pre-incubation with  
R. vagabundus followed by stress imposition. 
S
RVRV+S
9273
13
10
675
53145
S
BBBB+S
35369
53
43
520
393
379
Table 1- Comparison of numbers of genes differentially-expressed against 
controls. Legend: C- control; S– oxidative stress (300 µM H
2
O
2
, 3h);  
BB- incubation with commercial blackberry (0.5 µg GAE mL-1, 24 h); BB+S- pre- 
-incubation with commercial blackberry followed by stress imposition;  
RV- incubation with R. vagabundus (0.5 µg GAE mL-1, 24 h); RV+S- pre-incubation 
with R. vagabundus followed by stress imposition. 
 Up-regulated Down-regulated Total 
S 495 472 967 
BB 316 208 524 
BB + S 487 357 844 
RV 48 37 85 
RV + S 258 183 441 
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associated to “endosome- and vesicle-mediated transport”. BB treatment 
promoted the alteration in transcription of genes mainly associated with 
terms related to “response to stimulus”, “carbohydrate metabolic process” 
and “regulation of cell migration” pathways. When pre-incubation was 
followed by H
2
O
2
 treatment (BB+S), the differentially-expressed genes were 
mostly associated with  changes in components of the “Ras GTPases” and 
“ATP-grasp” (enzymes, catalyzing ATP-dependent ligation of a carboxylate 
containing molecule to an amino or thiol group-containing molecule) 
superfamilies. In case of RV and RV+S, the differentially-expressed genes 
could not be grouped in any significant term, and presented widespread 
locations, functions and properties. 
Using gene enrichment algorithms, it was possible to associate alterations 
with pathways that showed genes differentially expressed as result of 
treatments applied (Table 3). For each comparison of treatments, the top 
ten  pathways were determined using MetaCoreTM 13. The ranked pathways 
are those that displayed higher number of differentially-expressed genes 
in response to the treatments. Differentially-expressed genes in these 
pathways and their respective fold changes are listed in supplementary 
material and are grouped by pathways (Table S1). Among the pathways 
highlighted,  were those related to basic/general cell functions, such as 
nucleotide metabolism (“ATP/ITP”, “CTP/UTP” and “GTP-XTP” metabolism). 
Their importance is supported by their presence in the top 10 of almost 
all treatments tested. Other representative pathways were related with 
transport, cell cycle, and DNA repair, and 14 pathways were identified 
amongst all treatments that play important roles on these events. 
S treatment mainly induced changes in genes associated with nucleotide 
metabolism, cell cycle and DNA repair functions.  
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Table 2– Functional categories significantly over-represented in differentially expressed genes. Enrichment term analysis was 
performed using Functional Annotation Clustering on DAVID. Only clusters presenting an enrichment score higher than 1.3 
(equivalent to p<0.05) were considered. All comparisons were performed against the control. Legend: C- control; S-stress 
imposition (300 µM H
2
O
2
, 3h); BB- commercial blackberry incubation (0.5 µg GAE mL-1, 24 h); BB+S- commercial blackberry 
pre-incubation followed by stress imposition; RV- R. vagabundus incubation (0.5 µg GAE mL-1, 24 h); RV+S- R. vagabundus 
pre-incubation followed by stress imposition. 
 
 S BB BB+S RV RV+S 
  Term 
Enrichment 
score 
Term 
Enrichment 
score 
Term 
Enrichment 
score 
Term 
Enrichment 
score 
Term 
Enrichment 
score 
1 Endosome 1.671 
Response to 
stimulus 1.737 
Ras 
GTPases 1.766 - - - - 
2 
Vesicle-mediated 
transport 1.403 
Carbohydrate 
metabolic 
process 1.515 ATP-grasp 1.340 
3 
Regulation of 
cell migration 1.329 
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Table 3- Pathways identified by gene enrichment in top 10 of each comparison, 
sorted using the criterion 'Statistically significant Maps'. Genes differentially 
expressed genes were analyzed using a manually curated proprietary database 
(MetaCoreTM, GeneGo, by Thomson Reuters, St. Joseph, MI).  
Pathway 
Nucleotide metabolism 
ATP/ITP metabolism 
CTP/UTP metabolism 
GTP-XTP metabolism 
Transport 
Clathrin-coated vesicle cycle 
Aldosterone-mediated regulation of ENaC sodium 
transport 
CFTR folding and maturation (norm and CF) 
Normal wtCFTR traffic/ER-to-Golgi 
Delta508-CFTR traffic/ER-to-Golgi in CF 
Ran regulation pathway 
Cell cycle 
Role of Nek in cell cycle regulation 
Transition and termination of DNA replication 
Chromosome condensation in prometaphase 
Spindle assembly and chromosome separation 
DNA repair 
Role of Brca1 and Brca2 in DNA repair 
NHEJ mechanisms of DSBs repair 
Mismatch repair 
Nucleotide excision repair 
Translation Regulation of eIF2 activity 
Amino acid biosynthetic process Glycine, serine, cysteine and threonine metabolism 
Peptide hormone processing POMC processing 
ENac, epithelium sodium channel; CFTR, cystic fibrosis transmembrane conductance regulator; ER, 
endoplasmic reticulum; Nek, NimA related kinase; Brca, breast and ovarian cancer susceptibility protein; 
NHEJ, non-homologous end joining; DSBs, double strain breaks; eIF2, eukaryotic translation initiation 
factor 2. 
 
However, when cells were incubated with berry metabolites, the 
enrichment pattern was altered. The group composed of “ATP/ITP”, 
“CTP/UTP” and “GTP-XTP” metabolism was affected in all conditions.  
Pathways related to transport function were more prevalent amongst 
those affected when cells were (pre-)incubated with berry extracts, 
especially in R. vagabundus treatments (RV and RV+S). Pathways related 
with the cell cycle were less impacted upon by pre-incubation  with berry 
ingested metabolites, most clearly in R. vagabundus treatments. The 
remaining highlighted pathways were related with DNA repair, translation, 
amino acid biosynthetic process and peptide hormone processing. Those 
pathways appear to be affected by blackberry incubation per se 
irrespective of the source species (BB and RV). 
For the more prevalently representative pathways, genes that showed 
differential expression following pre-incubation with blackberry 
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metabolites  reversed the changes induced by S treatment were 
considered for detailed analysis (Figs. 2 to 4). For pathways related to 
transport function, the “clathrin-coated vesicle cycle” was affected by S 
treatment and some of the genes implicated in this pathway were 
differentially-expressed in response to blackberry pre-incubation (Fig. 2). 
These genes included those encoding clathrin and other genes that 
encode Rab proteins or proteins that regulate their activity, such as  
Rab-5A, Rab-7, RABGDIA, RAB9P40, Rab-8 and Rab-11A. For  Rab-11A 
expression, pre-incubation with R. vagabundus ,and for Rab-8 expresssion 
pre-incubations with R. vagabundus and commercial blackberry 
maintained transcript levels at the same level as control conditions. In 
addition, the pathways associated with “Cystic Fibrosis Transmembrane 
conductance Regulator (CFTR) folding and maturation” and “CFTR traffic 
from ER to Golgi” were affected by S treatment as well as by blackberry 
metabolite treatments (Fig. 2). Moreover, there were differences between 
the responses to BB+S and RV+S treatments. In response to S treatment, 
levels of important genes that regulate CFTR function were enhanced but 
this enhancement was inhibited or repressed by BB+S treatment for 
oligosaccharyltransferase (OST) complex, HSP70 and HSP90beta genes, 
which are related with folding and maturation of CFTR. Treatment with 
RV+S modulated the levels of diverse transcripts, related with “CFTR 
folding and maturation” and also “CFTR traffic” (including OST complex, 
HSP40, HSP70, HSP90beta, ATPase homolog 1 (Aha1), coat protein 
complex-II (COPII), syntaxin 6 and coatomer). “Aldosterone-mediated 
regulation of epithelium sodium channel (ENaC)”, a pathway related and 
regulated by CFTR pathway 14, was also affected by the treatments (Tables 
3 and S1 on Supplementary material). Some genes of the “aldosterone-
mediated regulation of ENaC” pathway were significantly differentially-
expressed by S treatment and by blackberry (pre-)incubation (results not 
shown). The neuronal precursor cell expressed developmentally 
downregulated 4 (NEDD4) gene, an important player in “ENaC regulatory” 
pathway had its transcript levels altered by S treatment but they were 
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restored to C levels in response to pre-incubation with R. vagabundus 
(RV+S) (Table S1 on Supplementary material). The “Ras-related nuclear 
protein (RAN) regulation” pathway is also related with transport function. 
However, due to its crucial role in cell cycle and DNA replication 15, results 
concerning the changes in their transcript levels are presented associated 
to cell cycle (Fig. 3). 
Concerning the cell cycle, four pathways appear as differentially-regulated 
at transcriptomic level by blackberry metabolites (Fig. 3): “transition and 
termination of DNA replication”, “chromosome condensation in 
prometaphase”, “spindle assembly and chromosome separation” and “Ran 
regulation”. The first three have a role in specific phases of the cell cycle, 
while the Ran regulation pathway is important throughout the entire cycle 
(Fig. 3).  In the “transition and termination of DNA replication” pathway, S 
treatment changed levels of DNA ligase I, DNA polymerase alpha/primase, 
DNA polymerase delta, DNA polymerase epsilon, topoisomerase I and II 
(TOPI and TOPII) and ribonuclease H1 transcripts.  BB+S treatment only 
reverted transcript levels of ribonuclease H1, to levels below C. Conversely, 
RV+S treatment diminished levels of DNA ligase I, DNA polymerase 
alpha/primase, DNA polymerase delta, DNA polymerase epsilon, TOP2 
and ribonuclease H1 transcripts in relation to stress, although in the last 
case to levels lower than C. In the “chromosome condensation in 
prometaphase” pathway, the levels of condensin transcripts were 
enhanced by S treatment and similar levels were noted in response to 
BB+S. However, RV+S treatment was accompanied by a smaller increase in 
transcription but not to the level exhibited in the control. This pattern was 
also followed for the “spindle assembly and chromosome separation” 
pathway (anaphase-promoting complex/cell division cycle 20 homolog 
(APC/CDC20 complex)). In the “Ran regulation” pathway, importin 
(karyopherin)-alpha transcripts were also up-regulated by S treatment but 
these levels were not reversed by pre-incubation by pre-incubation with 
either blackberry. 
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Fig. 2- Transcript levels of some important genes that regulate CFTR folding and maturation, CFTR traffic/ER-to-Golgi and 
clathrin-coated vesicle cycle, pathways related with transport process. Transcript levels correspond to fold change in comparison 
to control cells. Legend:  BB;   BB+S;  RV;  RV+S;  S.  
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Concerning DNA repair, diverse pathways were differentially-regulated at 
the transcriptomic level, these included: the “role of breast and ovarian 
cancer susceptibility protein 1 and 2 (Brca1 and Brca2) in DNA repair”, 
“non-homologous end joining (NHEJ) mechanism of double strain breaks 
(DSBs) repair”, “mismatch repair (MMR)” and “nucleotide excision repair 
 
Fig. 3- Transcript levels of some important genes that regulate Ran regulation, 
transition and termination of DNA replication, chromosome condensation in 
prometaphase and spindle assembly and chromosome separation pathways, 
related with cell cycle. Transcript levels correspond to fold change in comparison 
to control cells. Legend:  BB;  BB+S;  RV;  RV+S;  S. 
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(NER)” (Fig. 4). In the “Brca1/Brca2 role in DNA repair” pathway, the 
transcript levels of histone H2AX were enhanced by S treatment (Fig. 4) 
and these levels were decreased by RV+S but not to C levels. The 
transcript levels of Brca1, a protein indirectly controlled by histone H2AX, 
were not changed by stress conditions, in the presence or absence of 
blackberry  metabolites. In the MMR pathway, four genes were highlighted 
as differentially expressed: MutSalpha complex, MutLalpha complex, 
MutLbeta complex and proliferating cell nuclear antigen (PCNA). The 
MutSalpha complex, which recognizes single base mismatches and small 
insertion/deletion in DNA, showed enhanced levels of transcripts in 
response to S treatment, whereas RV+S treatment reduced expression, 
without reaching C values. MutLalpha and MutLbeta complex also 
presented different expression patterns in response to S treatment. BB+S 
treatment reversed the effects of S treatment, whereas RV+S only affected 
MutLbeta transcript levels. The transcript levels of PCNA, a processivity 
factor, was also enhanced under S treatment. However, pre-incubation 
with commercial blackberry metabolites, decreased PCNA transcript levels 
to below C values and pre-incubation with R. vagabundus returned PCNA 
transcript levels to C values. This gene is also involved in the “NER” 
pathway, where various other genes were differentially-expressed from 
the “lesion type recognition to the repair process”, these included DNA- 
-directed RNA polymerase II subunit A (POLR2A), RNA polymerase II, 
Xeroderma pigmentosum complementation group G (XPG), DNA 
polymerase delta, DNA polymerase epsilon, transcription factor II H (TFIIH) 
and DNA ligase I. The transcript levels of POLR2A and RNA polymerase II, 
which are involved in  recognition steps, were enhanced by S but were 
significantly reduced in response to pre-incubation with R. vagabundus 
(RV+S), although they remained higher than C. The same pattern was 
noted for DNA polymerase delta, TFIIH and DNA ligase I. For XPG, 
transcript levels in response to both BB+S and RV+S treatments decreased 
to values below C, reversing the effect of S treatment. 
Chapter 6: Differential expression of genes involved in neuroprotection conferred by blackberry polyphenols after simulated 
gastrointestinal digestion 
 
186 
 
 
 
NER
MMR NHEJ
MutLalpha MutLbeta
MutSalpha
PCNA
MRN complex
R
e
p
a
ir
re
co
m
b
in
a
tio
n
R
e
co
g
n
itio
n
ste
p
s
Histone H2AX
Brca1
Brca1/Brca2 role in DNA repair
-1
0
1
2
Lo
g
2
ra
ti
o
-1
0
1
2
Lo
g
2
ra
ti
o
-1
0
1
2
MRE11 Rad50
Lo
g
2
ra
ti
o
-1
0
1
2
X
P
G
D
N
A
 
p
o
ly
m
e
ra
se
 
d
el
ta
D
N
A
 
p
o
ly
m
e
ra
se
 
e
p
si
lo
n
T
FI
IH
D
N
A
 li
g
a
se
 I
Lo
g
2
ra
ti
o
-1
0
1
2
Ku70/80
Lo
g
2
ra
ti
o
-1
0
1
2
Lo
g
2
ra
ti
o
-1
0
1
2
Lo
g
2
ra
ti
o
-1
0
1
2
Lo
g
2
ra
ti
o
-1
0
1
2
Lo
g
2
ra
ti
o
-1
0
1
2
POLR2A RNA 
polymerase II
Lo
g
2
ra
ti
o
Fig. 4- Transcipt levels of some important 
genes that regulate Brca1/Brca2 role in DNA 
repair, MMR, NER and NHEJ pathways, involved 
in DNA repair process. Transcript levels 
correspond to fold change in comparison to 
control cells. Legend:  BB;  BB+S;  RV; 
  RV+S;  S. 
Brca, breast and ovarian cancer susceptibility 
protein; MMR, mismatch repair; NER, nucleotide 
excision repair; NHEJ, non-homologous end joining; 
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In the “NHEJ mechanism of DSBs repair” pathway, among diverse genes 
differentially expressed, three genes, Ku70/80, MRE11 and Rad50 were 
highlighted (Fig. 4). The first two genes showed increased levels of 
transcripts in response to S treatment but BB+S and RV+S treatments 
diminished  these levels to values below C. MRE11 together with nibrin 
and Rad50 constitute the MRN complex. However, Rad50 did not show the 
same expression pattern as MRE11. Although S treatment enhanced 
Rad50 transcript levels, BB+S and RV+S treatments did not alter these 
transcript levels. Nibrin expression was not affected by any treatment. 
In the pathway “regulation of eukaryotic translation initiation factor 2 
(eIF2) activity”, various genes presented altered expression levels in 
response to  S treatment and some of these alterations were reversed by 
pre-incubation with berry metabolites (Table S1 on Supplementary 
material). However, once again, the effects of blackberry pre-incubation 
were different between the commercial and wild blackberries, with  
R. vagabundus more efficacious.  
3.3. Examination of biochemical pathways previously implicated in 
neuroprotection 
Two important biochemical targets previously suggested to be regulated 
by pre-incubation of neuroblastoma cells with blackberry metabolites were 
caspases and glutathione-related pathways, namely the apoptosis and 
glutathione metabolism pathways6. Indeed, in the “Bad phosphorylation” 
pathway, which is related with cell apoptosis and survival, various genes 
were differentially regulated, mainly those involved in the direct 
phosphorylation/dephosphorylation of Bad, such as protein phosphatase 
catalytic subunit (PP1-cat) alpha, protein phosphatase 2A catalytic subunit 
(PP2A), protein phosphatase 2B (calcineurin A), protein phosphatase 2C 
(PP2C) and cAMP-dependent protein kinase (PKA) (Table S1 in 
Supplementary material). Also proteins presenting a broader occurrence, 
such as ERK and MEKs, are differentially expressed and may participate in 
Bad phosphorylation. 
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Concerning glutathione metabolism, two genes were highlighted as 
differentially-expressed (phospholipid hydroperoxide glutathione 
metabolizing peroxidase (GPx4) and glutathione peroxide (GPx7);  
Table S1 in Supplementary material). Both genes encode glutathione 
peroxidases with different specificities and metabolites from both 
blackberries contradicted the alterations promoted by the stress 
treatment.  
4. Discussion 
Neurological benefits have been associated with the consumption of berry 
fruits with the implication being that of reducing the risk of incidence of 
age-related neurodegeneration. Our previous work has shown that small 
quantitative chemical differences could mediate different cell responses 
concerning neuroprotection by blackberry metabolites 6. Consequently, it 
is important to understand which molecular pathways that underpin the 
differential protection if these fruit are to be successful exploited for 
human health benefits. Therefore, the gene expression alterations 
mediated by the metabolites of a commercial variety and a wild species of 
blackberry were evaluated. The commercial variety was reported as able to 
protect cell viability but not mitochondria functionality in model systems, 
while R. vagabundus, the wild blackberry, was able to protect both 
viability and mitochondria functionality as well as activating adaptive 
cellular stress response pathways such as caspase activation and GSH 
modulation 6.  Transcript levels of neuroblastoma cells subjected to 
different conditions were determined. Treatment of SK-N-MC 
neuroblastoma cells with H
2
O
2
 300 µM for 24 h was already reported to 
promote cell death 6. In the present work, H
2
O
2 
treatment was conducted 
for a shorter period to allow the evaluation of early events at 
transcriptomic level. To elucidate the possible role of blackberry digested 
metabolites on cells, neuroblastoma cells were also incubated with 
digested metabolites of commercial and wild blackberries for 24 h, 
followed or not by H
2
O
2
 treatment and their transcript levels evaluated.  
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Oxidative stress (S treatment) induced the differential-expression of 967 
genes (Table 1 and Fig. 1). However, when cells were pre-incubated with 
blackberry metabolites prior to H
2
O
2
 treatment, the number of genes 
changed was reduced, especially for R. vagabundus treatment (to around 
half this number). R. vagabundus metabolites were more efficacious to 
contradict the effect of oxidative stress, since only 29 % of genes altered 
by S treatment were changed in response to RV+S and 42 % of genes were 
changed by BB+S.  These results suggest that the reduction in total 
number of altered genes due to blackberries pre-incubation (BB+S and 
RV+ S) in comparison with stress alone could be associated to their 
previously described neuroprotective ability 6. In addition, after incubation 
with blackberry metabolite alone, the number of differentially-expressed 
genes was considerably higher for commercial blackberry than for  
R. vagabundus (524 and 85, respectively). It appears that the commercial 
blackberry extract induced more changes in gene expression than  
R. vagabundus, however, without mediating such efficacious protection. 
Since RV treatment was considerably more effective in this 
neuroprotection model5, it is tempting to assume that the lower number 
of genes affected by RV treatment are those most crucial to the process. 
These considerations are reflected in the absence of terms associated to 
RV and RV+S in gene enrichment analysis (Table 2). Terms associated with 
stress treatment alone highlighted those terms associated with transport 
mechanisms (endosome- and vesicle-mediated transport). In fact, during 
neurodegeneration, the fragmentation of neuronal GA and disruption of 
cellular/axonal transport are important features 16-19. Indeed, GA 
fragmentation is thought that may contribute to the initiation of apoptotic 
pathway 20,21. Pre-treatment with blackberry metabolites, commercial 
blackberry was the only one whose treatments (BB and BB+S) were 
associated with enrichment terms. These results show the difference in 
impact that the two blackberries have in cells at transcriptomic level. 
Although R. vagabundus also induce alteration in gene expression of  
SK-N-MC neuroblastoma cells, those changes were affecting different 
Chapter 6: Differential expression of genes involved in neuroprotection conferred 
by blackberry polyphenols after simulated gastrointestinal digestion 
190 
 
 
targets, with different functions and locations, reason why it was not 
associated with any term with statistical significance.  
To assess which specific pathways were significantly impacted upon with 
respect to transcriptional changes due to digested metabolites of the two 
blackberries, an  approach based on the use of enrichment analysis of 
canonical pathways was followed. With respect to gene enrichment terms 
analysis, “transport” was a term highly associated to the transciptomic 
alterations induced by S treatment. This importance was corroborated 
using MetacoreTM analysis that applies a different algorithm of enrichment 
analysis. Some genes that encode proteins from “clathrin-coated vesicle 
cycle”, “CFTR folding and maturation” and “CFTR traffic” pathways had 
their levels of expression altered due to S treatment (Fig. 2). However, pre- 
-incubation with R. vagabundus digested metabolites made the 
expression levels of Rab-8, Rab-11A return to C levels and decrease the 
levels of COPII, syntaxin 6, coatomer, Aha1, HSP70 and HSP40 in 
comparison with stress. CFTR are ATP-binding cassette (ABC) transporters 
and are important in regulation of membrane vesicles trafficking/fusion, 
acidification of organelles, normal anion transport such as chloride and 
neuropeptide transport 22. They are widespread in the human brain and 
involved in the transport of GSH, which could act in brain as 
neurotransmitter and neuromodulator. Furthermore CFTR also controls 
ENaC activity 14,22,23. The CNS could be affected by CFTR (dis)function, for 
instance, by the maintenance of the steady state of cellular electrolytes 22. 
Other phenolic compounds, as curcumin, have already been identified as 
interfering in CFTR genes 24. ENaC transporters are non-voltage-gated 
channels associated with sodium and water transport 25 and have been 
identified in sensory neurons as putative mechanosensors wherein they 
may participate in neuronal regeneration after injury or degenerative 
diseases 25. Their activity is dependent on an increase in CFTR activity 14. 
Therefore, it is not surprising that the “aldosterone-mediated regulation of 
ENaC activity” pathway was highlighted as differentially-expressed.  
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Another important pathway differentially regulated was the “Ran 
regulation” pathway. Ran is a protein that plays a central role in the 
nucleocytoplasmic transport and organizes the microtubules during the M 
phase of cell cycle. Consequently, this pathway is important in transport 
function as well as in the cell cycle, being essential through phases G1, S, 
G2 and M 15.  
Other pathways that play a role in the cell cycle were differentially- 
-expressed (Fig. 3) e.g. the “transition and termination of DNA replication”, 
the “chromosome condensation in prometaphase” and “spindle assembly 
and chromosome separation” pathways all play a role in specific phases of 
the cell cycle. The expression of genes associated with these pathways 
was altered in response to S treatment and treatment with  blackberry 
metabolites tended to reverse this alteration, bringing gene expression 
level closer to the control values. As in the previous pathways, the 
changes in transcript levels mediated by commercial blackberry was 
different from those mediated by wild blackberry, and in most cases, the 
latter was more effective in minimizing the alterations promoted by stress. 
Overall, these results point to the cell cycle as an important target of 
oxidative stress and that blackberry metabolites tend to ameliorate or 
reduce the impact of that stress. However, further biochemical studies are 
required to better understand the specific effects of each treatment on 
cell cycle, such as the cell cycle analysis by flow cytometry.  
Beyond their participation in “transition and termination of DNA 
replication” pathway, DNA polymerase delta and DNA polymerase epsilon, 
as well as DNA ligase, are also shared by DNA repair mechanisms. Among 
the DNA repair pathways, genes associated with “NER”, “MMR”, “NHEJ” and 
“Brca1/Brca2 roles” were modulated following the stress treatment (Fig. 4). 
The “Brca1” pathway assumes a central role in DNA repair, facilitating the 
assessment of DNA repair machinery. Brca1 activation by phosphorylation 
is mediated indirectly by participation of histone H2AX in the activation of 
the cell cycle checkpoint kinase 2 (Chk2). On the other hand, Brca1 
directly regulates histone H2AX activity by ubiquitination. Histone H2AX 
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transcript levels were affected by stress treatment and RV+S treatment 
attenuated these stress-induced transcript alterations. However, Brca1 
transcripts were not regulated according to this pattern. It is possible that  
regulation of Brca1 could be mediated by Histone H2AX but not at 
transcriptomic level and thus not reflected in the transcriptomic data 
pattern seen here. This is an example of one case where activity/levels 
must be verified by complementary methodologies, to better understand 
the general regulation of pathways. Among the DNA repair systems, genes 
differentially regulated in recognition steps and in repair steps were 
identified. Concerning “NER”, which combines subpathways of global 
genomic NER and transcription-coupled NER, the latter seemed to be more 
affected by treatments. In terminally differentiated neurons and 
neuroblastoma cells, where synthesis of new DNA molecules is not 
occurring, global genomic NER is described as poorly active 26,27. However, 
the transcription process is active and transcription-coupled NER ensures 
that errors in DNA during transcription are repaired to maintain the 
quality of genetic information for future transcription. Oxidative stress is 
well known to promote DNA damage, therefore transcription of genes 
involved in DNA repair mechanisms are activated. Results suggest that 
pre-incubation with digested metabolites could protect DNA damage, 
directly or indirectly, reducing the requirement of further increase in 
transcription. 
Another point of regulation at transcriptional level is the regulation of 
eIF2 activity pathway. This pathway regulates mRNA translation, 
transferring Met-tRNA to the 40S ribosomal subunit, which also involves 
GTP/GDP conversion 28. The initiator factor eIF2 controls gene expression 
under conditions of stress, such as viral infection and apoptosis 28. The 
regulation of this pathway also appears associated to protein unfolded 
diseases, an important hallmark in most NDDs. Protein unfolding causes 
endoplasmatic reticulum stress, activating the apoptosis pathway and the 
control of eIF2 attenuates the unfolded protein synthesis 29. The fact that 
blackberry metabolites regulated the activation at transcriptional level of 
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the eIF2 pathway is an important clue unraveling a potential protective 
mechanism. 
Previous work has also shown that the differences on cell protection 
mediated by commercial and wild blackberry species was accompanied by 
capases-3 and -7 activation and a differential modulation of GSH levels 6. 
Therefore, caspases and glutathione related pathways, namely apoptosis 
and glutathione metabolism pathways were relevant to be analyzed in the 
present work. In the Bad phosphorylation pathway, genes involved in the 
direct phosphorylation/dephosphorylation of Bad were differentially 
affected by S treatment and by blackberry metabolites. However, some 
genes linked to signaling functions (MEK, ERK, etc) are ubiquitous thereby 
making it difficult to understand the specific events/alteration occurring 
due to the treatments imposed. Concerning glutathione metabolism, two 
genes that encode glutathione peroxidases were differentially expressed 
(GPX4 and GPX7). Both enzymes mediate the conversion of GSH (reduced 
form) to GSSG (oxidized form) but use different electron acceptors. While 
GPX7 exhibits a strong capacity to neutralize H
2
O
2
 independent of 
glutathione, GPX4 can use a wide range of reducing substrates in addition 
to glutathione and act directly to reduce lipid peroxides and other 
membrane-bound complex hydroperoxides in addition to H
2
O
2
 30,31.  Lipid 
hydroperoxides have important metabolic roles, since they can (i) activate 
of lipoxygenase and cyclooxygenase, (ii) act as signal molecules, in 
apoptotic cell death and receptor-mediated signal transduction, and  
(iv) participate in inflammation 30. Therefore, GPX4 plays a key role in 
mammalian cells. The up-regulation of GPX4 transcripts by the stress here 
indicates its need to deal with the damage stimulus promoted by 
oxidative condition. The fact that blackberry metabolites contradicted that 
up-regulation, returning transcription to levels of C (in the case of RV) or 
even below it (in the case of BB), indicates an interesting shift in oxidative 
metabolism. 
Among the highlighted pathways, seven exhibited a common regulation 
by small GTP-binding proteins (Fig. 5). Small GTP-binding proteins are 
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monomeric G proteins with molecular masses of 20 to 40 kDa that have 
both GDP/GTP-binding and GTPase activities. More than 100 members of 
this superfamily have been identified 32 and they are classified in five 
families: Ras, mainly regulators of gene expression; Rho regulators of 
cytoskeletal reorganization and gene expression; Rab regulators of 
intracellular vesicle trafficking; Sar1/Arf also regulators of intracellular 
vesicle trafficking; Ran regulators of nucleocytoplasmic transport during 
G1, S and G2 phases of the cell cycle and microtubule organization during 
the M phase 15. The families more represented in the presented work as 
differentially-expressed were Ras, Rab, Sar1/Arf and Ran (Fig. 5). 
Functions associated to these proteins were previously identified in term 
enrichment analysis (BB and BB+S; Table 2) as “regulation of cell 
migration”, “Ras GTPases” and “response to stimulus”. In mammalian cells, 
Ras proteins directly bind to and activate Raf protein kinase, which then 
induces gene expression through the MAPK cascade in response to 
various extracellular signaling stimuli 33. They regulate cell proliferation, 
differentiation, morphology and apoptosis. The plasma membrane 
localization is essential for their functions and their association to ER and 
GA assumes an important role in this function. In this work, three 
pathways were highlighted as regulated by Ras family proteins: the 
“aldosterone-mediated regulation of ENaC sodium transport”, the 
“regulation of eIF2 activity” and the “Bad phosphorylation” pathways. Rho 
proteins are involved in diverse cellular events, such as cell growth, 
membrane trafficking, development, axon guidance and extension. Rho 
family proteins regulate actin polymerization, required for reorganization 
of actin cytoskeleton and by this way, regulating cell shape changes, cell 
motility, cell adhesion and cytokenesis 34. However, among the highlighted 
pathways none were directly regulated by Rho proteins but their 
regulation is not negligible considering a significant term outline in  
Table 2 (Regulation of cell migration). Rab proteins have been identified 
as regulating intracellular vesicle trafficking from ER to GA and from this 
to the plasma membrane. Exocytosis, endocytosis and recycling are 
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performed by intracellular vesicle trafficking. Sar1/Arf proteins are also 
associated to vesicles formation and their trafficking. Vesicle budding 
requires the assembly of specific proteins coating the cytoplasmic face of 
a donor membrane to provide the mechanical force to pull the membrane 
into a bud and to capture specific receptors and their bound cargo 
molecules 35. Coated vesicles could be classified as clathrin-, COPI- and 
COPII-coated vesicles. Sar1 and Arf proteins play crucial roles in 
membrane recruitment of COPI and COPII components. In the present 
work, two pathways highlighted in top 10 (Table 3) are regulated by 
proteins belonging to Rab and Sar1/Arf families (Fig. 5). In the “clathrin- 
-coated vesicle cycle”, Rab proteins play an important role, with some 
transcripts that encode Rab proteins or proteins that regulate them being 
differentially expressed (Fig. 3). In “normal wtCFTR traffic/ER-to-Golgi” 
pathway both families, Rab and Sar1/Arf, are involved (Fig. 2). Ran 
proteins play a central role in nucleocytoplasmic transport, chromosome 
localization as well as in microtubule organization in M phase of cell cycle. 
Therefore, these proteins are vital in the cell cycle ensuring the transport 
from nucleus to cytoplasm and in the opposite direction, through the 
nuclear pore complexes. In this work, the Ran regulation pathway and the 
“spindle assembly and chromosome separation” pathway are both 
differentially regulated (Figs. 3 and 5).  
In general, small GTP-binding proteins regulate a wide and diverse range 
of cellular functions such as transport, cell cycle, translation and cell 
death/survival 15. Those proteins are affected by S treatment as well as by 
blackberry metabolites pre-incubation. Therefore these pathways 
associated to small GTP-binding proteins are interesting targets for 
further investigation as is the involvement of these proteins as possible 
common upstream regulators modulated by blackberry metabolites. 
Nevertheless, additional biochemical experiments must be conducted to 
connect this regulation with the neuroprotection afforded by blackberry 
metabolites. Different regulation at transcriptomic level was mediated by 
digested metabolites from the commercial and wild blackberry species, 
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which only had differences in the relative amounts of phytochemicals. 
However, to provide a clear distinction between mechanisms mediated by 
commercial and wild blackberries, further biochemical assays targeting 
molecules on pathways highlighted by microarrays analysis are required. 
 
5. Conclusion 
 Overall, blackberry metabolites were able to prevent some of the gene 
expression alterations caused by oxidative stress. R. vagabundus was 
more efficient, since its pre-incubation promotes a higher reduction in the 
number of genes altered by stress in comparison with commercial 
blackberry. Transcripts changed in response to  R. vagabundus pre-
incubation were spread among different cell locations and mechanisms 
and produced a different effect from commercial blackberry. Thus, 
different regulation at transcriptomic level seems to be mediated by 
metabolites from the commercial and wild blackberry species. 
Potential pathways differentially affected by stress and blackberry 
metabolites were identified, they were mainly related with functions of 
transport, cell cycle and DNA damaging. Also pathways related with 
apoptosis and GSH metabolism displayed some transcripts differentially 
expressed. The possibility that small GTP-binding proteins play a role on 
diverse pathways differentially regulated between blackberries and stress 
suggests a possible common regulation by blackberry metabolites. 
However, supplementary biochemical studies are necessary to understand 
possibly additional post-translational regulation and validate the 
differential protective role of blackberry metabolites on those pathways.  
Chapter 6: Differential expression of genes involved in neuroprotection conferred by blackberry polyphenols after simulated 
gastrointestinal digestion 
197 
 
 
Fig. 5– Pathways highlighted as differentially regulated in the present work and regulation by the respective small GTP-binding 
protein families. Small GTP-binding proteins as well as proteins directly involved in their regulation (up- and down-stream are 
indicated), such as guanine nucleotide exchange factors and GTPase activating proteins. Transcript fold changes of proteins 
indicated can be found in Table S1 in supplementary material. 
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8. Supplementary material 
Table S1- List of gene products codified by genes differential expressed, belonging to pathways of top 10 (Table 3), Bad 
phosphorylation and glutathione metabolism pathways. Legend: C- control; S- stress imposition (300 µM H
2
O
2
, 3h); BB- incubation 
with commercial blackberry (0.5 µg GAE mL-1, 24 h); BB+S- pre-incubation with commercial blackberry followed by stress 
imposition; RV- incubation with R. vagabundus (0.5 µg GAE mL-1, 24 h); RV+S- pre-incubation with R. vagabundus followed by 
stress imposition. 
 
 
    BB+S BB RV RV+S S 
Gene product Type Input IDs 
Log
2
 
ratio 
p-value 
Log
2
 
ratio 
p-value 
Log
2
 
ratio 
p-value 
Log
2
 
ratio 
p-value 
Log
2
 
ratio 
p-value 
ATP/ITP metabolism 
KAD6 Generic 
kinase 
9212_at; 9263_at; 9232_at; 2824_at; 2825_at; 
9235_at; 2760_at; 9236_at; 9213_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 0.68 0.00028
Ribonucleotide 
reductase 
Generic 
enzyme 
10849_at; 11041_at; 10788_at; 3052_at; 
4015_at; 4026_at; 5476_at; 2274_at; 5438_at; 
4048_at; 10847_at; 5458_at; 3081_at; 3006_at 
-0.84 0.00376 0.48 0.00142 0.43 0.00653 -0.36 0.00695 -0.51 0.00146
Exosome 
multienzyme 
ribonuclease 
complex 
Generic 
enzyme 
4288_at; 2633_at; 2107_at; 2138_at; 2354_at; 
2353_at; 8767_at; 8744_at; 8739_at; 2730_at; 
4300_at; 4299_at; 2137_at; 4684_at; 4677_at; 
4627_at; 4616_at; 2192_at; 2178_at; 5876_at; 
5868_at; 5837_at; 5802_at; 5792_at; 2355_at; 
2317_at; 2316_at; 2314_at; 8798_at; 8731_at; 
2744_at; 2737_at; 2736_at; 2729_at; 5795_at; 
8745_at; 8706_at; 8078_at; 4690_at; 4685_at; 
2146_at; 5831_at; 8754_at; 4640_at 
1.74 0.00023 -0.68 0.00443 0.42 0.00862 1.17 0.00824 1.68 0.00005
AMP deaminase 2 Generic 
enzyme 
9212_at; 9232_at; 9263_at; 2760_at; 2825_at; 
9235_at; 2824_at; 9236_at; 9213_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 0.68 0.00028
AMP deaminase Generic 
enzyme 
9212_at; 9232_at; 9263_at; 2760_at; 2825_at; 
9235_at; 2824_at; 9236_at; 9213_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 0.68 0.00028
NDPK complex  Generic 
enzyme 
10440_at; 10460_at; 1521_at; 2963_at; 
254958_at; 10432_at; 10456_at; 10457_at 
-0.97 0.00007 0.55 0.00562 -0.53 0.00044 -0.55 0.00114 -0.63 0.00040
PNPH Generic 
enzyme 
9824_at; 9814_at; 2959_at; 9787_at; 9821_at; 
9828_at; 9788_at; 9780_at; 2901_at; 2899_at; 
2843_at; 2882_at; 2957_at 
-0.97 0.00006 0.49 0.00497  -0.77 0.00003 -0.85 0.00001
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ADA  Generic 
enzyme 
8767_at; 8744_at; 8739_at; 2730_at; 2744_at; 
2729_at; 2736_at; 2737_at; 8731_at; 8798_at; 
8706_at; 8745_at; 8754_at 
1.00 0.00013 -0.49 0.00215  0.92 0.00006 1.03 0.00004
APRT Generic 
enzyme 
9212_at; 9263_at; 9232_at; 2824_at; 2825_at; 
9235_at; 2760_at; 9236_at; 9213_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 0.68 0.00028
AK2 Generic 
kinase 
2354_at; 2353_at; 2355_at; 2314_at; 2316_at; 
2317_at; 5876_at; 5868_at; 5837_at; 5802_at; 
5792_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
ADSSL1 Generic 
enzyme 
8767_at; 8744_at; 8739_at; 2730_at; 2744_at; 
2729_at; 2736_at; 2737_at; 8731_at; 8798_at; 
8706_at; 8745_at; 8754_at 
1.00 0.00013 -0.49 0.00215  0.92 0.00006 1.03 0.00004
ADSL Generic 
enzyme 
9787_at; 9814_at; 9824_at; 2959_at; 9828_at; 
9821_at; 9788_at; 9780_at; 2901_at; 2899_at; 
2882_at; 2843_at; 2957_at 
-0.97 0.00006 0.49 0.00497  -0.77 0.00003 -0.85 0.00001
RNA polymerase II  Generic 
enzyme 
2617_at; 2633_at; 2354_at; 2353_at; 4026_at; 
4015_at; 1594_at; 7030_at; 6999_at; 2527_at; 
5868_at; 5837_at; 5802_at; 5792_at; 2355_at; 
2317_at; 2316_at; 2314_at; 5876_at; 5795_at; 
7468_at; 7005_at; 8398_at; 8078_at; 5831_at; 
1486_at; 4048_at; 7025_at; 7020_at; 8336_at; 
7026_at; 7023_at; 2542_at 
1.74 0.00023 -0.68 0.00443 0.42 0.00862 1.17 0.00824 1.68 0.00005
RNA polymerase I  Generic 
enzyme 
2633_at; 2617_at; 8767_at; 8744_at; 8739_at; 
2730_at; 2527_at; 7030_at; 6999_at; 8798_at; 
8731_at; 2744_at; 2737_at; 2736_at; 2729_at; 
8745_at; 7468_at; 8706_at; 8078_at; 7025_at; 
7020_at; 7005_at; 7023_at; 7026_at; 8336_at; 
2542_at; 8754_at 
1.00 0.00013 -0.68 0.00443  0.92 0.00006 1.03 0.00004
CTP/UTP metabolism 
KCY Generic 
kinase 
10440_at; 10460_at; 2963_at; 10456_at; 
10432_at; 10457_at 
-0.97 0.00007 0.55 0.00562  -0.55 0.00114 -0.63 0.00040
Exosome 
multienzyme 
ribonuclease 
complex 
Generic 
enzyme 
2633_at; 2138_at; 8767_at; 8744_at; 8739_at; 
2730_at; 4288_at; 2107_at; 2354_at; 2353_at; 
2317_at; 2316_at; 2314_at; 5876_at; 5868_at; 
5837_at; 5802_at; 5792_at; 2355_at; 8798_at; 
8731_at; 2744_at; 2737_at; 2736_at; 2729_at; 
4300_at; 4299_at; 2137_at; 4684_at; 4677_at; 
4627_at; 4616_at; 2192_at; 2178_at; 5795_at; 
4690_at; 2146_at; 4685_at; 8745_at; 8706_at; 
8078_at; 5831_at; 4640_at; 8754_at 
1.74 0.00023 -0.68 0.00443 0.42 0.00862 1.17 0.00824 1.68 0.00005
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CDD  Generic 
enzyme 
9824_at; 9814_at; 9787_at; 2959_at; 2901_at; 
2899_at; 9828_at; 9821_at; 9780_at; 9788_at; 
2843_at; 2882_at; 2957_at 
-0.97 0.00006 0.49 0.00497  -0.77 0.00003 -0.85 0.00001
KCY Generic 
kinase 
10440_at; 10460_at; 2963_at; 10456_at; 
10432_at; 10457_at 
-0.97 0.00007 0.55 0.00562  -0.55 0.00114 -0.63 0.00040
AK2 Generic 
kinase 
2354_at; 2353_at; 5802_at; 5792_at; 2355_at; 
2317_at; 2316_at; 2314_at; 5837_at; 5876_at; 
5868_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
NDPK complex  Generic 
enzyme 
10460_at; 10440_at; 2963_at; 1521_at; 
254958_at; 10432_at; 10456_at; 10457_at 
-0.97 0.00007 0.55 0.00562 -0.53 0.00044 -0.55 0.00114 -0.63 0.00040
CTP synthase Generic 
enzyme 
10849_at; 3052_at; 10788_at; 10847_at; 
3006_at; 3081_at 
-0.84 0.00376 -0.41 0.00308  -0.36 0.00695 -0.41 0.00400
CTP synthase II Generic 
enzyme 
6999_at; 7030_at; 2527_at; 7020_at; 7005_at; 
7025_at; 7026_at; 7023_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
RNA polymerase II  Generic 
enzyme 
2354_at; 2353_at; 2617_at; 2633_at; 2527_at; 
7030_at; 6999_at; 4026_at; 4015_at; 1594_at; 
5876_at; 5868_at; 5837_at; 5802_at; 5792_at; 
2355_at; 2317_at; 2316_at; 2314_at; 5795_at; 
8078_at; 5831_at; 4048_at; 7468_at; 8398_at; 
1486_at; 7025_at; 7020_at; 7005_at; 7026_at; 
7023_at; 8336_at; 2542_at 
1.74 0.00023 -0.68 0.00443 0.42 0.00862 1.17 0.00824 1.68 0.00005
RNA polymerase I  Generic 
enzyme 
2617_at; 2633_at; 8767_at; 8744_at; 8739_at; 
2730_at; 7030_at; 6999_at; 2527_at; 8798_at; 
8731_at; 2744_at; 2737_at; 2736_at; 2729_at; 
8745_at; 7005_at; 8706_at; 7468_at; 8078_at; 
7025_at; 7020_at; 8754_at; 2542_at; 8336_at; 
7026_at; 7023_at 
1.00 0.00013 -0.68 0.00443  0.92 0.00006 1.03 0.00004
RNA polymerase 
III 
Generic 
enzyme 
2617_at; 2633_at; 2730_at; 2354_at; 2353_at; 
10460_at; 10440_at; 8767_at; 8744_at; 
8739_at; 2314_at; 5876_at; 5868_at; 5837_at; 
5802_at; 5792_at; 2355_at; 2317_at; 2316_at; 
2963_at; 8798_at; 8731_at; 2744_at; 2737_at; 
2736_at; 2729_at; 7030_at; 6999_at; 2527_at; 
5795_at; 8078_at; 8745_at; 8706_at; 7025_at; 
7020_at; 7005_at; 7468_at; 5831_at; 10456_at; 
10432_at; 8364_at; 8754_at; 7026_at; 7023_at; 
8336_at; 2542_at; 10457_at 
1.74 0.00023 -0.68 0.00443 0.42 0.00862 1.17 0.00824 1.68 0.00005
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GTP-XTP  metabolism 
KGUA Generic 
kinase 
2354_at; 2353_at; 5802_at; 5792_at; 2355_at; 
2317_at; 2316_at; 2314_at; 5837_at; 5876_at; 
5868_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
Exosome 
multienzyme 
ribonuclease 
complex 
Generic 
enzyme 
2354_at; 2138_at; 2353_at; 2633_at; 8767_at; 
8744_at; 8739_at; 2730_at; 4288_at; 2107_at; 
2317_at; 2316_at; 2314_at; 5876_at; 5868_at; 
5837_at; 5802_at; 5792_at; 2355_at; 4684_at; 
4677_at; 4627_at; 4616_at; 2192_at; 2178_at; 
4300_at; 4299_at; 2137_at; 8798_at; 8731_at; 
2744_at; 2737_at; 2736_at; 2729_at; 5795_at; 
5831_at; 8745_at; 8706_at; 8078_at; 4690_at; 
4685_at; 2146_at; 8754_at; 4640_at 
1.74 0.00023 -0.68 0.00443 0.42 0.00862 1.17 0.00824 1.68 0.00005
NDPK complex  Generic 
enzyme 
10460_at; 10440_at; 1521_at; 2963_at; 
254958_at; 10432_at; 10456_at; 10457_at 
-0.97 0.00007 0.55 0.00562 -0.53 0.00044 -0.55 0.00114 -0.63 0.00040
PNPH Generic 
enzyme 
9824_at; 9814_at; 9787_at; 2959_at; 2901_at; 
2899_at; 9828_at; 9821_at; 9780_at; 9788_at; 
2843_at; 2882_at; 2957_at 
-0.97 0.00006 0.49 0.00497  -0.77 0.00003 -0.85 0.00001
IMD1 Generic 
enzyme 
2107_at; 2959_at; 4288_at; 9212_at; 9824_at; 
9263_at; 9700_at; 9787_at; 9814_at; 9232_at; 
2137_at; 2899_at; 2901_at; 4299_at; 4300_at; 
9699_at; 9780_at; 9788_at; 9821_at; 9828_at; 
2760_at; 9235_at; 2824_at; 2882_at; 2843_at; 
2825_at; 9213_at; 9236_at; 2957_at 
-1.16 0.00010 0.74 0.00478  -0.77 0.00003 -0.85 0.00001
RNA polymerase II  Generic 
enzyme 
2617_at; 2633_at; 2354_at; 2353_at; 2317_at; 
2316_at; 2314_at; 5876_at; 5868_at; 5837_at; 
5802_at; 5792_at; 2355_at; 4026_at; 4015_at; 
1594_at; 7030_at; 6999_at; 2527_at; 5795_at; 
7025_at; 7020_at; 7005_at; 8078_at; 4048_at; 
5831_at; 7468_at; 8398_at; 1486_at; 7026_at; 
7023_at; 8336_at; 2542_at 
1.74 0.00023 -0.68 0.00443 0.42 0.00862 1.17 0.00824 1.68 0.00005
RNA polymerase I  Generic 
enzyme 
2617_at; 2633_at; 8767_at; 8744_at; 8739_at; 
2730_at; 7030_at; 6999_at; 2527_at; 8798_at; 
8731_at; 2744_at; 2737_at; 2736_at; 2729_at; 
8745_at; 7005_at; 8706_at; 7468_at; 8078_at; 
7025_at; 7020_at; 8754_at; 2542_at; 8336_at; 
7026_at; 7023_at 
1.00 0.00013 -0.68 0.00443  0.92 0.00006 1.03 0.00004
Chapter 6: Differential expression of genes involved in neuroprotection conferred by blackberry polyphenols after simulated 
gastrointestinal digestion 
204 
 
 
RNA polymerase 
III 
Generic 
enzyme 
2633_at; 2730_at; 8767_at; 8744_at; 8739_at; 
2617_at; 2354_at; 2353_at; 10460_at; 
10440_at; 2744_at; 2729_at; 5876_at; 5868_at; 
5837_at; 5802_at; 5792_at; 2355_at; 2317_at; 
2316_at; 2314_at; 7030_at; 6999_at; 2527_at; 
8798_at; 8731_at; 2737_at; 2736_at; 2963_at; 
5795_at; 7468_at; 8745_at; 8706_at; 5831_at; 
10456_at; 10432_at; 8078_at; 7025_at; 
7020_at; 7005_at; 2542_at; 8754_at; 10457_at; 
7026_at; 7023_at; 8336_at; 8364_at 
1.74 0.00023 -0.68 0.00443 0.42 0.00862 1.17 0.00824 1.68 0.00005
Guanine 
deaminase 
Generic 
enzyme 
2354_at; 2353_at; 5802_at; 5792_at; 2355_at; 
2317_at; 2316_at; 2314_at; 155054_at; 
5837_at; 5876_at; 5868_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
Clathrin-coated vesicle cycle 
Eps15 Generic 
binding 
protein 
2527_at; 6999_at; 7030_at; 7005_at; 7020_at; 
7025_at; 7026_at; 7023_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
Clathrin heavy 
chain 
Generic 
binding 
protein 
2138_at; 4677_at; 4684_at; 4627_at; 4616_at; 
2192_at; 2178_at; 2146_at; 4685_at; 4690_at; 
4640_at 
-0.64 0.00042 0.39 0.00914  -0.75 0.00138 0.87 0.00098
Rab-7 RAS - 
superfamily 
9212_at; 9263_at; 9232_at; 2825_at; 2760_at; 
2824_at; 9235_at; 9213_at; 9236_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 0.68 0.00028
Syntaxin 5 Transporter 9787_at; 9814_at; 9824_at; 2959_at; 9780_at; 
2901_at; 2899_at; 9788_at; 9821_at; 9828_at; 
2882_at; 2843_at; 2957_at 
-0.97 0.00006 0.49 0.00497  -0.77 0.00003 -0.85 0.00001
Rab-5A RAS - 
superfamily 
2633_at; 8078_at -0.76 0.00268 -0.68 0.00443  -0.68 0.00161 -0.74 0.00036
GOS-28 Transporter 4288_at; 2107_at; 2137_at; 4299_at; 4300_at -1.16 0.00010 -0.58 0.00064  -0.61 0.00020 -0.85 0.00006
YKT6 Generic 
enzyme 
10440_at; 10460_at; 2963_at; 10432_at; 
10456_at; 10457_at 
-0.97 0.00007 0.55 0.00562  -0.55 0.00114 -0.63 0.00040
PI3K cat class III 
(Vps34) 
Lipid kinase 2959_at; 9787_at; 9814_at; 9824_at; 9821_at; 
9828_at; 9788_at; 9780_at; 2901_at; 2899_at; 
2843_at; 2882_at; 2957_at 
-0.97 0.00006 0.49 0.00497  -0.77 0.00003 -0.85 0.00001
Syntaxin 12 Transporter 2633_at; 8078_at -0.76 0.00268 -0.68 0.00443  -0.68 0.00161 -0.74 0.00036
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AP complex 2  Transporter 10849_at; 10788_at; 3052_at; 10987_at; 
10847_at; 3006_at; 3081_at 
-0.84 0.00376 -0.41 0.00308  -0.36 0.00695 0.57 0.00316
NSF Generic 
binding 
protein 
2527_at; 6999_at; 7030_at; 7005_at; 7020_at; 
7025_at; 7026_at; 7023_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
RAB9P40 Protein 2138_at; 4684_at; 4616_at; 2192_at; 2178_at; 
4677_at; 4627_at; 2146_at; 4685_at; 4690_at; 
4640_at 
-0.64 0.00042 0.39 0.00914  -0.75 0.00138 0.87 0.00098
HIP1 Generic 
binding 
protein 
8739_at; 8744_at; 8767_at; 2730_at; 8731_at; 
2744_at; 2737_at; 2736_at; 2729_at; 8798_at; 
8745_at; 8706_at; 8754_at 
1.00 0.00013 -0.49 0.00215  0.92 0.00006 1.03 0.00004
Rab-11A RAS - 
superfamily 
5476_at; 2274_at; 5438_at; 5458_at -0.56 0.00285 0.42 0.00366 0.43 0.00653  -0.41 0.00560
Myosin I Generic 
binding 
protein 
10460_at; 9212_at; 9232_at; 9263_at; 
10440_at; 2963_at; 10432_at; 10456_at; 
2760_at; 2824_at; 2825_at; 9235_at; 9236_at; 
9213_at; 10457_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 0.68 0.00028
RABGDIA Regulators 
(GDI, GAP, 
GEF) 
5577_at; 5476_at; 2274_at; 5438_at; 5458_at -0.56 0.00285 0.42 0.00366 0.43 0.00653 -0.49 0.00090 -0.41 0.00560
Rab-8 RAS - 
superfamily 
5291_at; 5289_at; 5287_at; 5290_at 0.76 0.00050      -0.66 0.00018
PICALM Generic 
binding 
protein 
2138_at; 4288_at; 2107_at; 4300_at; 4299_at; 
2192_at; 2178_at; 2137_at; 4616_at; 4627_at; 
4684_at; 4677_at; 4685_at; 4690_at; 2146_at; 
4640_at 
-1.16 0.00010 -0.58 0.00064  -0.75 0.00138 0.87 0.00098
Eps15 Generic 
binding 
protein 
2527_at; 6999_at; 7030_at; 7005_at; 7020_at; 
7025_at; 7026_at; 7023_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
PI3K reg class III 
(p150) 
Generic 
binding 
protein 
2527_at; 6999_at; 7030_at; 7020_at; 7005_at; 
7025_at; 7026_at; 7023_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
Syntaxin 16 Transporter 2633_at; 8078_at -0.76 0.00268 -0.68 0.00443  -0.68 0.00161 -0.74 0.00036
Chapter 6: Differential expression of genes involved in neuroprotection conferred by blackberry polyphenols after simulated 
gastrointestinal digestion 
206 
 
 
VTI1A Transporter 9212_at; 9263_at; 9232_at; 2760_at; 9235_at; 
2825_at; 2824_at; 9213_at; 9236_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 0.68 0.00028
Syntaxin 6 Transporter 2353_at; 2354_at; 2316_at; 2314_at; 2317_at; 
2355_at; 5876_at; 5802_at; 5792_at; 5868_at; 
5837_at; 85458_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
ARF1 RAS - 
superfamily 
 1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
VPS45A Generic 
binding 
protein 
2138_at; 2192_at; 4616_at; 4684_at; 4677_at; 
4627_at; 2178_at; 4690_at; 4685_at; 2146_at; 
4640_at 
-0.64 0.00042 0.39 0.00914  -0.75 0.00138 0.87 0.00098
Aldosterone-mediated regulation of ENaC sodium transport 
MEK1/2 Protein 
kinase 
2354_at; 2353_at; 2316_at; 2314_at; 2317_at; 
2355_at; 5792_at; 5802_at; 5837_at; 5876_at; 
5868_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
GCR-alpha Transcriptio
n factor 
706_at   0.56 0.00187      
NEDD4L Generic 
enzyme 
5476_at; 2274_at; 5438_at; 5458_at -0.56 0.00285 0.42 0.00366 0.43 0.00653  -0.41 0.00560
ERK2 (MAPK1) Protein 
kinase 
2138_at; 2178_at; 2192_at; 4616_at; 4627_at; 
4677_at; 4684_at; 4690_at; 4685_at; 2146_at; 
4640_at 
-0.64 0.00042 0.39 0.00914  -0.75 0.00138 0.87 0.00098
SGK1 Protein 
kinase 
973_at -0.43 0.00202 -0.33 0.00922      
ICMT Generic 
enzyme 
2354_at; 2353_at; 5837_at; 5876_at; 5792_at; 
2355_at; 2317_at; 2316_at; 2314_at; 5802_at; 
5868_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
SAHH Generic 
enzyme 
5476_at; 2274_at; 5438_at; 5458_at -0.56 0.00285 0.42 0.00366 0.43 0.00653  -0.41 0.00560
CFTR folding and maturation (norm and CF) 
MA1B1 Generic 
enzyme 
10849_at; 3052_at; 10788_at; 10847_at; 
3006_at; 3081_at 
-0.84 0.00376 -0.41 0.00308  -0.36 0.00695 -0.41 0.00400
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Aha1 Generic 
binding 
protein 
2353_at; 2354_at; 5876_at; 5868_at; 5837_at; 
5802_at; 5792_at; 2355_at; 2317_at; 2316_at; 
2314_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
HSP40 Generic 
binding 
protein 
8739_at; 8744_at; 8767_at; 2730_at; 2744_at; 
2737_at; 2736_at; 2729_at; 8731_at; 8798_at; 
8745_at; 8706_at; 8754_at 
1.00 0.00013 -0.49 0.00215  0.92 0.00006 1.03 0.00004
OST complex  Generic 
enzyme 
2138_at; 4627_at; 4616_at; 2192_at; 2178_at; 
4684_at; 4677_at; 4690_at; 4685_at; 2146_at; 
4640_at 
-0.64 0.00042 0.39 0.00914  -0.75 0.00138 0.87 0.00098
HSP90 beta Generic 
binding 
protein 
2617_at; 9263_at; 9232_at; 9212_at; 2760_at; 
2824_at; 2825_at; 7468_at; 9235_at; 9236_at; 
9213_at; 2542_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 0.68 0.00028
Calnexin Generic 
binding 
protein 
3157_at; 3156_at; 3097_at; 11238_at; 
11272_at 
0.50 0.00079  0.47 0.00901 0.59 0.00093 0.46 0.00147
HSP70 Generic 
binding 
protein 
2617_at; 10849_at; 7030_at; 6999_at; 2527_at; 
3052_at; 10788_at; 5476_at; 2274_at; 
10847_at; 7025_at; 7020_at; 7005_at; 7468_at; 
5438_at; 5458_at; 3081_at; 3006_at; 7026_at; 
7023_at; 2542_at 
-0.84 0.00376 -0.57 0.00334 0.43 0.00653 0.53 0.00156 0.75 0.00111
Normal wtCFTR traffic/ER-to-Golgi and Delta 508-CFTR traffic/ER-to-Golgi in CF 
Coatomer  Generic 
binding 
protein 
2353_at; 2354_at; 2138_at; 2730_at; 8739_at; 
8744_at; 8767_at; 2617_at; 115361_at; 
8798_at; 8731_at; 2744_at; 2737_at; 2736_at; 
2729_at; 5876_at; 5868_at; 5837_at; 5802_at; 
5792_at; 2355_at; 2317_at; 2316_at; 2314_at; 
4684_at; 4677_at; 4627_at; 4616_at; 2192_at; 
2178_at; 5795_at; 2146_at; 5831_at; 8745_at; 
8706_at; 7468_at; 4690_at; 4685_at; 8754_at; 
2542_at; 4640_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
COPII Generic 
binding 
protein 
9824_at; 9814_at; 9787_at; 2959_at; 2617_at; 
2354_at; 2353_at; 4288_at; 2107_at; 9828_at; 
9821_at; 9788_at; 9780_at; 2901_at; 2899_at; 
5876_at; 5868_at; 5837_at; 5802_at; 5792_at; 
2355_at; 2317_at; 2316_at; 2314_at; 2137_at; 
4026_at; 4015_at; 4300_at; 4299_at; 5795_at; 
2843_at; 2882_at; 7468_at; 4048_at; 5831_at; 
2542_at; 2957_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
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Syntaxin 6 Transporter 2354_at; 2353_at; 5837_at; 5802_at; 5792_at; 
2355_at; 2317_at; 2316_at; 2314_at; 5868_at; 
85458_at; 5876_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
Ran regulation pathway 
NTF2 Transporter 5476_at; 2274_at; 5438_at; 5458_at -0.56 0.00285 0.42 0.00366 0.43 0.00653  -0.41 0.00560
Ran RAS - 
superfamily 
9824_at; 2633_at; 9787_at; 2959_at; 9814_at; 
9780_at; 2901_at; 2899_at; 1839_at; 9828_at; 
9821_at; 9788_at; 8078_at; 2882_at; 2843_at; 
2957_at 
-0.97 0.00006 -0.68 0.00443  -0.77 0.00003 -0.85 0.00001
RCC1  Regulators 
(GDI, GAP, 
GEF) 
2138_at; 2178_at; 2192_at; 4616_at; 4627_at; 
4677_at; 4684_at; 1196_at; 2146_at; 4685_at; 
4690_at; 4640_at 
-0.64 0.00042 0.39 0.00914  -0.75 0.00138 0.87 0.00098
E2I Generic 
enzyme 
2354_at; 2353_at; 2317_at; 2316_at; 2314_at; 
2355_at; 5792_at; 5802_at; 5837_at; 5876_at; 
5868_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
RanBP1 Regulators 
(GDI, GAP, 
GEF) 
2354_at; 2353_at; 5802_at; 5792_at; 2355_at; 
2317_at; 2316_at; 2314_at; 5837_at; 5876_at; 
5868_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
Importin 
(karyopherin)-beta 
Transporter 9212_at; 9787_at; 9814_at; 9824_at; 9232_at; 
9263_at; 2959_at; 9828_at; 9821_at; 9788_at; 
9780_at; 2901_at; 2899_at; 2760_at; 2825_at; 
9235_at; 2882_at; 2843_at; 2824_at; 2957_at; 
9236_at; 9213_at 
-1.04 0.00002 0.74 0.00478  -0.77 0.00003 -0.85 0.00001
Role of Nek in cell cycle regulation 
RCC1  Regulators 
(GDI, GAP, 
GEF) 
2138_at; 4616_at; 2192_at; 2178_at; 4627_at; 
4684_at; 4677_at; 1196_at; 4690_at; 4685_at; 
2146_at; 4640_at 
0.39 0.00914 -0.64 0.00042 -0.75 0.00138 0.87 0.00098
Cyclin B1 Generic 
binding 
protein 
2617_at; 7468_at; 2542_at -0.40 0.00411 0.73 0.00019 0.53 0.00156 0.53 0.00132
Insulin receptor Receptor 
with 
enzyme 
activity 
65110_at       -0.45 0.00356
MAD1 (mitotic 
checkpoint) 
Generic 
binding 
protein 
2138_at; 2192_at; 2178_at; 4616_at; 4627_at; 
4684_at; 4677_at; 2146_at; 4690_at; 4685_at; 
4640_at 
0.39 0.00914 -0.64 0.00042 -0.75 0.00138 0.87 0.00098
Chapter 6: Differential expression of genes involved in neuroprotection conferred by blackberry polyphenols after simulated 
gastrointestinal digestion 
209 
 
 
Ran RAS - 
superfamily 
9824_at; 2633_at; 9787_at; 2959_at; 9814_at; 
9828_at; 9821_at; 9788_at; 9780_at; 2901_at; 
2899_at; 1839_at; 2843_at; 8078_at; 2882_at; 
2957_at 
-0.68 0.00443 -0.97 0.00006 -0.77 0.00003 -0.85 0.00001
HEC Generic 
binding 
protein 
4026_at; 4015_at; 4048_at 0.48 0.00142    -0.51 0.00146
Transition and termination of DNA replication 
PCNA Generic 
binding 
protein 
6999_at; 2527_at; 7030_at; 7020_at; 7005_at; 
7025_at; 7023_at; 7026_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
TOP2 Generic 
enzyme 
8767_at; 2730_at; 8739_at; 8744_at; 2737_at; 
2736_at; 2729_at; 8798_at; 8731_at; 2744_at; 
8706_at; 8745_at; 8754_at 
1.00 0.00013 -0.49 0.00215  0.92 0.00006 1.03 0.00004
TOP1 Generic 
enzyme 
2633_at; 8078_at -0.76 0.00268 -0.68 0.00443  -0.68 0.00161 -0.74 0.00036
PCNA Generic 
binding 
protein 
6999_at; 2527_at; 7030_at; 7020_at; 7005_at; 
7025_at; 7023_at; 7026_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
DNA ligase I Generic 
enzyme 
2354_at; 2353_at; 2355_at; 5792_at; 2317_at; 
2316_at; 2314_at; 5876_at; 5837_at; 5868_at; 
5802_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
RFC complex  Generic 
binding 
protein 
2633_at; 10849_at; 1054_at; 8767_at; 8744_at; 
2730_at; 8739_at; 7030_at; 6999_at; 2527_at; 
8798_at; 8731_at; 2744_at; 2737_at; 2736_at; 
2729_at; 3052_at; 10788_at; 8078_at; 
10847_at; 7020_at; 8706_at; 8745_at; 7025_at; 
7005_at; 8754_at; 3081_at; 3006_at; 7023_at; 
7026_at 
1.00 0.00013 -0.68 0.00443  0.92 0.00006 1.03 0.00004
MCM2 Generic 
binding 
protein 
2527_at; 7030_at; 6999_at; 7020_at; 7025_at; 
7005_at; 7023_at; 7026_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
FEN1 Generic 
enzyme 
10460_at; 10440_at; 2963_at; 10456_at; 
10432_at; 10457_at 
-0.97 0.00007 0.55 0.00562  -0.55 0.00114 -0.63 0.00040
RFC1 Generic 
binding 
protein 
 -0.76 0.00268 -0.68 0.00443  -0.68 0.00161 -0.74 0.00036
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DNA polymerase 
alpha/primase 
Generic 
enzyme 
10460_at; 2730_at; 10440_at; 8767_at; 
8744_at; 8739_at; 4015_at; 4026_at; 8798_at; 
8731_at; 2744_at; 2737_at; 2736_at; 2963_at; 
2729_at; 4048_at; 8706_at; 8745_at; 10432_at; 
10456_at; 8754_at; 10457_at 
1.00 0.00013 0.55 0.00562  0.92 0.00006 1.03 0.00004
CDK2 Protein 
kinase 
7030_at; 6999_at; 2527_at; 7005_at; 7020_at; 
7025_at; 7023_at; 7026_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
POLD cat (p125) Generic 
enzyme 
2354_at; 2353_at; 2317_at; 2316_at; 2314_at; 
5876_at; 5868_at; 5837_at; 5802_at; 5792_at; 
2355_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
DNA polymerase 
epsilon 
Generic 
enzyme 
8767_at; 8744_at; 8739_at; 2730_at; 2729_at; 
2736_at; 2737_at; 8798_at; 2744_at; 8731_at; 
8706_at; 8745_at; 8754_at 
1.00 0.00013 -0.49 0.00215  0.92 0.00006 1.03 0.00004
Brca1/Bard1 Generic 
enzyme 
604_at   -0.53 0.00054      
Ubiquitin Generic 
binding 
protein 
9787_at; 9814_at; 9824_at; 2959_at; 9780_at; 
2901_at; 2899_at; 9788_at; 9821_at; 9828_at; 
2882_at; 2843_at; 2957_at 
-0.97 0.00006 0.49 0.00497  -0.77 0.00003 -0.85 0.00001
Ribonuclease H1 Generic 
enzyme 
9263_at; 9232_at; 9212_at; 9373_at; 2824_at; 
2760_at; 2825_at; 9235_at; 9213_at; 9236_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 0.68 0.00028
Chromosome condensation in prometaphase 
Cyclin B  Generic 
binding 
protein 
2617_at; 7468_at; 2542_at 0.73 0.00019 -0.40 0.00411  0.53 0.00156 0.53 0.00132
TOP2 Generic 
enzyme 
2730_at; 8739_at; 8744_at; 8767_at; 8798_at; 
8731_at; 2744_at; 2737_at; 2736_at; 2729_at; 
8745_at; 8706_at; 8754_at 
1.00 0.00013 -0.49 0.00215  0.92 0.00006 1.03 0.00004
TOP1 Generic 
enzyme 
2633_at; 8078_at -0.76 0.00268 -0.68 0.00443  -0.68 0.00161 -0.74 0.00036
Aurora-A  Protein 
kinase 
2617_at; 7468_at; 2542_at 0.73 0.00019 -0.40 0.00411  0.53 0.00156 0.53 0.00132
BRRN1 Protein 6999_at; 2527_at; 7030_at; 7005_at; 7020_at; 
7025_at; 7023_at; 7026_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
Histone H1 Generic 
binding 
protein 
2617_at; 7468_at; 2542_at 0.73 0.00019 -0.40 0.00411  0.53 0.00156 0.53 0.00132
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Histone H3 Generic 
binding 
protein 
8767_at; 2730_at; 8739_at; 8744_at; 2729_at; 
2527_at; 8798_at; 8731_at; 7030_at; 6999_at; 
2744_at; 2737_at; 2736_at; 8745_at; 7005_at; 
7025_at; 7020_at; 8706_at; 8754_at; 7026_at; 
7023_at 
1.00 0.00013 -0.57 0.00334  0.92 0.00006 1.03 0.00004
Condensin Protein 2353_at; 2354_at; 9824_at; 9814_at; 9787_at; 
2959_at; 5802_at; 5792_at; 2355_at; 2317_at; 
2316_at; 2314_at; 5876_at; 5868_at; 5837_at; 
2901_at; 2899_at; 5291_at; 5289_at; 5287_at; 
9828_at; 9821_at; 9788_at; 9780_at; 7030_at; 
6999_at; 2527_at; 5795_at; 2843_at; 2882_at; 
7025_at; 7020_at; 7005_at; 5831_at; 2957_at; 
7026_at; 7023_at; 5290_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
Spindle assembly and chromosome separation 
Tubulin (in 
microtubules) 
Generic 
binding 
protein 
9212_at; 9232_at; 9263_at; 5287_at; 5289_at; 
5291_at; 2824_at; 2760_at; 9235_at; 2825_at; 
5290_at; 9213_at; 9236_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 0.68 0.00028
Ran RAS - 
superfamily 
9824_at; 2633_at; 9787_at; 2959_at; 9814_at; 
9780_at; 2901_at; 2899_at; 1839_at; 9828_at; 
9821_at; 9788_at; 2843_at; 2882_at; 8078_at; 
2957_at 
-0.97 0.00006 -0.68 0.00443  -0.77 0.00003 -0.85 0.00001
APC/CDC20 
complex  
Generic 
enzyme 
10460_at; 2353_at; 10440_at; 2138_at; 
2354_at; 4288_at; 2107_at; 2963_at; 90637_at; 
4684_at; 4677_at; 4627_at; 4616_at; 2192_at; 
2178_at; 2355_at; 2317_at; 2316_at; 2314_at; 
4300_at; 4299_at; 2137_at; 5876_at; 5868_at; 
5837_at; 5802_at; 5792_at; 7030_at; 6999_at; 
2527_at; 5795_at; 162466_at; 5831_at; 
7025_at; 7020_at; 7005_at; 10456_at; 
10432_at; 4690_at; 4685_at; 2146_at; 7026_at; 
7023_at; 10457_at; 4640_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
Ubiquitin Generic 
binding 
protein 
9787_at; 9814_at; 9824_at; 2959_at; 9780_at; 
2901_at; 2899_at; 9788_at; 9821_at; 9828_at; 
2882_at; 2843_at; 2957_at 
-0.97 0.00006 0.49 0.00497  -0.77 0.00003 -0.85 0.00001
Mitotic cohesin 
complex  
Protein 10849_at; 5287_at; 5289_at; 3052_at; 
10788_at; 5291_at; 10847_at; 3081_at; 
3006_at; 5290_at 
-0.84 0.00376 -0.41 0.00308  -0.36 0.00695 -0.66 0.00018
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HEC Generic 
binding 
protein 
4026_at; 4015_at; 4048_at   0.48 0.00142    -0.51 0.00146
CSE1L Transporter 2138_at; 2178_at; 2192_at; 4616_at; 4627_at; 
4684_at; 4677_at; 4685_at; 4690_at; 2146_at; 
4640_at 
-0.64 0.00042 0.39 0.00914  -0.75 0.00138 0.87 0.00098
Importin 
(karyopherin)-beta 
Transporter 9212_at; 9787_at; 9814_at; 9824_at; 9232_at; 
9263_at; 2959_at; 9828_at; 9821_at; 9788_at; 
9780_at; 2901_at; 2899_at; 2760_at; 2825_at; 
9235_at; 2882_at; 2843_at; 2824_at; 2957_at; 
9236_at; 9213_at 
-1.04 0.00002 0.74 0.00478  -0.77 0.00003 -0.85 0.00001
Importin 
(karyopherin)-
alpha 
Transporter 8767_at; 2730_at; 8739_at; 8744_at; 2729_at; 
8798_at; 8731_at; 2744_at; 2737_at; 2736_at; 
8745_at; 8706_at; 8754_at 
1.00 0.00013 -0.49 0.00215  0.92 0.00006 1.03 0.00004
Aurora-A  Protein 
kinase 
2617_at; 7468_at; 2542_at 0.73 0.00019 -0.40 0.00411  0.53 0.00156 0.53 0.00132
Role of Brca1 and Brca2 in DNA repair 
Brca1 Generic 
binding 
protein 
604_at   -0.53 0.00054      
MSH2 Generic 
binding 
protein 
860_at; 2633_at; 8078_at -0.76 0.00268 -0.68 0.00443 -0.59 0.00049 -0.68 0.00161 -0.74 0.00036
MSH6 Generic 
binding 
protein 
2353_at; 2354_at; 5802_at; 5792_at; 2355_at; 
2317_at; 2316_at; 2314_at; 5868_at; 5876_at; 
5837_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
MLH1 Generic 
binding 
protein 
9212_at; 9232_at; 9263_at; 1850_at; 9235_at; 
2824_at; 2825_at; 2760_at; 9213_at; 9236_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 1.09 0.00045
Brca1 Generic 
binding 
protein 
604_at   -0.53 0.00054      
Histone H2AX Generic 
binding 
protein 
2354_at; 2353_at; 5876_at; 5868_at; 5837_at; 
5802_at; 5792_at; 2527_at; 2355_at; 2317_at; 
2316_at; 2314_at; 7030_at; 6999_at; 5795_at; 
7005_at; 5831_at; 7025_at; 7020_at; 7026_at; 
7023_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
Chapter 6: Differential expression of genes involved in neuroprotection conferred by blackberry polyphenols after simulated 
gastrointestinal digestion 
213 
 
 
Brca1/Bard1 Generic 
enzyme 
604_at   -0.53 0.00054      
NHEJ mechanisms of DSBs repair 
DNA ligase IV Generic 
enzyme 
2633_at; 8078_at -0.68 0.00443 -0.76 0.00268 -0.68 0.00161 -0.74 0.00036
Brca1 Generic 
binding 
protein 
604_at -0.53 0.00054      
Ku70 Generic 
binding 
protein 
 0.74 0.00478 -1.04 0.00002 -0.76 0.00028 0.68 0.00028
Ku70/80  Generic 
binding 
protein 
9263_at; 9212_at; 9232_at; 9235_at; 2825_at; 
2824_at; 2760_at; 585_at; 9213_at; 9236_at 
0.74 0.00478 -1.04 0.00002 -0.76 0.00028 0.68 0.00028
Casein kinase II, 
alpha chains 
Protein 
kinase 
2633_at; 4026_at; 4015_at; 4048_at; 8078_at -0.68 0.00443 -0.76 0.00268 -0.68 0.00161 -0.74 0.00036
Ku80 Generic 
binding 
protein 
9263_at; 9232_at; 9212_at; 2760_at; 9235_at; 
2825_at; 2824_at; 9236_at; 9213_at; 585_at 
0.74 0.00478 -1.04 0.00002 -0.76 0.00028 0.68 0.00028
Casein kinase II, 
beta chain 
(Phosvitin) 
Generic 
binding 
protein 
2633_at; 8078_at -0.68 0.00443 -0.76 0.00268 -0.68 0.00161 -0.74 0.00036
Mismatch repair 
MutLalpha 
complex  
Generic 
enzyme 
9263_at; 9232_at; 9212_at; 8767_at; 8744_at; 
8739_at; 2730_at; 8798_at; 8731_at; 2744_at; 
2737_at; 2736_at; 2729_at; 1850_at; 9235_at; 
2825_at; 2824_at; 2760_at; 8745_at; 8706_at; 
9236_at; 9213_at; 8754_at 
-1.04 0.00002 0.74 0.00478  0.92 0.00006 1.09 0.00045
MutLbeta complex  Generic 
enzyme 
9212_at; 9232_at; 9263_at; 1850_at; 2825_at; 
9235_at; 2760_at; 2824_at; 9236_at; 9213_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 1.09 0.00045
DNA polymerase 
epsilon 
Generic 
enzyme 
8767_at; 8744_at; 8739_at; 2730_at; 2729_at; 
2736_at; 2737_at; 8798_at; 2744_at; 8731_at; 
8706_at; 8745_at; 8754_at 
1.00 0.00013 -0.49 0.00215  0.92 0.00006 1.03 0.00004
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RFC complex  Generic 
binding 
protein 
8767_at; 10849_at; 1054_at; 2730_at; 8739_at; 
8744_at; 2633_at; 3052_at; 7030_at; 6999_at; 
2527_at; 10788_at; 2729_at; 2736_at; 2737_at; 
2744_at; 8731_at; 8798_at; 7020_at; 8078_at; 
7025_at; 10847_at; 8706_at; 8745_at; 7005_at; 
7026_at; 7023_at; 8754_at; 3081_at; 3006_at 
1.00 0.00013 -0.68 0.00443  0.92 0.00006 1.03 0.00004
RPA1 Generic 
binding 
protein 
11238_at; 3097_at; 3157_at; 3156_at; 
11272_at 
0.50 0.00079  0.47 0.00901 0.59 0.00093 0.46 0.00147
MutSbeta complex Generic 
binding 
protein 
860_at; 2633_at; 8078_at -0.76 0.00268 -0.68 0.00443 -0.59 0.00049 -0.68 0.00161 -0.74 0.00036
MutSalpha 
complex  
Generic 
binding 
protein 
860_at; 2353_at; 2633_at; 2354_at; 5876_at; 
5868_at; 5837_at; 5802_at; 5792_at; 2355_at; 
2317_at; 2316_at; 2314_at; 5795_at; 8078_at; 
5831_at 
1.74 0.00023 -0.68 0.00443 -0.59 0.00049 1.17 0.00824 1.68 0.00005
RPA2 Generic 
binding 
protein 
8739_at; 2730_at; 8767_at; 8744_at; 8798_at; 
2729_at; 8731_at; 2744_at; 2737_at; 2736_at; 
8706_at; 8745_at; 9172_at; 1119_at; 8754_at 
1.00 0.00013 -0.71 0.00008  0.92 0.00006 1.03 0.00004
PCNA Generic 
binding 
protein 
7030_at; 2527_at; 6999_at; 7020_at; 7005_at; 
7025_at; 7026_at; 7023_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
Nucleotide excision repair 
RPA1 Generic 
binding 
protein 
11238_at; 3157_at; 3156_at; 3097_at; 
11272_at 
0.50 0.00079  0.47 0.00901 0.59 0.00093 0.46 0.00147
TFIIH  Generic 
enzyme 
9787_at; 2959_at; 2617_at; 2354_at; 2353_at; 
9824_at; 9814_at; 2899_at; 5876_at; 5868_at; 
5837_at; 5802_at; 5792_at; 2355_at; 2317_at; 
2316_at; 2314_at; 2901_at; 9780_at; 4026_at; 
4015_at; 5476_at; 9828_at; 9821_at; 9788_at; 
5795_at; 2274_at; 7468_at; 5831_at; 4048_at; 
5438_at; 2882_at; 2843_at; 2542_at; 5458_at; 
2957_at 
1.74 0.00023 0.62 0.00158 0.43 0.00653 1.17 0.00824 1.68 0.00005
XPF Generic 
enzyme 
2617_at; 7468_at; 2542_at 0.73 0.00019 -0.40 0.00411  0.53 0.00156 0.53 0.00132
Chapter 6: Differential expression of genes involved in neuroprotection conferred by blackberry polyphenols after simulated 
gastrointestinal digestion 
215 
 
 
DNA polymerase 
epsilon 
Generic 
enzyme 
8767_at; 8744_at; 8739_at; 2730_at; 2729_at; 
2736_at; 2737_at; 8798_at; 2744_at; 8731_at; 
8706_at; 8745_at; 8754_at 
1.00 0.00013 -0.49 0.00215  0.92 0.00006 1.03 0.00004
XPG Generic 
binding 
protein 
2138_at; 2192_at; 2178_at; 4616_at; 4627_at; 
4684_at; 4677_at; 2146_at; 4685_at; 4690_at; 
4640_at; 4734_at 
-0.64 0.00042 0.39 0.00914  -0.75 0.00138 0.87 0.00098
Ubiquitin Generic 
binding 
protein 
9814_at; 9787_at; 2959_at; 9824_at; 9828_at; 
2901_at; 9780_at; 9788_at; 9821_at; 2899_at; 
2882_at; 2843_at; 2957_at 
-0.97 0.00006 0.49 0.00497  -0.77 0.00003 -0.85 0.00001
ERCC6 Generic 
enzyme 
10849_at; 10788_at; 3052_at; 10847_at; 
3006_at; 3081_at 
-0.84 0.00376 -0.41 0.00308  -0.36 0.00695 -0.41 0.00400
POLD cat (p125) Generic 
enzyme 
2354_at; 2353_at; 2316_at; 2314_at; 5876_at; 
5868_at; 5837_at; 5802_at; 5792_at; 2355_at; 
2317_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
COP9 signalosome  Generic 
enzyme 
1789_at -0.46 0.00426        
RAD23B  Generic 
binding 
protein 
5476_at; 2274_at; 5438_at; 5458_at -0.56 0.00285 0.42 0.00366 0.43 0.00653  -0.41 0.00560
DNA ligase I Generic 
enzyme 
2354_at; 2353_at; 5802_at; 5792_at; 2355_at; 
2317_at; 2316_at; 2314_at; 5837_at; 5876_at; 
5868_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
RAD23B  Generic 
binding 
protein 
5476_at; 2274_at; 5438_at; 5458_at -0.56 0.00285 0.42 0.00366 0.43 0.00653  -0.41 0.00560
RPA2 Generic 
binding 
protein 
8739_at; 2730_at; 8767_at; 8744_at; 8798_at; 
2729_at; 8731_at; 2744_at; 2737_at; 2736_at; 
1119_at; 8706_at; 8745_at; 9172_at; 8754_at 
1.00 0.00013 -0.71 0.00008  0.92 0.00006 1.03 0.00004
RNA polymerase II  Generic 
enzyme 
2353_at; 2354_at; 2633_at; 2617_at; 5802_at; 
5792_at; 2355_at; 2317_at; 2316_at; 2314_at; 
5876_at; 5868_at; 5837_at; 2527_at; 6999_at; 
7030_at; 1594_at; 4015_at; 4026_at; 5795_at; 
8078_at; 4048_at; 7025_at; 7020_at; 7005_at; 
5831_at; 1486_at; 7468_at; 8398_at; 8336_at; 
2542_at; 7023_at; 7026_at 
1.74 0.00023 -0.68 0.00443 0.42 0.00862 1.17 0.00824 1.68 0.00005
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RFC complex  Generic 
binding 
protein 
8767_at; 2633_at; 10849_at; 1054_at; 2730_at; 
8739_at; 8744_at; 2736_at; 2729_at; 2527_at; 
6999_at; 7030_at; 8798_at; 2737_at; 2744_at; 
8731_at; 10788_at; 3052_at; 8745_at; 8706_at; 
8078_at; 7005_at; 7020_at; 7025_at; 10847_at; 
8754_at; 7026_at; 7023_at; 3006_at; 3081_at 
1.00 0.00013 -0.68 0.00443  0.92 0.00006 1.03 0.00004
PCNA Generic 
binding 
protein 
2527_at; 7030_at; 6999_at; 7005_at; 7020_at; 
7025_at; 7023_at; 7026_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
Regulation of eIF2 activity 
MEK1(MAP2K1) Protein 
kinase 
2353_at; 2354_at; 5792_at; 2355_at; 2317_at; 
2316_at; 2314_at; 5802_at; 5837_at; 5868_at; 
5876_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
GSK3 alpha/beta Protein 
kinase 
9212_at; 9493_at; 9263_at; 9232_at; 2760_at; 
2824_at; 2825_at; 9235_at; 9236_at; 9213_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 0.68 0.00028
Insulin receptor Receptor 
with 
enzyme 
activity 
65110_at         -0.45 0.00356
GCN2 Protein 
kinase 
2354_at; 2353_at; 5802_at; 5792_at; 2355_at; 
2317_at; 2316_at; 2314_at; 5837_at; 5876_at; 
5868_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
PP1-cat Protein 
phosphatas
e 
5476_at; 2274_at; 5438_at; 5458_at -0.56 0.00285 0.42 0.00366 0.43 0.00653  -0.41 0.00560
GAB1 Generic 
binding 
protein 
60488_at   0.53 0.00338      
eIF2B  Regulators 
(GDI, GAP, 
GEF) 
10460_at; 2353_at; 2354_at; 9814_at; 
10440_at; 2959_at; 9787_at; 2138_at; 9824_at; 
4677_at; 4627_at; 4616_at; 2192_at; 2178_at; 
5876_at; 5868_at; 5837_at; 5802_at; 5792_at; 
2355_at; 2317_at; 2316_at; 2314_at; 4684_at; 
4919_at; 2899_at; 2901_at; 9780_at; 9788_at; 
9821_at; 9828_at; 2963_at; 5795_at; 10456_at; 
10432_at; 2882_at; 2843_at; 4690_at; 4685_at; 
2146_at; 5831_at; 10457_at; 2957_at; 4640_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
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eIF2B5 Regulators 
(GDI, GAP, 
GEF) 
2354_at; 2353_at; 5837_at; 5802_at; 5792_at; 
2355_at; 2317_at; 2316_at; 2314_at; 5876_at; 
5868_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
eIF2 Generic 
binding 
protein 
2617_at; 10849_at; 10788_at; 3052_at; 
8013_at; 10847_at; 7468_at; 3081_at; 3006_at; 
2542_at 
-0.84 0.00376 -0.41 0.00308  0.53 0.00156 0.53 0.00132
Casein kinase I Protein 
kinase 
8767_at; 8744_at; 8739_at; 4288_at; 2730_at; 
2107_at; 8798_at; 2137_at; 2729_at; 2736_at; 
2737_at; 2744_at; 4299_at; 4300_at; 8731_at; 
8706_at; 8745_at; 8754_at 
-1.16 0.00010 -0.58 0.00064  0.92 0.00006 1.03 0.00004
Casein kinase II, 
alpha chains 
Protein 
kinase 
2633_at; 4015_at; 4026_at; 8078_at; 4048_at -0.76 0.00268 -0.68 0.00443  -0.68 0.00161 -0.74 0.00036
PP1-cat alpha Protein 
phosphatas
e 
5476_at; 2274_at; 5438_at; 5458_at -0.56 0.00285 0.42 0.00366 0.43 0.00653  -0.41 0.00560
ERK1/2 Protein 
kinase 
2138_at; 6999_at; 2527_at; 7030_at; 2178_at; 
2192_at; 4616_at; 4627_at; 4677_at; 4684_at; 
7025_at; 7020_at; 2146_at; 4685_at; 4690_at; 
7005_at; 4640_at; 7023_at; 7026_at 
-0.64 0.00042 -0.57 0.00334  -0.75 0.00138 0.87 0.00098
Casein kinase II, 
beta chain 
(Phosvitin) 
Generic 
binding 
protein 
2633_at; 8078_at -0.76 0.00268 -0.68 0.00443  -0.68 0.00161 -0.74 0.00036
Glycine, serine, cystein and threonine metabolism 
SerRS Generic 
enzyme 
2354_at; 2353_at; 5802_at; 5792_at; 2355_at; 
2317_at; 2316_at; 2314_at; 5837_at; 5876_at; 
5868_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
CBS Generic 
enzyme 
2138_at; 2178_at; 2192_at; 4616_at; 4627_at; 
4677_at; 4684_at; 2146_at; 4685_at; 4690_at; 
4640_at 
-0.64 0.00042 0.39 0.00914  -0.75 0.00138 0.87 0.00098
SHMT1 Generic 
enzyme 
9787_at; 9814_at; 9824_at; 2959_at; 9821_at; 
9788_at; 9780_at; 2901_at; 2899_at; 9828_at; 
2843_at; 2882_at; 2957_at 
-0.97 0.00006 0.49 0.00497  -0.77 0.00003 -0.85 0.00001
GlyRS Generic 
enzyme 
6999_at; 2527_at; 7030_at; 7005_at; 7020_at; 
7025_at; 7026_at; 7023_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
AGXT  Generic 
enzyme 
5291_at; 5289_at; 5287_at; 5290_at 0.76 0.00050      -0.66 0.00018
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SYTC Generic 
enzyme 
4015_at; 4026_at; 4048_at   0.48 0.00142    -0.51 0.00146
SHMT2 Generic 
enzyme 
2527_at; 7030_at; 6999_at; 7020_at; 7025_at; 
7005_at; 7083_at; 7023_at; 7026_at 
-0.57 0.00066 -0.57 0.00334    0.75 0.00111
SARS2 Generic 
enzyme 
4288_at; 2107_at; 2137_at; 4299_at; 4300_at -1.16 0.00010 -0.58 0.00064  -0.61 0.00020 -0.85 0.00006
PISD Generic 
enzyme 
8744_at; 8767_at; 2730_at; 8739_at; 8798_at; 
2729_at; 2736_at; 2737_at; 2744_at; 8731_at; 
8706_at; 8745_at; 8754_at; 9044_at 
1.00 0.00013 -0.49 0.00215  0.92 0.00006 1.03 0.00004
GCSP Generic 
enzyme 
9232_at; 9263_at; 9212_at; 2824_at; 2760_at; 
2825_at; 9235_at; 9213_at; 9236_at 
-1.04 0.00002 0.74 0.00478  -0.76 0.00028 0.68 0.00028
GCST Generic 
enzyme 
2353_at; 2354_at; 2355_at; 5792_at; 5802_at; 
5837_at; 5868_at; 5876_at; 2317_at; 2316_at; 
2314_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
DLDH Generic 
enzyme 
5291_at; 5289_at; 5287_at; 5290_at 0.76 0.00050      -0.66 0.00018
ALAS2 Generic 
enzyme 
2354_at; 2353_at; 5802_at; 5792_at; 2355_at; 
2317_at; 2316_at; 2314_at; 5837_at; 5876_at; 
5868_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
PSAT Generic 
enzyme 
2633_at; 8078_at -0.76 0.00268 -0.68 0.00443  -0.68 0.00161 -0.74 0.00036
AGXT  Generic 
enzyme 
5291_at; 5289_at; 5287_at; 5290_at 0.76 0.00050      -0.66 0.00018
CTH Generic 
enzyme 
11238_at; 3097_at; 3156_at; 3157_at; 
11272_at 
0.50 0.00079  0.47 0.00901 0.59 0.00093 0.46 0.00147
PEMT Generic 
enzyme 
10849_at; 10788_at; 3052_at; 10847_at; 
3006_at; 3081_at 
-0.84 0.00376 -0.41 0.00308  -0.36 0.00695 -0.41 0.00400
POMC processing 
PC1 Generic 
protease 
8767_at; 2730_at; 8739_at; 8744_at; 9110_at; 
8798_at; 8731_at; 2744_at; 2737_at; 2736_at; 
2729_at; 8745_at; 8706_at; 8754_at 
-0.49 0.00215 1.00 0.00013 0.92 0.00006 1.03 0.00004
Bad phosphorylation 
Bax Generic 
binding 
protein 
2066_at         -0.53 0.00498
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MEK1(MAP2K1) Protein 
kinase 
2353_at; 2354_at; 5792_at; 2355_at; 2317_at; 
2316_at; 2314_at; 5802_at; 5837_at; 5868_at; 
5876_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
PKA-reg (cAMP-
dependent) 
Generic 
binding 
protein 
4026_at; 4015_at; 4048_at   0.48 0.00142    -0.51 0.00146
ERK1/2 Protein 
kinase 
2138_at; 4684_at; 4677_at; 4627_at; 4616_at; 
2192_at; 2178_at; 7030_at; 6999_at; 2527_at; 
7020_at; 2146_at; 4685_at; 4690_at; 7005_at; 
7025_at; 7023_at; 7026_at; 4640_at 
-0.64 0.00042 -0.57 0.00334  -0.75 0.00138 0.87 0.00098
Calcineurin A 
(catalytic) 
Protein 
phosphatas
e 
2959_at; 9787_at; 9212_at; 9232_at; 9824_at; 
9814_at; 9263_at; 2899_at; 9780_at; 9788_at; 
9821_at; 9828_at; 2901_at; 2882_at; 2843_at; 
2824_at; 2825_at; 9235_at; 2760_at; 9213_at; 
9236_at; 2957_at 
-1.04 0.00002 0.74 0.00478  -0.77 0.00003 -0.85 0.00001
PP1-cat alpha Protein 
phosphatas
e 
5476_at; 2274_at; 5438_at; 5458_at -0.56 0.00285 0.42 0.00366 0.43 0.00653  -0.41 0.00560
Bcl-2 Generic 
binding 
protein 
2060_at; 1909_at -0.47 0.00846 0.40 0.00678      
PP2A catalytic Protein 
phosphatas
e 
2354_at; 2353_at; 5802_at; 5792_at; 2355_at; 
2317_at; 2316_at; 2314_at; 5837_at; 5876_at; 
5868_at; 5795_at; 5831_at 
1.74 0.00023 0.62 0.00158 0.42 0.00862 1.17 0.00824 1.68 0.00005
p70 S6 kinase1 Protein 
kinase 
238_at   -0.63 0.00208      
PP2C Protein 
phosphatas
e 
2633_at; 1870_at; 8078_at -0.76 0.00268 -0.68 0.00443  -0.68 0.00161 -0.74 0.00036
Bcl-XL Generic 
binding 
protein 
1615_at   0.37 0.00897      
GSH metabolism 
GGT1 Generic 
enzyme 
9814_at; 9787_at; 2959_at; 9824_at; 9821_at; 
9828_at; 2899_at; 2901_at; 9780_at; 9788_at; 
2843_at; 2882_at; 2957_at 
0.49 0.00497 -0.97 0.00006 -0.77 0.00003 -0.85 0.00001
GSHR Generic 
enzyme 
2617_at; 7468_at; 2542_at -0.40 0.00411 0.73 0.00019 0.53 0.00156 0.53 0.00132
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5-oxoprolinase Generic 
enzyme 
10797_at; 10460_at; 10440_at; 2963_at; 
10456_at; 10432_at; 10457_at 
0.55 0.00562 -0.97 0.00007 -0.55 0.00114 -0.63 0.00040
GPX4 (PHGPx) Generic 
enzyme 
7030_at; 2527_at; 6999_at; 7020_at; 7025_at; 
7005_at; 7026_at; 7023_at 
-0.57 0.00334 -0.57 0.00066   0.75 0.00111
GCL cat Generic 
enzyme 
10849_at; 10788_at; 3052_at; 10847_at; 
3081_at; 3006_at 
-0.41 0.00308 -0.84 0.00376 -0.36 0.00695 -0.41 0.00400
GSHB  Generic 
enzyme 
2633_at; 8078_at -0.68 0.00443 -0.76 0.00268 -0.68 0.00161 -0.74 0.00036
GPX7 Generic 
enzyme 
4026_at; 4015_at; 4048_at 0.48 0.00142   
    
  -0.51 0.00146
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The increase in population lifespan has enhanced the incidence of 
neurodegenerative diseases, for which there is no cure, yet. A common 
feature of this diseases group is the occurrence of oxidative stress, on 
which there are still some uncertainties about its role on the onset and/or 
propagation of disease 
1
. Among the natural compounds exhibiting 
potential on neuroprotective activity, polyphenols are important 
molecules, due to their chemical properties 
2,3
. Therefore, plants 
displaying high content in polyphenols constitute interesting sources of 
those compounds to be evaluated for neuroprotective purposes. Portugal 
display a great diversity of plants, several of them endemic and 
chemically uncharacterized. Therefore, they represents a huge reservoir 
of phytochemicals with potential to be explored. 
The present work aimed to study the protective potential of polyphenols 
from juniper leaves and blackberry fruits on a neurodegenerative cell 
model. 
In the literature it can be found several reports about potential cellular 
bioactivities that rely on the antioxidant capacities of several compounds, 
however they are usually evaluated by chemical assays, using pure 
compounds and at very high concentrations. With that approach cell 
environment is not taken into account; possible existence of synergisms 
and/or antagonism within compounds that occur in plants could be 
missing; high concentrations of compounds tested could mediate 
different mechanisms of action even conducting to cell toxicity. These 
issues were taken into consideration in this thesis: to maximize protective 
effects derived from compounds interactions, phenolic extracts were 
obtained from plants; to avoid toxicity derived from solvents, Generally 
Recognized As Safe (GRAS) solvents were used for polyphenols extraction; 
to pursue a physiological approach, non-toxic concentrations of extracts 
were used on the treatment of cell models. 
Concerning juniper leaves evaluation, it was considered four species 
occurring in different areas of Portugal, one of them an endemism  
(J. navicularis). Junipers leaves are already described as used in 
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traditional medicine and they are also  used as seasonings or as drink 
flavourings.  A possible pharmacological application was studied for 
juniper leaves polyphenols. Non-cytotoxic concentrations of phenolic-
enriched fractions of the four junipers were evaluated on a 
neurodegenerative cell model, constituted by neuroblastoma cells 
subjected to an oxidative insult. From the four species evaluated only  
J. oxycedrus badia was able to protect cell viability and ensure 
mitochondrial functionality, being considered as potentially 
neuroprotective. ROS scavenging are among the possible mechanisms 
involved in that protection. This species exhibited intracellular 
antioxidant capacity prior and after oxidative insult, mediated by direct 
scavenging and indirect antioxidant mechanisms. However, SOD an CAT 
antioxidant activities were excluded as involved in the indirect protection 
verified. Other enzymes activated by Nrf2/ARE transcription factor 
pathway, other than SOD and CAT, could be involved, such as gamma-
glutamylcysteine synthetase, GPx, GR, thioredoxin reductase, 
peroxiredoxin and HO-1. Several polyphenols have been identified as 
hormetic effectors and activating Nrf2 (kaempferol, resveratrol, quercetin, 
EGCG, hesperidin, cyaniding-3-rutinoside, etc) 
4
. Thus, further work is 
necessary to elucidate molecular mechanisms underpin the observed 
neuroprotection. Another complementary bioactivity  used as rationale on 
the search of new neuroprotective compounds is AChE inhibitory activity 
that was also identified in junipers leaves, especially in J. phoenicea and  
J. turbinata. The use of juniper phenolic-enriched extracts in this 
exploratory stage does not exclude the possibilities of future bio-guided 
fractionation in order to produce a refined NP or the isolation of a lead for 
future drug development. Actually, this should constitute a future step on 
this research in attempt to associate particular phytochemicals to those 
bioactivities. Many phytochemicals are characterized by a biphasic dose- 
-response relationship 
5
. Although the concentrations tested in this work 
were not toxic for cells, in possible future applications toxicity studies on 
animal models are an important issue to be considered.  
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Having the perspective of a pharmaceutical application of juniper 
polyphenols, their content in plant material is an important issue for 
industrial processing. Since junipers are evergreen plant, plant material 
are available all year. However, phytochemicals content can vary, since 
they are greatly influenced by the environmental conditions 
6
. Then, 
understand polyphenols dynamics and their possible modulation through 
control of external conditions is an important subject to be addressed. In 
fact, all four species registered seasonal variations in their phenolics and 
flavonoids contents, being winter the best period for plant harvesting, 
when plants are not actively growing. Although pholyphenols content is 
higher in winter, the relative amount of individual compounds is not 
greatly affected, only being registered a decrease on procyanidin dimer 
relative content for J. phoenicea. Polyphenols content modulation was 
studied and it was verified that the different species have differential 
susceptibility to stresses, probably reflecting their adaptation to the 
environment where they are usually found. Polyphenols from J. oxycedrus 
badia that previously showed to protected neuroblastoma cells from 
oxidative stress, can have their content enhanced through salinity 
treatment. Polyphenols from J. phoenicea that presented AChE inhibitory 
activity could also be modulated through MeJa treatment. In both 
treatments only epicatechin, procyanidins and quercetin derivatives had 
their relative contents altered. Although those alterations did not privilege 
any particular class of compounds, the maintenance of the cell 
bioactivities detected must be confirmed. The enrichment in epicatechin, 
procyanidin or quercetin can potentiate activities related with the contest 
of NNDs such as modulation of pro-inflammatory signals 
7,8
. Total 
phenolics contents variation was supported by PAL transcripts 
quantification. Transcripts profiles anticipated the changes verified on the 
phytochemicals contents. Transcripts levels of J. phoenicea treated with 
MeJa are better related with alterations in the content of specific 
compounds than transcript levels of J. oxycedrus badia subjected to 
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salinity. Those results suggest a differential post-transcriptional and/or 
post-translational regulation specific of treatments/species. 
Regarding blackberries evaluation it was considered a nutritional 
perspective. In literature the majority of works that evaluate food 
phytochemicals does not take into account alterations occurring in 
gastrointestinal track as well as the concentrations that metabolites are 
usually found in serum. Then, following the purpose of a physiological 
approach, an IVD model already adopted on phytochemicals evaluation 
9
 
was used. In order to show the impact that gastrointestinal digestion 
produces on phytochemicals alterations and consequently on their 
bioactivities, it was conducted the comparison of effects produced on 
cells by blackberry polyphenols before and after IVD. In addition to the 
different chemical profile presented by phenolic extracts before and after 
IVD, cell protection, ROS scavenging and GSH/GSSG balance were also 
differentially affected. IVD potentiated protection of cell membrane 
integrity, however not mediated by ROS scavenging neither by GSH 
modulation. Contrarily, undigested extract did not protect cells although 
it was able to scavenge ROS and to modulate GSH redox status. This work 
really stated the necessity of considering gastrointestinal digestion on the 
study of phytochemicals effects from foods. Additionally, the protection 
promoted by the digested extract, not associated to antioxidant 
mechanisms, highlighted the occurrence of other protective mechanism 
mediated by polyphenols. Actually as consequence of IVD the antioxidant 
capacity of metabolites is greatly lost, deterring a possible antioxidant 
effect on cells. Moreover, the effective and non-cytotoxic concentrations 
of digested extract were on the range of physiologic concentrations of 
polyphenols found in plasma 
10
.  
Once clarified the importance of using physiological conditions on 
bioactivities study of food phytochemicals, that approach was used to 
evaluate the neuroprotective potential of two Portuguese wild blackberry 
species (R. brigantinus and R. vagabundus). R. brigantinus is actually a 
Portuguese endemic species. In comparison with a commercial blackberry 
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variety, the two wild species presented different relative contents of some 
metabolites, inducing different cellular effect. While the digested phenolic 
extracts of the two wild species protected cell membrane integrity and 
mitochondria functionality, being considered neuroprotective, the 
digested extract of the commercial variety only was able to protect cell 
membrane integrity. Then wild blackberries are more protective since 
they ensure the functionality of mitochondria, essential for energy 
production and crucial on neurodegenerative diseases. The 
neuroprotection conferred by wild blackberries should be mediated by 
decrease of ROS levels, GSH content augmentation and caspases 
activation prior to stress imposition. These effects indicate that digested 
metabolites should constitute a stimulus that activate cells defenses that 
make them able to withstand to stress. This effect has been already 
described for pure undigested polyphenols 
4
, however, as far as we know, 
not for a digested phenolic extracts. 
It was verified that few relative differences in the chemical composition of 
blackberries were responsible by the different cell protection produced. 
Then, it is crucial to introduce the wild species in culture conditions and 
confirm the stability of their chemical profiles as well as their biological 
activities. The recognition of wild Portuguese blackberry species as 
potential neuroprotective fruits is important in diverse perspectives: i) for 
consumers have access to fruits with nutritional add value; ii) for farmers 
produce plants well adapted to Portuguese environment and to growing 
conditions with lower inputs, eventually more adapted to a sustainable 
agriculture; iii) for species conservation; iv) for public health policies, 
making possible to reduce future cost associated to neurodegenerative 
diseases through a nutritional prevention. 
Another important issue to be addressed is the attribution of bioactivities 
to specific classes of polyphenols. A possible approach to be followed is 
the comparison of polyphenols bioactivities derived from isogenic fruits. 
The use of varieties that present markedly different chemical composition 
and then considered quasi-isogenic fruits could constitutes a good tool. 
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The advantage of using these fruits on studies with a similar approach to 
the one used in this thesis, is that fruits present all the same matrix and 
are enriched in specific polyphenols classes. Then, factors that could 
determine the extractability of compounds or possible interferences on 
some methods are similar within fruits, working as true matched matrix 
control. 
Until now, and mostly due to animal experiments, it is known that 
flavonoids should act on neurodegeneration due to modulation of 
signaling cascades and activating intracellular defenses, however no 
specific molecular pathways are known 
11
. In order to have some clues 
about the pathways differentially affected by wild and commercial 
blackberries that make cells able to cope with oxidative stress, a 
transcriptomic approach was followed. Although further experiments are 
needed for pathways/targets confirmation, interesting results were 
already found. The wild blackberry tested (R. vagabundus) revealed to 
better contradict the number of transcripts altered due to stress 
imposition, than the commercial blackberry. Alterations contradicted by 
wild blackberry pre-incubation prior to stress could be responsible by the 
protective effect demonstrated. Among blackberries pre-incubation, 
differential levels of transcripts were verified in some pathways. Products 
encoded by those transcripts are considered important targets to be 
followed by complementary biochemical experiments. Among pathways 
differentially expressed by blackberries and stressed cells were 
highlighted some related to transport (clathrin-coated vesicles cycle, CFTR 
folding/maturation/traffic, aldosterone-mediated regulation of ENaC 
transport), DNA repair mechanism (role of Brca1/Brac2 on DNA repair, 
NHEJ mechanism of DSBs repair and nucleotide excision repair) and cell 
cycle (Ran regulation pathway, transition and termination of DNA 
replication, chromosome condensation in prometaphase and spindle 
assembly and chromosome separation). Transport assume high 
importance in NDDs, since fragmentation of neuronal GA and disruption 
of cellular/axonal transport are common features of those diseases 
12-15
. 
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Actually, GA fragmentation is thought that may contribute to the initiation 
of apoptotic pathway 
16,17
. If blackberries treatment could revert that 
process, it could protect cells to enter into apoptosis. Moreover, DNA 
repair mechanisms are fundamental to counteract the deleterious effects 
of oxidative stress. Oxidative stress promotes DNA damage, therefore 
enhancing transcription of genes involved in DNA repair. All these 
differential responses induced by blackberries pre-incubation must help 
cells to counteract stress effects. In addition, small GTP-binding proteins 
also emerged as possible regulators to ensure the maintenance of cell 
homeostasis. Although those proteins not always showed changes in their 
transcript levels, other proteins/enzymes that belong to highlighted 
pathways and are described as down-stream regulated by small GTP- 
-binding proteins (Bad phosphorylation, regulation of eIF2 activity, spindle 
assembly and chromosome separation, RAN regulation, clathrin-coated 
vesicles cycle, CFTR traffic and aldosterone-mediated regulation of ENaC 
transport) were differentially regulated. However, all these indications 
must be confirmed by adequate biochemical experiments. 
Overall, among plants from the two groups in study, there are potential 
sources of neuroprotective compounds to be further investigated. Cell 
models relying on other features of neurodegeneration beyond oxidative 
stress could constitute interesting and complementary tools to further 
investigated juniper and blackberry beneficial effects. Moreover, more 
representative cells, such as primary neurons can be explored. 
Furthermore, the question of BBB permeability should be also taken into 
account and then appropriate models should be used to verify the 
concentrations and metabolites that reach brain tissues. 
Juniper phenolic-enriched fractions constitute a good source of a NP or a 
lead for pharmaceutical purposes. However, fractions should be refined by 
bioguided purification and after in vivo activity confirmation, toxicity tests 
and future animal trials must be conducted.  
From the nutritional perspective, the use of digested metabolites was an 
improvement. However, IVD model used does not mimic true bioavailable 
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metabolites since active transport in gut barrier, colon microflora 
metabolization and metabolites conjugation are missing. Nevertheless, 
there is no model accomplishing all these aspects and also delivering 
metabolites to be further tested. The fruits could be also investigated in 
long-term intervention studies on animals and/or humans to really access 
the benefits ascribed.  
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Abstract  
Background: RNA quality and quantity are important factors for ensuring 
the accuracy of gene expression analysis and other RNA-based 
downstream applications. Extraction of high quality nucleic acids is 
difficult from neuronal cells and brain tissues as they are particularly rich 
in lipids. In addition, most common RNA extraction methods are phenol-
based, resulting in RNA that may be incompatible with downstream 
applications such as gene expression. 
Findings: In this work, a comparative analysis of the RNA quality obtained 
from SK-N-MC cells was performed using six commonly used RNA 
isolation kits: two phenol-based kits and four non-phenol based kits. The 
non-phenol based kits tested AxyPrep Multisource Total RNA Miniprep, 
RNeasy® Mini, EasySpin and Ilustra RNAspin Mini RNA Isolation, all 
performed well and resulted in the isolation of high quality RNA, as 
evaluated by A
260
/A
280
. The RNA extracted with AxyPrep Multisource Total 
RNA Miniprep, RNeasy® Mini and EasySpin provided the highest RNA 
yields. In particular, the RNA isolated by AxyPrep Multisource Total RNA 
Miniprep Kit did not show any detectable genomic DNA contamination 
even without previous DNase treatment or after RNA direct PCR 
amplification using universal 18S primers. 
Conclusions: The RNA extracted from SK-N-MC cells with AxyPrep 
Multisource Total RNA Miniprep Kit was superior with respect to the RNA 
quality and concentration. This kit does not use aggressive organic 
solvents and RNA free of genomic DNA was isolated without the need for 
DNase treatment.  
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1. Introduction 
The accuracy of gene expression evaluation is influenced by the 
concentration and quality of input RNA. The purity and integrity of RNA 
are critical elements for the overall success of RNA-based analyses 1. 
Starting with a low quality RNA may compromise the results of 
downstream applications which are often labour-intensive, time-
consuming and very expensive 2,3. The integrity of the total RNA used 
should be examined prior to its use in quantitative RT-PCR, microarrays 
and any array-based applications.  
To ensure acceptable total RNA quality, the RNA extraction procedure 
must fulfill  a number of requirements: including, the final preparation 
must be free from protein, genomic DNA or enzyme inhibitors and must 
not include any phenol or alcohol carryover which may compromise 
downstream reactions 4. Also, the purified RNA should also be free of 
nucleases to maintain integrity under appropriate storage conditions. 
Reverse transcriptase and PCR reactions are strongly dependent on the 
purification and clean-up methods, as well as on the presence of 
exogenous contaminants. For example, the presence of hemoglobin, fat, 
glycogen, Ca2+, high genomic DNA concentrations, DNA binding proteins 
or other cell constituents are critical contaminants 5,6. 
There are three major techniques extensively used for RNA extraction: 
organic extraction, such as phenol-Guanidine Isothiocyanate (GITC)-based 
solutions, silica-membrane based spin column technology, and 
paramagnetic particle technology. One of the most commonly used 
methods is the phenol-GITC-based organic extraction. However, RNA 
samples isolated by this method are frequently contaminated with 
proteins and other cellular materials, organic solvents such as phenol-
chloroform, salts and ethanol. Additionally, these methods require safety 
precautions (i.e., the use of fume hoods) which lengthen the procedure 
and employ liquid-liquid extraction leading to incomplete phase 
separation and increased carryover contamination with genomic DNA. 
Silica column and paramagnetic particle based RNA isolation systems do 
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not require the use of toxic organic solvents, are relatively simple, 
efficient, low cost, and yield total intact RNA with low levels of 
contamination from proteins and other cellular materials 7. However, these 
methods can often result in significant levels of genomic DNA 
contamination.  
Digestion with DNase removes traces of DNA and is compulsory if the RNA 
samples are destined for use in RT-qPCR. DNase digestion after the final 
RNA precipitation step involves adding extra salts and proteins to the 
sample and since this can affect the efficiency of the cDNA synthesis, 
additional purification steps are required.  
In this work, a comparative analysis of the RNA quality achieved from a 
neuroblastoma cell line (SK-N-MC) by six commonly used RNA isolation 
kits is presented; two phenol-based kits and four kits utilizing non-
aggressive solvents. For the SK-N-MC cell line in particular, both types of 
extraction methods have previously been described, but RNA has been 
isolated mainly using phenol-GITC-based methods 8-13.  
 
2. Methods 
2.1. Cell culture 
Human neuroblastoma SK-N-MC cells were obtained from the European 
Collection of Cell Cultures (ECACC) and were cultured in EMEM 
supplemented with 2 mM glutamine, 10% (v/v) heat-inactivated fetal 
bovine serum (Gibco), 1% (v/v) of non-essential amino acids (Sigma) and 1 
mM sodium pyruvate. Cells were cultivated at 37 °C in a humidified 
atmosphere containing 5% (v/v) CO
2
. For routine culture, cells were grown 
until reaching approximately 90% confluence. For RNA isolation, cells were 
harvested using trypsin and stored frozen at -80 ºC. 
2.2. RNA isolation 
For SK-N-MC cell RNA isolation, six commercially available kits were tested: 
AxyPrep Multisource Total RNA Miniprep (Axygen), RNeasy® Mini (Qiagen), 
EasySpin (Citomed), Illustra RNAspin Mini RNA Isolation (GE), TRIzol® Plus 
RNA Purification System (Invitrogen) and E.Z.N.A.TM Total RNA kit II (Omega 
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Bio-Tek). The same amount of cells (6.92 x 106) and the manufacturer 
protocols were followed for each kit. 
When appropriate, the isolated RNA was treated with TurboTM DNase I 
(Ambion), accordingly to the manufacturer’s instructions. 
2.3. RNA quality and yield 
For assessing RNA quality and yield, A
260/A280
 and A
260/A230 
ratios for RNA 
preparation samples were analysed with a Nano-Drop® ND-1000 
spectrophotometer (NanoDrop Technologies). RNA integrity and DNA 
contamination were determined by 28S/18S rRNA visualization in agarose 
gel, stained with ethidium bromide. 
PCR was used to detect potential DNA contamination, using primers 
specific for 18S rRNA as Quantum RNA Universal 18S Internal Standards 
primers (Ambion). PCR reaction contained 1 µL of input (20-200 ng RNA), 
0.6 U Taq DNA Polymerase (Fermentas), 2.5 µL of 18S PCR Primer Pair 
(Ambion), 2 mM MgCl
2
, 0.2 mM of each dNTP (Invitrogen), 75 mM Tris-HCl 
(pH 8.8 at 25 ºC), 20 mM (NH
4
)
2
SO
4
 and 0.01% (v/v)  Tween 20. The 
following program was applied: 1 cycle of 3 min. at 95 °C for 
denaturation, followed by 30 cycles (30 s at 95 ºC for denaturation, 30 s 
at 57 ºC for annealing, 30 s at 72 ºC for extension) and a final 5 min 
extension at 72 °C. 
PCR products were visualized in agarose gels, stained with ethidium 
bromide. 
 
3. Results 
RNA isolation methods such as acid phenol extraction, glass fibre filter 
purification, and single-step reagents can provide RNA with acceptable 
quality. However, all RNA isolation methods do not have the ability to 
completely remove genomic DNA contamination from RNA samples. To 
evaluate the differential efficiency in obtaining RNA with minimal DNA 
contamination, six commercial kits for RNA extraction were tested using 
SK-N-MC cells. Among these kits, two of them (TRIzol® Plus RNA 
Purification System (Invitrogen) and E.Z.N.A.TM Total RNA kit II (Omega Bio-
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Tek)) involve a more aggressive methodology which includes a mono-
phasic solution of phenol and guanidine isothiocyanate. E.Z.N.A.TM Total 
RNA Kit II was selected for this analysis because it is mainly designed for 
fatty tissues by combining the advantage of one step RNA isolation 
technology and silica-membrane technology.  
Among the six kits tested, AxyPrep Multisource Total RNA Miniprep, 
RNeasy® Mini, EasySpin and Illustra RNAspin Mini RNA Isolation allow the 
isolation of higher quality RNA when compared to the other two kits 
(Table 1). The kits from Axygen, Qiagen, Citomed and GE, respectively, 
were qualitatively superior, providing a good A
260
/A
280
 ratio (around 2.10). 
An A
260
/A
280
 ratio greater than 1.8 is usually considered an acceptable 
indicator of good quality RNA with a low level of protein contamination 14,15. 
An A
260
/A
230
 ratio higher than 1.8 is used as an indicator of extracted RNA 
with a low level of polysaccharides contamination. Quantitatively, the 
highest RNA concentration and yield was obtained by the AxyPrep 
Multisource Total RNA Miniprep kit while RNeasy® Mini kit, EasySpin kit 
and TRIzol® Plus RNA Purification System presented intermediate values, 
and Illustra RNAspin Mini RNA Isolation kit and E.Z.N.A.TM Total RNA kit II 
provided the lowest recovery values (Table 1). However, based on the 
standard deviation illustrated in Table 1, the TRIzol® Plus RNA Purification 
System -(GITC based procedure) demonstrates low RNA recovery 
reproducibility. In terms of yield, among Axygen, Qiagen and Citomed kits, 
clearly the highest and most reproducible is the AxyPrep Multisource Total 
RNA Miniprep Kit, where RNA yield is at least four fold higher than the 
other methods. E.Z.N.A.TM Total RNA Kit II, a GITC based kit, and Illustra 
RNAspin Mini RNA Isolation Kit revealed rather poor efficiencies of RNA 
extraction from this neuroblastoma cell line (Table 1). 
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Table 1- Evaluation of quality and quantity parameters of RNA samples extracted 
from SK-N-MC neuroblastoma. 
Kit A230 A260 A280 A260/A280 A260/A230
Concentration 
(ng/µL)
Elution 
volume (µL)
Yield
(µg RNA/1 x 106 cells)
AxyPrep Multisource Total 
RNA Miniprep Kit (Axygen)
5.38 6.82 3.29 2.07 1.26 272.80±28.55 100 3.94±0.41
RNeasy ® Mini Kit (Qiagen) 1.32 2.14 1.03 2.07 1.63 85.74±72.26 50 0.62±0.52
EasySpin (Citomed) 1.79 3.54 1.73 2.06 1.92 141.5±74.58 50 1.02±0.54
Illustra RNAspin Mini RNA 
Isolation Kit (GE)
0.3 0.15 0.07 2.13 0.37 5.98±7.44 100 0.09±0.11
TRIzol® Plus RNA 
Purification System 
(Invitrogen)
1.13 2.31 1.15 1.86 1.65 92.4±111.50 50 0.67±0.80
E.Z.N.A. TM Total RNA Kit II 
(Omega bio-tek)
0.30 0.55 0.29 1.89 1.52 21.87±4.14 50 0.16±0.03
 
Fig. 1- Electrophoresis of RNA samples in 2% 
(w/v) agarose gel, stained with ethidium 
bromide. L- 100 bp ladder; 1- RNA 
(untreated sample) isolated by AxyPrep 
Multisource Total RNA Miniprep kit (Axygen); 
2- RNA (treated with TurboTM DNase,Ambion) 
isolated by AxyPrep Multisource Total RNA 
Miniprep kit (Axygen); 3- RNA (DNase I 
untreated sample) isolated by RNeasy ® Mini 
kit (Qiagen); 4- RNA (treated with TurboTM
DNase, Ambion)  isolated by RNeasy ® Mini 
kit (Qiagen). 
L  1  2  3  4               
Most gene expression experiments require RNA samples free of DNA 
contamination; therefore it is imperative to minimize this contamination. 
Removal of DNA is especially critical for RT-PCR applications, since DNA 
can be amplified during the PCR portion of the experiment, resulting in 
false positive results and high background “noise” levels.  
DNase I digestion has 
consistently proven to be the 
most effective method for 
removing DNA contamination 
from RNA samples. DNase I 
treatment efficacy test was 
evaluated for the two best 
performing kits; RNA extracted 
with AxyPrep Multisource, 
Total RNA Miniprep and 
RNeasy® Mini. Kits, with or 
without DNase treatment, were 
visualized in agarose gel 
stained with ethidium bromide 
(Fig. 1). RNA isolated with 
AxyPrep Multisource Total RNA 
Miniprep kit did not show 
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visible genomic DNA contamination even without DNase treatment (Fig. 1, 
lanes 1 and 2). On the contrary, RNA extracted using the RNeasy® Mini Kit 
clearly contained DNA contamination, which disappeared promptly after 
DNase treatment. Very low levels of DNA contamination, albeit not 
detectable by agarose gel electrophoresis, may be amplified and then 
corrupt the results obtained by highly sensitive techniques such as Real-
Time PCR. In an attempt to address and evaluate this hypothesis, RNA 
samples (with and without DNase treatment) isolated by Axygen and 
Qiagen kits were directly amplified by PCR using universal 18S primers. 
The corresponding reaction products where visualized by agarose gel 
electrophoresis (Fig. 2). Although not visualized by direct RNA 
electrophoresis in Figure 1, RNA isolated using the RNeasy® Mini kit and 
treated with DNase was shown 
to contain DNA contamination 
after PCR amplification (Fig. 2, 
lanes 3 and 4). This result was 
obtained after confirming 
experimentally that the PCR 
product amplification was a 
result of the RNA concentration 
in the sample (and therefore 
the DNA contaminant amount) 
and was not due to extensive 
amplification (results not 
shown). After direct PCR 
amplification, the RNA isolated 
by AxyPrep Multisource Total 
RNA Miniprep kit (with or 
without previous DNase 
treatment) did not reveal the 
presence of any band on the 
agarose gel (Fig. 2, lanes 1 and 
 
Fig. 2- Electrophoresis of 18S PCR 
amplification products of RNA samples 
without reverse transcription, in 2% (w/v) 
agarose gel, stained with ethidium bromide.
18S PCR amplification products from RNA 
isolated by AxyPrep Multisource Total RNA 
Miniprep Kit (Axygen); 2- 18S PCR 
amplification from RNA isolated by AxyPrep 
Multisource Total RNA Miniprep Kit (Axygen) 
and treated with TurboTM DNase (Ambion); 
3- 18S PCR amplification products from RNA 
isolated by RNeasy ® Mini Kit (Qiagen); 4- 18S 
PCR amplification products from RNA 
isolated by RNeasy ® Mini Kit (Qiagen) and 
treated with TurboTM DNase (Ambion); 5-
18S PCR amplification products from water 
(negative control); L- 100 bp ladder. 
1 2   3 4   5   L 
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2). Therefore, the Axygen kit provides reliable and good quality RNA 
isolation from SK-N-MC neuroblastoma cells, thus suitable for a successful 
RNA amplification without the need of any DNase treatment. DNase 
treatment is considered disadvantageous by some investigators, as it adds 
extra salts and protein to the sample and can affect the efficiency of the 
subsequent cDNA synthesis. 
 
4. Conclusions 
Quality control is an extremely important issue when isolating RNA, 
especially when the quantity is small and the amount required is large, for 
example microarray experiments (15 µg).  In regards to quality and yield 
the AxyPrep Multisource Total RNA Miniprep kit was determined to be the 
best kit tested for the isolation of RNA from SK-N-MC cells. This kit uses 
no aggressive organic solvents and delivers RNA devoid of genomic DNA, 
without the need for DNase treatment. This is an important finding, 
especially in large scale gene-expression studies, since DNase treatment is 
time consuming and adds a substantial cost to the overall cost for such 
experiments. Furthermore, DNase treatment may lead to a loss in both 
RNA amount and mRNA integrity due to the exposure of the RNA samples 
to high temperatures during the heat inactivation step required for many 
commercial DNases. This effect extends further to include any 
downstream applications demanding compulsory genomic DNA removal. 
AxyPrep Multisource Total RNA Miniprep Kit allows the use of mild 
treatments minimizing the introduction of further contaminants to the 
extracted RNA. 
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